Loading...
Header Logo
Keywords
Last Name
Institution

JOHN S MCMURRAY

TitleAssociate Professor
InstitutionMD Anderson
DepartmentExperimental Therapeutics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction:PARADIGM-HF. Circulation. 2019 Sep 12. PMID: 31510768.
      View in: PubMed
    2. Docherty KF, McMurray JJV. PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction. Cardiovasc Res. 2019 Sep 08. PMID: 31497841.
      View in: PubMed
    3. Conrad N, Judge A, Canoy D, Tran J, Pinho-Gomes AC, Millett ERC, Salimi-Khorshidi G, Cleland JG, McMurray JJV, Rahimi K. Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86?000 Individuals. JAMA Cardiol. 2019 Sep 03. PMID: 31479100.
      View in: PubMed
    4. Coiro S, Girerd N, Sharma A, Rossignol P, Tritto I, Pitt B, Pfeffer MA, McMurray JJV, Ambrosio G, Dickstein K, Moss A, Zannad F. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. Eur J Heart Fail. 2019 Sep 02. PMID: 31476097.
      View in: PubMed
    5. Ferreira JP, Kraus S, Mitchell S, Perel P, Piñeiro D, Chioncel O, Colque R, de Boer RA, Gomez-Mesa JE, Grancelli H, Lam CSP, Martinez-Rubio A, McMurray JJV, Mebazaa A, Panjrath G, Piña IL, Sani M, Sim D, Walsh M, Yancy C, Zannad F, Sliwa K. World Heart Federation Roadmap for Heart Failure. Glob Heart. 2019 09; 14(3):197-214. PMID: 31451235.
      View in: PubMed
    6. Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019 Sep 01. PMID: 31475794.
      View in: PubMed
    7. McMurray JJV, Docherty KF. Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides? J Am Coll Cardiol. 2019 Aug 20; 74(7):902-904. PMID: 31416534.
      View in: PubMed
    8. Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Køber L, Petrie MC, McMurray JJV. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019 Aug 14. PMID: 31422062.
      View in: PubMed
    9. Tromp J, Shen L, Jhund PS, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Køber L, Swedberg K, Zile MR, Pitt B, Lam CSP, McMurray JJV. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2019 Aug 06; 74(5):601-612. PMID: 31370950.
      View in: PubMed
    10. Leong DP, McMurray JJV, Joseph PG, Yusuf S. From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5). J Am Coll Cardiol. 2019 Aug 06; 74(5):683-698. PMID: 31370961.
      View in: PubMed
    11. Lee MMY, Sattar N, McMurray JJV, Packard CJ. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence. Curr Atheroscler Rep. 2019 Jul 27; 21(10):41. PMID: 31350612.
      View in: PubMed
    12. McMurray JJV, DeMets DL, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Bengtsson O, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD. The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics. Eur J Heart Fail. 2019 Jul 15. PMID: 31309699.
      View in: PubMed
    13. Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, Wander GS, Sawhney JPS, Yap J, MacDonald MR, Ling LH, Sattar N, McMurray JJV, Richards AM, Anand I, Lam CSP. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction. Diabetes Care. 2019 Sep; 42(9):1792-1799. PMID: 31292141.
      View in: PubMed
    14. Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 Jul 10. PMID: 31302043.
      View in: PubMed
    15. Shen L, Rørth R, Cosmi D, Kristensen SL, Petrie MC, Cosmi F, Latini R, Køber L, Anand IS, Carson PE, Granger CB, Komajda M, McKelvie RS, Solomon SD, Staszewsky L, Swedberg K, Huynh T, Zile MR, Jhund PS, McMurray JJV. Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. Eur J Heart Fail. 2019 Aug; 21(8):974-984. PMID: 31271255.
      View in: PubMed
    16. Platz E, Jhund PS, Girerd N, Pivetta E, McMurray JJV, Peacock WF, Masip J, Martin-Sanchez FJ, Miró Ò, Price S, Cullen L, Maisel AS, Vrints C, Cowie MR, DiSomma S, Bueno H, Mebazaa A, Gualandro DM, Tavares M, Metra M, Coats AJS, Ruschitzka F, Seferovic PM, Mueller C. Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. Eur J Heart Fail. 2019 Jul; 21(7):844-851. PMID: 31218825.
      View in: PubMed
    17. Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV. Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. Eur J Heart Fail. 2019 Aug; 21(8):1022-1031. PMID: 31168885.
      View in: PubMed
    18. Shah SJ, Voors AA, McMurray JJV, Kitzman DW, Viethen T, Bomfim Wirtz A, Huang E, Pap AF, Solomon SD. Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2019 06 04; 321(21):2101-2112. PMID: 31162568.
      View in: PubMed
    19. Dewan P, Docherty KF, McMurray JJV. Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction. Korean Circ J. 2019 Jun; 49(6):469-484. PMID: 31172710.
      View in: PubMed
    20. Conrad N, Judge A, Canoy D, Tran J, O'Donnell J, Nazarzadeh M, Salimi-Khorshidi G, Hobbs FDR, Cleland JG, McMurray JJV, Rahimi K. Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients. PLoS Med. 2019 May; 16(5):e1002805. PMID: 31112552.
      View in: PubMed
    21. Stienen S, Ferreira JP, Vincent J, Busselen M, Li B, McMurray JJV, Pitt B, Girerd N, Rossignol P, Zannad F. Estimated Long-Term Survival With Eplerenone. J Am Coll Cardiol. 2019 May 14; 73(18):2357-2359. PMID: 31072582.
      View in: PubMed
    22. Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC Heart Fail. 2019 Jun; 7(6):457-465. PMID: 31078482.
      View in: PubMed
    23. McMurray JJV. Urinalysis: A Window to the Heart. JACC Heart Fail. 2019 May; 7(5):402-403. PMID: 31047020.
      View in: PubMed
    24. Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019 05 11; 393(10184):1937-1947. PMID: 30995972.
      View in: PubMed
    25. Ahmad FA, Petrie MC, McMurray JJV, Lang NN. Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it. Eur J Heart Fail. 2019 Jun; 21(6):699-702. PMID: 30972879.
      View in: PubMed
    26. Shen L, Jhund PS, Docherty KF, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Komajda M, McKelvie RS, Pfeffer MA, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2019 May; 7(5):418-427. PMID: 30981744.
      View in: PubMed
    27. Beggs SAS, Rørth R, Gardner RS, McMurray JJV. Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis. Heart. 2019 Sep; 105(17):1325-1334. PMID: 30962190.
      View in: PubMed
    28. Stienen S, Ferreira JP, Girerd N, Duarte K, Lamiral Z, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative. Clin Res Cardiol. 2019 Apr 05. PMID: 30953180.
      View in: PubMed
    29. Grodin JL, Liebo MJ, Butler J, Metra M, Felker GM, Hernandez AF, Voors AA, McMurray JJ, Armstrong PW, O'Connor C, Starling RC, Troughton RW, Tang WHW. Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF. J Card Fail. 2019 Apr 04. PMID: 30953792.
      View in: PubMed
    30. McMurray JJV, DeMets DL, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Bengtsson O, Ponikowski P, Sabatine MS, Sjöstrand M, Solomon SD. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail. 2019 May; 21(5):665-675. PMID: 30895697.
      View in: PubMed
    31. Verma S, McMurray JJV. The Serendipitous Story of SGLT2 Inhibitors in Heart Failure. Circulation. 2019 May 28; 139(22):2537-2541. PMID: 30882236.
      View in: PubMed
    32. Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2019 May; 21(5):1199-1208. PMID: 30672083.
      View in: PubMed
    33. Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 Mar 26; 73(11):1264-1272. PMID: 30846338.
      View in: PubMed
    34. Kristensen SL, Mogensen UM, Jhund PS, Rørth R, Anand IS, Carson PE, Desai AS, Pitt B, Pfeffer MA, Solomon SD, Zile MR, Køber L, McMurray JJV. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Circ Heart Fail. 2019 Mar; 12(3):e005766. PMID: 30871349.
      View in: PubMed
    35. Zile MR, O'Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefkowitz M, Rouleau J. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF. J Am Coll Cardiol. 2019 Feb 26; 73(7):795-806. PMID: 30784673.
      View in: PubMed
    36. Ferreira JP, Abreu P, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Vincent J, Lins K, Rossignol P, Pitt B, Zannad F. Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial. Eur J Heart Fail. 2019 03; 21(3):345-351. PMID: 30768732.
      View in: PubMed
    37. Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. Eur J Heart Fail. 2019 03; 21(3):337-341. PMID: 30741494.
      View in: PubMed
    38. Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. JACC Heart Fail. 2019 Apr; 7(4):336-346. PMID: 30738981.
      View in: PubMed
    39. Rørth R, Dewan P, Kristensen SL, Jhund PS, Petrie MC, Køber L, McMurray JJV. Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction. Clin Res Cardiol. 2019 Aug; 108(8):868-877. PMID: 30689020.
      View in: PubMed
    40. Claggett B, Pocock S, Wei LJ, Pfeffer MA, McMurray JJV, Solomon SD. Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials". Circulation. 2019 Jan 15; 139(3):422-423. PMID: 30640547.
      View in: PubMed
    41. Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women. J Am Coll Cardiol. 2019 Jan 08; 73(1):29-40. PMID: 30621948.
      View in: PubMed
    42. Loader J, Chan YK, Hawley JA, Moholdt T, McDonald CF, Jhund P, Petrie MC, McMurray JJ, Scuffham PA, Ramchand J, Burrell LM, Stewart S. Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: Analysis of 1598 patients and 4588 patient-years follow-up. Int J Cardiol. 2019 Mar 15; 279:126-132. PMID: 30638747.
      View in: PubMed
    43. Chin KL, Collier T, Pocock S, Pitt B, McMurray JJV, van Veldhuisen DJ, Swedberg K, Vincent J, Zannad F, Liew D. Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate. Clin Res Cardiol. 2019 Jul; 108(7):806-814. PMID: 30604047.
      View in: PubMed
    44. Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA. Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2019 Mar; 73(3):309-315. PMID: 30578152.
      View in: PubMed
    45. Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA. Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration. J Diabetes Res. 2018; 2018:1631263. PMID: 30648112.
      View in: PubMed
    46. Tromp J, MacDonald MR, Tay WT, Teng TK, Hung CL, Narasimhan C, Shimizu W, Ling LH, Ng TP, Yap J, McMurray JJV, Zile MR, Richards AM, Anand IS, Lam CSP. Heart Failure With Preserved Ejection Fraction in the Young. Circulation. 2018 Dec 11; 138(24):2763-2773. PMID: 30565987.
      View in: PubMed
    47. Rørth R, Jhund PS, Kristensen SL, Desai AS, Køber L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. Eur J Heart Fail. 2019 01; 21(1):40-49. PMID: 30537261.
      View in: PubMed
    48. Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. Eur J Heart Fail. 2019 May; 21(5):577-587. PMID: 30536678.
      View in: PubMed
    49. Beggs SAS, Gardner RS, McMurray JJV. Who Benefits From a Defibrillator-Balancing the Risk of Sudden Versus Non-sudden Death. Curr Heart Fail Rep. 2018 12; 15(6):376-389. PMID: 30413991.
      View in: PubMed
    50. Srivastava PK, Claggett BL, Solomon SD, McMurray JJV, Packer M, Zile MR, Desai AS, Rouleau JL, Swedberg K, Fonarow GC. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial. JAMA Cardiol. 2018 Dec 01; 3(12):1226-1231. PMID: 30484837.
      View in: PubMed
    51. Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med. 2019 01 31; 380(5):447-458. PMID: 30365356.
      View in: PubMed
    52. Beggs SAS, Jhund PS, McMurray JJV. Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA. Eur Heart J. 2018 Oct 23. PMID: 30357375.
      View in: PubMed
    53. Lee MMY, McMurray JJV, Lorenzo-Almorós A, Kristensen SL, Sattar N, Jhund PS, Petrie MC. Diabetic cardiomyopathy. Heart. 2018 Oct 18. PMID: 30337334.
      View in: PubMed
    54. Campbell RT, Petrie MC, McMurray JJV. Redefining heart failure phenotypes based on ejection fraction. Eur J Heart Fail. 2018 12; 20(12):1634-1635. PMID: 30328651.
      View in: PubMed
    55. Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Steenkamp R, Tomson CRV, Wheeler DC, Winearls CG, Ford I. Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data. Am J Nephrol. 2018; 48(4):260-268. PMID: 30304714.
      View in: PubMed
    56. Ramires FJA, Martinez F, Gómez EA, Demacq C, Gimpelewicz CR, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. ESC Heart Fail. 2018 12; 5(6):1069-1071. PMID: 30298996.
      View in: PubMed
    57. Haynes R, Judge PK, Staplin N, Herrington WG, Storey BC, Bethel A, Bowman L, Brunskill N, Cockwell P, Hill M, Kalra PA, McMurray JJV, Taal M, Wheeler DC, Landray MJ, Baigent C. Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease. Circulation. 2018 Oct 09; 138(15):1505-1514. PMID: 30002098.
      View in: PubMed
    58. Campbell RT, Petrie MC, McMurray JJV. Talking to patients with heart failure about end of life. Eur J Heart Fail. 2018 12; 20(12):1763-1765. PMID: 30295978.
      View in: PubMed
    59. Hernandez AF, Green JB, Janmohamed S, D'Agostino RB, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018 10 27; 392(10157):1519-1529. PMID: 30291013.
      View in: PubMed
    60. Rush CJ, Campbell RT, Jhund PS, Petrie MC, McMurray JJV. Association is not causation: treatment effects cannot be estimated from observational data in heart failure. Eur Heart J. 2018 Oct 01; 39(37):3417-3438. PMID: 30085087.
      View in: PubMed
    61. Januzzi JL, Packer M, Claggett B, Liu J, Shah AM, Zile MR, Pieske B, Voors A, Gandhi PU, Prescott MF, Shi V, Lefkowitz MP, McMurray JJV, Solomon SD. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure. Circ Heart Fail. 2018 10; 11(10):e005133. PMID: 30354399.
      View in: PubMed
    62. Rossello X, Ariti C, Pocock SJ, Ferreira JP, Girerd N, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials. Clin Res Cardiol. 2019 May; 108(5):477-486. PMID: 30264282.
      View in: PubMed
    63. Voors AA, Shah SJ, Bax JJ, Butler J, Gheorghiade M, Hernandez AF, Kitzman DW, McMurray JJV, Wirtz AB, Lanius V, van der Laan M, Solomon SD. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction. Eur J Heart Fail. 2018 11; 20(11):1601-1610. PMID: 30225882.
      View in: PubMed
    64. Bouabdallaoui N, Claggett B, Zile MR, McMurray JJV, O'Meara E, Packer M, Prescott MF, Swedberg K, Solomon SD, Rouleau JL. Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2018 12; 20(12):1701-1709. PMID: 30204280.
      View in: PubMed
    65. Ueland T, Gullestad L, Kou L, Aukrust P, Anand IS, Broughton MN, McMurray JJ, van Veldhuisen DJ, Warren DJ, Bolstad N. Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study. ESC Heart Fail. 2018 12; 5(6):1052-1059. PMID: 30145817.
      View in: PubMed
    66. Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia. 2018 10; 61(10):2108-2117. PMID: 30132036.
      View in: PubMed
    67. Claggett B, Pocock S, Wei LJ, Pfeffer MA, McMurray JJV, Solomon SD. Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials. Circulation. 2018 08 07; 138(6):570-577. PMID: 29588314.
      View in: PubMed
    68. Idzerda NMA, Persson F, Pena MJ, Brenner BM, Brunel P, Chaturvedi N, McMurray JJ, Parving HH, de Zeeuw D, Heerspink HJL. N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk. Diabetes Obes Metab. 2018 12; 20(12):2899-2904. PMID: 29987919.
      View in: PubMed
    69. Fudim M, Parikh KS, Dunning A, DeVore AD, Mentz RJ, Schulte PJ, Armstrong PW, Ezekowitz JA, Tang WHW, McMurray JJV, Voors AA, Drazner MH, O'Connor CM, Hernandez AF, Patel CB. Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF). Am J Cardiol. 2018 11 01; 122(9):1506-1512. PMID: 30172362.
      View in: PubMed
    70. Docherty KF, Jhund PS, McMurray JJV. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018 08 02; 379(5):491-2. PMID: 30070094.
      View in: PubMed
    71. Grodin JL, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Hernandez AF, O'Connor C, Starling RC, Tang WHW. Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. J Card Fail. 2018 Aug; 24(8):512-519. PMID: 30012361.
      View in: PubMed
    72. Ferreira JP, Duarte K, Pitt B, Dickstein K, McMurray JJV, Zannad F, Rossignol P. Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials. J Hypertens. 2018 08; 36(8):1736-1742. PMID: 29683884.
      View in: PubMed
    73. Abraityte A, Aukrust P, Kou L, Anand IS, Young J, Mcmurray JJV, van Veldhuisen DJ, Gullestad L, Ueland T. T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF. Clin Res Cardiol. 2019 Feb; 108(2):133-141. PMID: 30051179.
      View in: PubMed
    74. Kraus WE, Yates T, Tuomilehto J, Sun JL, Thomas L, McMurray JJV, Bethel MA, Holman RR. Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial. BMJ Open Diabetes Res Care. 2018; 6(1):e000523. PMID: 30073088.
      View in: PubMed
    75. Ferreira JP, Duarte K, McMurray JJV, Pitt B, van Veldhuisen DJ, Vincent J, Ahmad T, Tromp J, Rossignol P, Zannad F. Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns. Circ Heart Fail. 2018 07; 11(7):e004926. PMID: 29997240.
      View in: PubMed
    76. Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O'Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J, Yilmaz MB, Zhou J, Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 07; 11(7):e004962. PMID: 29980595.
      View in: PubMed
    77. Campbell RT, Petrie MC, Jackson CE, Jhund PS, Wright A, Gardner RS, Sonecki P, Pozzi A, McSkimming P, McConnachie A, Finlay F, Davidson P, Denvir MA, Johnson MJ, Hogg KJ, McMurray JJV. Which patients with heart failure should receive specialist palliative care? Eur J Heart Fail. 2018 09; 20(9):1338-1347. PMID: 29952090.
      View in: PubMed
    78. Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV. Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. Am Heart J. 2018 09; 203:30-38. PMID: 30015066.
      View in: PubMed
    79. McMurray JJV. Only Trials Tell the Truth About Treatment Effects. J Am Coll Cardiol. 2018 06 12; 71(23):2640-2642. PMID: 29880123.
      View in: PubMed
    80. Docherty KF, McMurray JJV. Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction. Int J Cardiol. 2019 Apr 15; 281:179-185. PMID: 29891240.
      View in: PubMed
    81. Simpson J, McMurray JJV. Prognostic Modeling in Heart Failure: Time for a Reboot. JACC Heart Fail. 2018 Jun; 6(6):463-464. PMID: 29852930.
      View in: PubMed
    82. Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD. Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2018 Jun 01; 3(6):498-505. PMID: 29617523.
      View in: PubMed
    83. Cosmi F, Staszewsky L, McMurray JJV, Latini R. Risk stratification according to insulin type: reply. Eur J Heart Fail. 2018 10; 20(10):1498. PMID: 29851246.
      View in: PubMed
    84. Tromp J, Tay WT, Ouwerkerk W, Teng TK, Yap J, MacDonald MR, Leineweber K, McMurray JJV, Zile MR, Anand IS, Richards AM, Lam CSP. Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med. 2018 05; 15(5):e1002583. PMID: 29799848.
      View in: PubMed
    85. Knight JM, Mandal P, Morlacchi P, Mak G, Li E, Madison M, Landers C, Saxton B, Felix E, Gilbert B, Sederstrom J, Varadhachary A, Singh MM, Chatterjee D, Corry DB, McMurray JS. Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040. PMID: 29739850.
      View in: PubMed
    86. Kristensen SL, Rørth R, Jhund PS, Shen L, Lee MMY, Petrie MC, Køber L, McMurray JJV. Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial. Eur J Heart Fail. 2018 11; 20(11):1549-1556. PMID: 29727039.
      View in: PubMed
    87. O'Meara E, Prescott MF, Claggett B, Rouleau JL, Chiang LM, Solomon SD, Packer M, McMurray JJV, Zile MR. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circ Heart Fail. 2018 05; 11(5):e004446. PMID: 29748349.
      View in: PubMed
    88. Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. Lancet Diabetes Endocrinol. 2018 07; 6(7):547-554. PMID: 29661699.
      View in: PubMed
    89. Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC Heart Fail. 2018 Jun; 6(6):489-498. PMID: 29655829.
      View in: PubMed
    90. Rørth R, Jhund PS, Mogensen UM, Kristensen SL, Petrie MC, Køber L, McMurray JJV. Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction. Diabetes Care. 2018 06; 41(6):1285-1291. PMID: 29626073.
      View in: PubMed
    91. Vardeny O, Claggett B, Kachadourian J, Pearson SM, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circ Heart Fail. 2018 04; 11(4):e004745. PMID: 29643067.
      View in: PubMed
    92. Tromp J, Tay WT, Ouwerkerk W, Teng TK, Yap J, MacDonald MR, Leineweber K, McMurray JJV, Zile MR, Anand IS, Richards AMR, Lam CSP. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med. 2018 03; 15(3):e1002541. PMID: 29584721.
      View in: PubMed
    93. Bethel MA, McMurray JJV. Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist. Circulation. 2018 03 20; 137(12):1218-1220. PMID: 29555706.
      View in: PubMed
    94. Mogensen UM, Køber L, McMurray JJV. Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device. J Am Coll Cardiol. 2018 03 13; 71(10):1188-1189. PMID: 29519363.
      View in: PubMed
    95. Seferovic PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA, Farmakis D, Doehner W, Lambrinou E, Lopatin Y, Piepoli MF, Theodorakis MJ, Wiggers H, Lekakis J, Mebazaa A, Mamas MA, Tschöpe C, Hoes AW, Seferovic JP, Logue J, McDonagh T, Riley JP, Milinkovic I, Polovina M, van Veldhuisen DJ, Lainscak M, Maggioni AP, Ruschitzka F, McMurray JJV. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 05; 20(5):853-872. PMID: 29520964.
      View in: PubMed
    96. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J Am Coll Cardiol. 2018 03 06; 71(9):1021-1034. PMID: 29495982.
      View in: PubMed
    97. Vaduganathan M, Claggett B, Packer M, McMurray JJV, Rouleau JL, Zile MR, Swedberg K, Solomon SD. Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure. JACC Heart Fail. 2018 Jul; 6(7):564-569. PMID: 29501807.
      View in: PubMed
    98. Abdul-Rahim AH, Shen L, Rush CJ, Jhund PS, Lees KR, McMurray JJV. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Eur J Heart Fail. 2018 07; 20(7):1139-1145. PMID: 29493058.
      View in: PubMed
    99. Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. Eur J Heart Fail. 2018 05; 20(5):888-895. PMID: 29488676.
      View in: PubMed
    100. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018 02 27; 137(9):961-972. PMID: 29483172.
      View in: PubMed
    101. Ferreira JP, Girerd N, Gregson J, Latar I, Sharma A, Pfeffer MA, McMurray JJV, Abdul-Rahim AH, Pitt B, Dickstein K, Rossignol P, Zannad F. Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. J Am Coll Cardiol. 2018 02 20; 71(7):727-735. PMID: 29447733.
      View in: PubMed
    102. Mogensen UM, Gong J, Jhund PS, Shen L, Køber L, Desai AS, Lefkowitz MP, Packer M, Rouleau JL, Solomon SD, Claggett BL, Swedberg K, Zile MR, Mueller-Velten G, McMurray JJV. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2018 04; 20(4):760-768. PMID: 29431251.
      View in: PubMed
    103. Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, Swedberg K, Yusuf S, Granger CB, Pfeffer MA, McMurray JJV, Solomon SD. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail. 2018 08; 20(8):1230-1239. PMID: 29431256.
      View in: PubMed
    104. McMurray JJV. Renin-angiotensin system inhibition-it's been a long but fruitful journey. Eur J Heart Fail. 2018 04; 20(4):687-688. PMID: 29405513.
      View in: PubMed
    105. Frikha Z, Ferreira JP, Bozec E, McMurray JJV, Pitt B, Dickstein K, Rossignol P, Zannad F, Girerd N. Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative). Am J Cardiol. 2018 05 01; 121(9):1015-1020. PMID: 29631805.
      View in: PubMed
    106. van der Meer P, Grote Beverborg N, Pfeffer MA, Olson K, Anand IS, Westenbrink BD, McMurray JJV, Swedberg K, Young JB, Solomon SD, van Veldhuisen DJ. Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations. Circ Heart Fail. 2018 02; 11(2):e004431. PMID: 29367268.
      View in: PubMed
    107. McMurray JJV. Reply: Vildagliptin and Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: One Step Forward. JACC Heart Fail. 2018 02; 6(2):178. PMID: 29413378.
      View in: PubMed
    108. Schwartz GG, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Nicholls SJ, Olsson AG, Shah PK, Tardif JC, Kittelson J. Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial. JAMA Cardiol. 2018 02 01; 3(2):164-168. PMID: 29071331.
      View in: PubMed
    109. Ferreira JP, Duarte K, Pfeffer MA, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative. Eur J Heart Fail. 2018 02; 20(2):323-331. PMID: 29314455.
      View in: PubMed
    110. Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018 Jan 01; 39(1):26-35. PMID: 29040525.
      View in: PubMed
    111. McMurray JJV, Trueman D, Hancock E, Cowie MR, Briggs A, Taylor M, Mumby-Croft J, Woodcock F, Lacey M, Haroun R, Deschaseaux C. Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. Heart. 2018 06; 104(12):1006-1013. PMID: 29269379.
      View in: PubMed
    112. Mc Causland FR, Claggett B, Pfeffer MA, Burdmann EA, Eckardt KU, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. Am J Nephrol. 2017; 46(6):488-497. PMID: 29241199.
      View in: PubMed
    113. Jorsal A, Wiggers H, McMurray JJV. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinol Metab Clin North Am. 2018 03; 47(1):117-135. PMID: 29407047.
      View in: PubMed
    114. Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, Woodward WA. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):1034-1043. PMID: 29485045.
      View in: PubMed
    115. Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Jhund PS, Petrie MC, Schou M, Gislason GH, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL. Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure. JACC Heart Fail. 2018 01; 6(1):41-48. PMID: 29226811.
      View in: PubMed
    116. Kristensen SL, Jhund PS, Lee MMY, Køber L, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, McMurray JJV. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes. Cardiovasc Drugs Ther. 2017 Dec; 31(5-6):545-549. PMID: 28948430.
      View in: PubMed
    117. Mogensen UM, Køber L, Jhund PS, Desai AS, Senni M, Kristensen SL, Dukát A, Chen CH, Ramires F, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Solomon SD, Swedberg K, Packer M, McMurray JJV. Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF. Eur J Heart Fail. 2018 03; 20(3):514-522. PMID: 29193563.
      View in: PubMed
    118. Wolsk E, Claggett B, Køber L, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. Eur J Heart Fail. 2018 03; 20(3):504-510. PMID: 29193462.
      View in: PubMed
    119. Senni M, McMurray JJV, Wachter R, McIntyre HF, Anand IS, Duino V, Sarkar A, Shi V, Charney A. Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study. Eur J Heart Fail. 2018 03; 20(3):491-500. PMID: 29164797.
      View in: PubMed
    120. Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, Rahimi K. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018 02 10; 391(10120):572-580. PMID: 29174292.
      View in: PubMed
    121. Rørth R, Fosbøl EL, Mogensen UM, Kragholm K, Numé AK, Gislason GH, Jhund PS, Petrie MC, McMurray JJV, Torp-Pedersen C, Køber L, Kristensen SL. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure. Eur J Heart Fail. 2018 02; 20(2):240-247. PMID: 29148231.
      View in: PubMed
    122. Hallow KM, Helmlinger G, Greasley PJ, McMurray JJV, Boulton DW. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes Obes Metab. 2018 03; 20(3):479-487. PMID: 29024278.
      View in: PubMed
    123. Mogensen UM, Jhund PS, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Køber L, McMurray JJV. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017 Nov 14; 70(20):2490-2500. PMID: 29145948.
      View in: PubMed
    124. Seferovic JP, Pfeffer MA, Claggett B, Desai AS, de Zeeuw D, Haffner SM, McMurray JJV, Parving HH, Solomon SD, Chaturvedi N. Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. Diabetologia. 2018 03; 61(3):581-588. PMID: 29098323.
      View in: PubMed
    125. Shen L, Jhund PS, McMurray JJV. Declining Risk of Sudden Death in Heart Failure. N Engl J Med. 2017 11 02; 377(18):1794-5. PMID: 29091558.
      View in: PubMed
    126. Solomon SD, McMurray JJV. Reply: An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition. JACC Heart Fail. 2017 11; 5(11):852-853. PMID: 29096798.
      View in: PubMed
    127. Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Circ Heart Fail. 2017 Nov; 10(11). PMID: 29141857.
      View in: PubMed
    128. Wolsk E, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber L, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Circulation. 2017 10 17; 136(16):1560-1562. PMID: 29038210.
      View in: PubMed
    129. McMurray JJV, Ponikowski P, Bolli GB, Lukashevich V, Kozlovski P, Kothny W, Lewsey JD, Krum H. Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial. JACC Heart Fail. 2018 01; 6(1):8-17. PMID: 29032139.
      View in: PubMed
    130. Beggs SAS, Jhund PS, Jackson CE, McMurray JJV, Gardner RS. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis. Heart. 2018 01; 104(2):144-150. PMID: 28986406.
      View in: PubMed
    131. Kristensen SL, Jhund PS, Mogensen UM, Rørth R, Abraham WT, Desai A, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Køber L, McMurray JJV. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Circ Heart Fail. 2017 Oct; 10(10). PMID: 29018174.
      View in: PubMed
    132. Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV. Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. Eur J Heart Fail. 2018 02; 20(2):268-277. PMID: 28960777.
      View in: PubMed
    133. Lupón J, Simpson J, McMurray JJV, de Antonio M, Vila J, Subirana I, Barallat J, Moliner P, Domingo M, Zamora E, Bayes-Genis A. Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. Eur J Heart Fail. 2018 05; 20(5):938-940. PMID: 28949101.
      View in: PubMed
    134. Kristensen SL, Mogensen UM, Tarnesby G, Gimpelewicz CR, Ali MA, Shao Q, Chiang Y, Jhund PS, Abraham WT, Dickstein K, McMurray JJV, Køber L. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial. Eur J Heart Fail. 2018 01; 20(1):136-147. PMID: 28948656.
      View in: PubMed
    135. Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 11; 5(11):877-886. PMID: 28917545.
      View in: PubMed
    136. Theodorakis MJ, Coleman RL, Feng H, Chan J, Chiasson JL, Ge J, Gerstein HC, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Tendera M, Tuomilehto J, Yang W, Hu D, Pan C, Holman RR. Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants. Am Heart J. 2018 05; 199:170-175. PMID: 29754657.
      View in: PubMed
    137. McDonald MA, Ashley EA, Fedak PWM, Hawkins N, Januzzi JL, McMurray JJV, Parikh VN, Rao V, Svystonyuk D, Teerlink JR, Virani S. Mind the Gap: Current Challenges and Future State of Heart Failure Care. Can J Cardiol. 2017 11; 33(11):1434-1449. PMID: 29111107.
      View in: PubMed
    138. Cotter G, Metra M, Davison BA, Jondeau G, Cleland JGF, Bourge RC, Milo O, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJV, Teerlink JR. Systolic blood pressure reduction during the first 24?h in acute heart failure admission: friend or foe? Eur J Heart Fail. 2018 02; 20(2):317-322. PMID: 28871621.
      View in: PubMed
    139. Platz E, Jhund PS, Claggett BL, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, McMurray JJ. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. Eur J Heart Fail. 2018 02; 20(2):295-303. PMID: 28872259.
      View in: PubMed
    140. Lewis EF, Claggett BL, McMurray JJV, Packer M, Lefkowitz MP, Rouleau JL, Liu J, Shi VC, Zile MR, Desai AS, Solomon SD, Swedberg K. Health-Related Quality of Life Outcomes in PARADIGM-HF. Circ Heart Fail. 2017 Aug; 10(8). PMID: 28784687.
      View in: PubMed
    141. Shen L, Jhund PS, Mogensen UM, Køber L, Claggett B, Rogers JK, McMurray JJV. Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits. JACC Heart Fail. 2017 08; 5(8):591-599. PMID: 28774394.
      View in: PubMed
    142. Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V, Pfeffer MA, Rossing P, Walsh M, Wanner C, Wheeler DC, Winkelmayer WC, McMurray JJV. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 08; 92(2):297-305. PMID: 28709600.
      View in: PubMed
    143. Griffin EA, Wonderling D, Ludman AJ, Al-Mohammad A, Cowie MR, Hardman SMC, McMurray JJV, Kendall J, Mitchell P, Shote A, Dworzynski K, Mant J. Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure. Value Health. 2017 09; 20(8):1025-1033. PMID: 28964433.
      View in: PubMed
    144. Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. Declining Risk of Sudden Death in Heart Failure. N Engl J Med. 2017 07 06; 377(1):41-51. PMID: 28679089.
      View in: PubMed
    145. Solomon SD, Rizkala AR, Gong J, Wang W, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Shi VC, Lefkowitz MP, McMurray JJV. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Fail. 2017 07; 5(7):471-482. PMID: 28662936.
      View in: PubMed
    146. Wong CM, Hawkins NM, Ezekowitz JA, Jhund PS, Savu A, MacDonald MR, Kristensen SL, Petrie MC, McMurray JJV, McAlister FA, Kaul P. Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis. Can J Cardiol. 2017 11; 33(11):1472-1477. PMID: 28941947.
      View in: PubMed
    147. MacDonald TM, Hawkey CJ, Ford I, McMurray JJV, Scheiman JM, Hallas J, Findlay E, Grobbee DE, Hobbs FDR, Ralston SH, Reid DM, Walters MR, Webster J, Ruschitzka F, Ritchie LD, Perez-Gutthann S, Connolly E, Greenlaw N, Wilson A, Wei L, Mackenzie IS. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). Eur Heart J. 2017 Jun 14; 38(23):1843-1850. PMID: 27705888.
      View in: PubMed
    148. Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, de Zeeuw D, Eckardt KU, McMurray JJV, Claggett B, Lewis EF, Pfeffer MA. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. Am J Kidney Dis. 2017 Oct; 70(4):522-531. PMID: 28599901.
      View in: PubMed
    149. Guimarães PO, Lopes RD, Wojdyla DM, Abdul-Rahim AH, Connolly SJ, Flaker GC, Wang J, Hanna M, Granger CB, Wallentin L, Lees KR, Alexander JH, McMurray JJV. Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. Cardiovasc Drugs Ther. 2017 Jun; 31(3):295-301. PMID: 28516318.
      View in: PubMed
    150. Platz E, Merz AA, Jhund PS, Vazir A, Campbell R, McMurray JJ. Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. Eur J Heart Fail. 2017 09; 19(9):1154-1163. PMID: 28557302.
      View in: PubMed
    151. Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017 May 29; 6(6). PMID: 28554908.
      View in: PubMed
    152. Stewart S, Keates AK, Redfern A, McMurray JJV. Seasonal variations in cardiovascular disease. Nat Rev Cardiol. 2017 Nov; 14(11):654-664. PMID: 28518176.
      View in: PubMed
    153. Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2017 05 01; 2(5):525-534. PMID: 28355434.
      View in: PubMed
    154. Packer M, McMurray JJV, Krum H, Kiowski W, Massie BM, Caspi A, Pratt CM, Petrie MC, DeMets D, Kobrin I, Roux S, Swedberg K. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials. JACC Heart Fail. 2017 05; 5(5):317-326. PMID: 28449795.
      View in: PubMed
    155. Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie MR, Maisel AS, Masip J, Miro O, McMurray JJ, Peacock WF, Martin-Sanchez FJ, Di Somma S, Bueno H, Zeymer U, Mueller C. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017 07; 14(7):427-440. PMID: 28447662.
      View in: PubMed
    156. Cannon JA, Moffitt P, Perez-Moreno AC, Walters MR, Broomfield NM, McMurray JJV, Quinn TJ. Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis. J Card Fail. 2017 Jun; 23(6):464-475. PMID: 28433667.
      View in: PubMed
    157. Böhm M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Packer M, McMurray JJV. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. Eur Heart J. 2017 04 14; 38(15):1132-1143. PMID: 28158398.
      View in: PubMed
    158. Packer M, O'Connor C, McMurray JJV, Wittes J, Abraham WT, Anker SD, Dickstein K, Filippatos G, Holcomb R, Krum H, Maggioni AP, Mebazaa A, Peacock WF, Petrie MC, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Kowarski LS, Schactman M, Holzmeister J. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964. PMID: 28402745.
      View in: PubMed
    159. Nymo SH, Aukrust P, Kjekshus J, McMurray JJ, Cleland JG, Wikstrand J, Muntendam P, Wienhues-Thelen U, Latini R, Askevold ET, Gravning J, Dahl CP, Broch K, Yndestad A, Gullestad L, Ueland T. Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. JACC Heart Fail. 2017 04; 5(4):256-264. PMID: 28359413.
      View in: PubMed
    160. Cowie MR, Filippatos GS, Alonso Garcia MLA, Anker SD, Baczynska A, Bloomfield DM, Borentain M, Bruins Slot K, Cronin M, Doevendans PA, El-Gazayerly A, Gimpelewicz C, Honarpour N, Janmohamed S, Janssen H, Kim AM, Lautsch D, Laws I, Lefkowitz M, Lopez-Sendon J, Lyon AR, Malik FI, McMurray JJV, Metra M, Figueroa Perez S, Pfeffer MA, Pocock SJ, Ponikowski P, Prasad K, Richard-Lordereau I, Roessig L, Rosano GMC, Sherman W, Stough WG, Swedberg K, Tyl B, Zannad F, Boulton C, De Graeff P. New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. Eur J Heart Fail. 2017 06; 19(6):718-727. PMID: 28345190.
      View in: PubMed
    161. Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. Lancet Diabetes Endocrinol. 2017 05; 5(5):333-340. PMID: 28330649.
      View in: PubMed
    162. Currie G, Bethel MA, Holzhauer B, Haffner SM, Holman RR, McMurray JJV. Effect of valsartan on kidney outcomes in people with impaired glucose tolerance. Diabetes Obes Metab. 2017 06; 19(6):791-799. PMID: 28093841.
      View in: PubMed
    163. Olivier A, Pitt B, Girerd N, Lamiral Z, Machu JL, McMurray JJV, Swedberg K, van Veldhuisen DJ, Collier TJ, Pocock SJ, Rossignol P, Zannad F, Pizard A. Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial. Eur J Heart Fail. 2017 09; 19(9):1186-1197. PMID: 28303624.
      View in: PubMed
    164. Mogensen UM, Køber L, Kristensen SL, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV. The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF. Am Heart J. 2017 Jun; 188:35-41. PMID: 28577679.
      View in: PubMed
    165. Cleland JGF, Teerlink JR, Davison BA, Shoaib A, Metra M, Senger S, Milo O, Cotter G, Bourge RC, Parker JD, Jondeau G, Krum H, O'Connor CM, Torre-Amione G, van Veldhuisen DJ, McMurray JJV. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail. 2017 06; 19(6):739-747. PMID: 28296139.
      View in: PubMed
    166. Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. Eur Heart J. 2017 Mar 07; 38(10):742-750. PMID: 28426886.
      View in: PubMed
    167. Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM. Updated risk factors should be used to predict development of diabetes. J Diabetes Complications. 2017 May; 31(5):859-863. PMID: 28319004.
      View in: PubMed
    168. Ho CY, McMurray JJV, Cirino AL, Colan SD, Day SM, Desai AS, Lipshultz SE, MacRae CA, Shi L, Solomon SD, Orav EJ, Braunwald E. The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. Am Heart J. 2017 May; 187:145-155. PMID: 28454798.
      View in: PubMed
    169. Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJ, Damman K. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data. Circ Heart Fail. 2017 Feb; 10(2). PMID: 28209765.
      View in: PubMed
    170. Ferreira JP, Girerd N, Duarte K, Coiro S, McMurray JJ, Dargie HJ, Pitt B, Dickstein K, Testani JM, Zannad F, Rossignol P. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative. Circ Heart Fail. 2017 Feb; 10(2). PMID: 28159825.
      View in: PubMed
    171. Docherty KF, Campbell RT, Jhund PS, Petrie MC, McMurray JJV. How robust are clinical trials in heart failure? Eur Heart J. 2017 02 01; 38(5):338-345. PMID: 27742808.
      View in: PubMed
    172. Pfeffer MA, McMurray JJ. Clinical Trials Involving Hypertension. N Engl J Med. 2017 01 19; 376(3):290. PMID: 28099831.
      View in: PubMed
    173. Harumi Higuchi Dos Santos M, Sharma A, Sun JL, Pieper K, McMurray JJ, Holman RR, Lopes RD. International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial. J Am Heart Assoc. 2017 01 13; 6(1). PMID: 28087508.
      View in: PubMed
    174. Hawkins NM, Khosla A, Virani SA, McMurray JJ, FitzGerald JM. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulm Med. 2017 01 10; 17(1):11. PMID: 28073350.
      View in: PubMed
    175. Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, Nicholls SJ, Shah PK, Tardif JC, Olsson AG, McMurray JJ, Kittelson J, Schwartz GG. Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure. J Am Heart Assoc. 2017 01 10; 6(1). PMID: 28073769.
      View in: PubMed
    176. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction). Circulation. 2017 Feb 21; 135(8):724-735. PMID: 28052977.
      View in: PubMed
    177. Burnett H, Earley A, Voors AA, Senni M, McMurray JJ, Deschaseaux C, Cope S. Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis. Circ Heart Fail. 2017 Jan; 10(1). PMID: 28087688.
      View in: PubMed
    178. Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2017 01 01; 2(1):79-85. PMID: 27842179.
      View in: PubMed
    179. Khder Y, Shi V, McMurray JJV, Lefkowitz MP. Sacubitril/Valsartan (LCZ696) in Heart Failure. Handb Exp Pharmacol. 2017; 243:133-165. PMID: 28004291.
      View in: PubMed
    180. Zile MR, Claggett BL, Prescott MF, McMurray JJ, Packer M, Rouleau JL, Swedberg K, Desai AS, Gong J, Shi VC, Solomon SD. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. J Am Coll Cardiol. 2016 Dec 06; 68(22):2425-2436. PMID: 27908347.
      View in: PubMed
    181. Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Nicholls SJ, Niesor EJ, Olsson AG, Shah PK, Tardif JC, Kittelson J, Schwartz GG. Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein. J Am Coll Cardiol. 2016 12 06; 68(22):2488-2490. PMID: 27908356.
      View in: PubMed
    182. Packer M, McMurray JJV. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure. Lancet. 2017 05 06; 389(10081):1831-1840. PMID: 27919443.
      View in: PubMed
    183. Teerlink JR, Felker GM, McMurray JJ, Solomon SD, Adams KF, Cleland JG, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcsányi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI, Honarpour N. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet. 2016 12 10; 388(10062):2895-2903. PMID: 27914656.
      View in: PubMed
    184. Nadruz W, Claggett BL, McMurray JJ, Packer M, Zile MR, Rouleau JL, Desai AS, Swedberg K, Lefkowitz M, Shi VC, Prescott MF, Solomon SD. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial). Circulation. 2016 11 29; 134(22):1785-1787. PMID: 27895026.
      View in: PubMed
    185. Rossignol P, Girerd N, Bakris G, Vardeny O, Claggett B, McMurray JJV, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Spanyers S, Vincent J, Fay R, Lamiral Z, Solomon SD, Zannad F, Pitt B. Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia. Eur J Heart Fail. 2017 06; 19(6):792-799. PMID: 27868385.
      View in: PubMed
    186. Cannon JA, Shen L, Jhund PS, Kristensen SL, Køber L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 01; 19(1):129-137. PMID: 27868321.
      View in: PubMed
    187. Packer M, Holcomb R, Abraham WT, Anker S, Dickstein K, Filippatos G, Krum H, Maggioni AP, McMurray JJV, Mebazaa A, O'Connor C, Peacock F, Ponikowski P, Ruschitzka F, van Veldhuisen DJ, Holzmeister J. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. Eur J Heart Fail. 2017 05; 19(5):673-681. PMID: 27862700.
      View in: PubMed
    188. Ferreira JP, Girerd N, Pellicori P, Duarte K, Girerd S, Pfeffer MA, McMurray JJ, Pitt B, Dickstein K, Jacobs L, Staessen JA, Butler J, Latini R, Masson S, Mebazaa A, Rocca HP, Delles C, Heymans S, Sattar N, Jukema JW, Cleland JG, Zannad F, Rossignol P. Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Med. 2016 Nov 10; 14(1):181. PMID: 27829460.
      View in: PubMed
    189. Pfeffer MA, McMurray JJ. Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension. N Engl J Med. 2016 Nov 03; 375(18):1756-1766. PMID: 27806228.
      View in: PubMed
    190. Emdin CA, Hsiao AJ, Kiran A, Conrad N, Salimi-Khorshidi G, Woodward M, Anderson SG, Mohseni H, McMurray JJ, Cleland JG, Dargie H, Hardman S, McDonagh T, Rahimi K. Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales). Am J Cardiol. 2017 Feb 01; 119(3):440-444. PMID: 27884420.
      View in: PubMed
    191. Kitai T, Grodin JL, Mentz RJ, Hernandez AF, Butler J, Metra M, McMurray JJ, Armstrong PW, Starling RC, O'Connor CM, Swedberg K, Tang WH. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. Eur J Heart Fail. 2017 02; 19(2):241-249. PMID: 27634557.
      View in: PubMed
    192. Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, McMurray JJ, Parfrey P, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2016 Dec; 68(6):873-881. PMID: 27646425.
      View in: PubMed
    193. Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circ Heart Fail. 2016 09; 9(9). PMID: 27618854.
      View in: PubMed
    194. McMurray JJ. Site Selection and Performance in Clinical Trials: The Need for Better Understanding. Circ Heart Fail. 2016 09; 9(9). PMID: 27623771.
      View in: PubMed
    195. Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, Rouleau JL, Zile MR, McMurray JJ, Solomon SD. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiol. 2016 09 01; 1(6):666-72. PMID: 27438344.
      View in: PubMed
    196. Hawkins NM, Jhund PS, Pozzi A, O'Meara E, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, Virani S, McMurray JJ. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. Eur J Heart Fail. 2016 09; 18(9):1162-71. PMID: 27594177.
      View in: PubMed
    197. McMurray JJ. The ICD in Heart Failure - Time for a Rethink? N Engl J Med. 2016 09 29; 375(13):1283-4. PMID: 27571386.
      View in: PubMed
    198. McMurray JJ, Dickstein K, Køber LV. Aliskiren, Enalapril, or Both in Heart Failure. N Engl J Med. 2016 08 18; 375(7):702. PMID: 27532843.
      View in: PubMed
    199. Emdin CA, Conrad N, Kiran A, Salimi-Khorshidi G, Woodward M, Anderson SG, Mohseni H, Dargie HJ, Hardman SM, McDonagh T, McMurray JJ, Cleland JG, Rahimi K. Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart. 2017 01 01; 103(1):55-62. PMID: 27530132.
      View in: PubMed
    200. Rørth R, Wong C, Kragholm K, Fosbøl EL, Mogensen UM, Lamberts M, Petrie MC, Jhund PS, Gerds TA, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL. Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study. Circulation. 2016 Oct 04; 134(14):999-1009. PMID: 27507406.
      View in: PubMed
    201. Desai AS, Claggett BL, Packer M, Zile MR, Rouleau JL, Swedberg K, Shi V, Lefkowitz M, Starling R, Teerlink J, McMurray JJV, Solomon SD. Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization. J Am Coll Cardiol. 2016 07 19; 68(3):241-248. PMID: 27417000.
      View in: PubMed
    202. Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJ. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. Eur J Heart Fail. 2016 12; 18(12):1508-1517. PMID: 27427441.
      View in: PubMed
    203. Martín-Sánchez FJ, Christ M, Miró Ò, Peacock WF, McMurray JJ, Bueno H, Maisel AS, Cullen L, Cowie MR, Di Somma S, Platz E, Masip J, Zeymer U, Vrints C, Price S, Mueller C. Practical approach on frail older patients attended for acute heart failure. Int J Cardiol. 2016 Nov 01; 222:62-71. PMID: 27458825.
      View in: PubMed
    204. McMurray JJ, Køber LV. End of the Road for Vagus Nerve Stimulation? J Am Coll Cardiol. 2016 07 12; 68(2):159-60. PMID: 27386768.
      View in: PubMed
    205. Arain F, Gullestad L, Nymo S, Kjekshus J, Cleland JG, Michelsen A, McMurray JJ, Wikstrand J, Aukrust P, Ueland T. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). Biomarkers. 2017 May - Jun; 22(3-4):261-267. PMID: 27325138.
      View in: PubMed
    206. Solomon SD, Claggett B, Packer M, Desai A, Zile MR, Swedberg K, Rouleau J, Shi V, Lefkowitz M, McMurray JJV. Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial. JACC Heart Fail. 2016 10; 4(10):816-822. PMID: 27395349.
      View in: PubMed
    207. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1573-1574. PMID: 27174369.
      View in: PubMed
    208. Solomon SD, Claggett B, McMurray JJ, Hernandez AF, Fonarow GC. Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. Eur J Heart Fail. 2016 Oct; 18(10):1238-1243. PMID: 27364182.
      View in: PubMed
    209. Kristensen SL, Martinez F, Jhund PS, Arango JL, Belohlávek J, Boytsov S, Cabrera W, Gomez E, Hagège AA, Huang J, Kiatchoosakun S, Kim KS, Mendoza I, Senni M, Squire IB, Vinereanu D, Wong RC, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJ. Geographic variations in the PARADIGM-HF heart failure trial. Eur Heart J. 2016 Nov 01; 37(41):3167-3174. PMID: 27354044.
      View in: PubMed
    210. Lopes RD, Pieper KS, Stevens SR, Solomon SD, McMurray JJ, Pfeffer MA, Leimberger JD, Velazquez EJ. Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction. J Am Heart Assoc. 2016 06 27; 5(6). PMID: 27353607.
      View in: PubMed
    211. Gandhi PU, Chow SL, Rector TS, Krum H, Gaggin HK, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Carson PE, Januzzi JL, Anand IS. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. J Card Fail. 2017 Jan; 23(1):20-28. PMID: 27317843.
      View in: PubMed
    212. Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, Teerlink JR, Desai AS, Lefkowitz M, Shi V, McMurray JJ, Solomon SD. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2016 Oct; 18(10):1228-1234. PMID: 27283779.
      View in: PubMed
    213. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F. Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]. Eur J Heart Fail. 2016 06; 18(6):727. PMID: 27324688.
      View in: PubMed
    214. Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, Zile M, Lefkowitz M, Shi V, Packer M. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial. Circ Heart Fail. 2016 06; 9(6). PMID: 27296397.
      View in: PubMed
    215. Jhund PS, McMurray JJ. The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan. Heart. 2016 09 01; 102(17):1342-7. PMID: 27207980.
      View in: PubMed
    216. Cannon JA, Shen L, Jhund PS, Anand IS, Komajda M, McKelvie RS, Zile MR, Carson PE, McMurray JJ. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial. Eur J Heart Fail. 2016 08; 18(8):1021-31. PMID: 27194023.
      View in: PubMed
    217. Senni M, McMurray JJ, Wachter R, McIntyre HF, Reyes A, Majercak I, Andreka P, Shehova-Yankova N, Anand I, Yilmaz MB, Gogia H, Martinez-Selles M, Fischer S, Zilahi Z, Cosmi F, Gelev V, Galve E, Gómez-Doblas JJ, Nociar J, Radomska M, Sokolova B, Volterrani M, Sarkar A, Reimund B, Chen F, Charney A. Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. Eur J Heart Fail. 2016 09; 18(9):1193-202. PMID: 27170530.
      View in: PubMed
    218. Campbell RT, Willox GP, Jhund PS, Hawkins NM, Huang F, Petrie MC, McMurray JJ. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review. Circ Heart Fail. 2016 05; 9(5). PMID: 27162229.
      View in: PubMed
    219. Sattar N, McLaren J, Kristensen SL, Preiss D, McMurray JJ. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? Diabetologia. 2016 07; 59(7):1333-1339. PMID: 27112340.
      View in: PubMed
    220. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, Anker SD, Sattar N, Petrie MC, Gardner RS, McMurray JJ. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. Eur J Heart Fail. 2016 12; 18(12):1491-1498. PMID: 27114189.
      View in: PubMed
    221. Sabe MA, Claggett B, Burdmann EA, Desai AS, Ivanovich P, Kewalramani R, Lewis EF, McMurray JJ, Olson KA, Parfrey P, Solomon SD, Pfeffer MA. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J Am Heart Assoc. 2016 04 23; 5(4). PMID: 27108247.
      View in: PubMed
    222. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davila M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational Profiles Reveal an Aberrant TGF-ß-CEA Regulated Pathway in Colon Adenomas. PLoS One. 2016; 11(4):e0153933. PMID: 27100181.
      View in: PubMed
    223. Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ. Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF). Circulation. 2016 Jun 07; 133(23):2254-62. PMID: 27143684.
      View in: PubMed
    224. McMurray JJ. Disease Management Programs in Cardiology: Extending the Success in Failure. Circulation. 2016 May 10; 133(19):1836-7. PMID: 27083508.
      View in: PubMed
    225. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. Eur J Heart Fail. 2016 05; 18(5):482-9. PMID: 27071916.
      View in: PubMed
    226. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32. PMID: 27043774.
      View in: PubMed
    227. Teerlink JR, Felker GM, McMurray JJV, Ponikowski P, Metra M, Filippatos GS, Ezekowitz JA, Dickstein K, Cleland JGF, Kim JB, Lei L, Knusel B, Wolff AA, Malik FI, Wasserman SM. Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study. J Am Coll Cardiol. 2016 Mar 29; 67(12):1444-1455. PMID: 27012405.
      View in: PubMed
    228. McMurray JJ, Køber L. Trials and the 'real world' - how different are they? Eur J Heart Fail. 2016 04; 18(4):411-3. PMID: 27019978.
      View in: PubMed
    229. Metra M, Mentz RJ, Hernandez AF, Heizer GM, Armstrong PW, Clausell N, Corbalan R, Costanzo MR, Dickstein K, Dunlap ME, Ezekowitz JA, Howlett JG, Komajda M, Krum H, Lombardi C, Fonarow GC, McMurray JJ, Nieminen MS, Swedberg K, Voors AA, Starling RC, Teerlink JR, O'Connor CM. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). Am J Cardiol. 2016 Jun 01; 117(11):1771-8. PMID: 27108685.
      View in: PubMed
    230. Whellan DJ, Stebbins A, Hernandez AF, Ezekowitz JA, McMurray JJ, Mather PJ, Hasselblad V, O'Connor CM. Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial. J Card Fail. 2016 Jun; 22(6):409-16. PMID: 26952241.
      View in: PubMed
    231. Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan Ö, Dukat A, Lefkowitz MP, McMurray JJ. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016 Mar; 9(3):e002744. PMID: 26915374.
      View in: PubMed
    232. Miró Ò, Peacock FW, McMurray JJ, Bueno H, Christ M, Maisel AS, Cullen L, Cowie MR, Di Somma S, Martín Sánchez FJ, Platz E, Masip J, Zeymer U, Vrints C, Price S, Mebazaa A, Mueller C. European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. Eur Heart J Acute Cardiovasc Care. 2017 Jun; 6(4):311-320. PMID: 26900163.
      View in: PubMed
    233. Abdul-Rahim AH, MacIsaac RL, Jhund PS, Petrie MC, Lees KR, McMurray JJ. Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. Int J Cardiol. 2016 Apr 15; 209:310-6. PMID: 26913372.
      View in: PubMed
    234. Chin KL, Collier TJ, Pitt B, McMurray JJ, Swedberg K, van Veldhuisen DJ, Pocock SJ, Vincent J, Turgonyi E, Zannad F, Krum H. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study. Eur J Heart Fail. 2016 09; 18(9):1175-81. PMID: 26833642.
      View in: PubMed
    235. Sarkar A, Balakrishnan K, Chen J, Patel V, Neelapu SS, McMurray JS, Gandhi V. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma. Oncotarget. 2016 Jan 19; 7(3):3461-76. PMID: 26658105.
      View in: PubMed
    236. Heerspink HJ, Persson F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, Desai AS, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial. Lancet Diabetes Endocrinol. 2016 Apr; 4(4):309-17. PMID: 26774608.
      View in: PubMed
    237. Zile MR, Jhund PS, Baicu CF, Claggett BL, Pieske B, Voors AA, Prescott MF, Shi V, Lefkowitz M, McMurray JJ, Solomon SD. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study. Circ Heart Fail. 2016 Jan; 9(1). PMID: 26754625.
      View in: PubMed
    238. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016 Jan; 9(1). PMID: 26754626.
      View in: PubMed
    239. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. JACC Heart Fail. 2016 Feb; 4(2):152-158. PMID: 26746371.
      View in: PubMed
    240. Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Tang WH, Armstrong PW, Ezekowitz JA, Butler J, McMurray JJ, Teerlink JR, Voors AA, Metra M, Mentz RJ, O'Connor CM, Patel CB, Hernandez AF. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail. 2016 04; 18(4):424-32. PMID: 26707029.
      View in: PubMed
    241. Cannon JA, McKean AR, Jhund PS, McMurray JJ. What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold? Open Heart. 2015; 2(1):e000283. PMID: 26719808.
      View in: PubMed
    242. Damman K, Kjekshus J, Wikstrand J, Cleland JG, Komajda M, Wedel H, Waagstein F, McMurray JJ. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Eur J Heart Fail. 2016 Mar; 18(3):328-36. PMID: 26693947.
      View in: PubMed
    243. Cotter G, Davison BA, Milo O, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Metra M, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJ, Teerlink JR. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS. J Card Fail. 2016 Oct; 22(10):815-22. PMID: 26721775.
      View in: PubMed
    244. Pocock SJ, McMurray JJV, Collier TJ. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials. J Am Coll Cardiol. 2015 Dec 15; 66(23):2648-2662. PMID: 26670066.
      View in: PubMed
    245. Hawkins NM, Virani SA, Sperrin M, Buchan IE, McMurray JJ, Krahn AD. Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges. Eur J Heart Fail. 2016 08; 18(8):977-86. PMID: 26663507.
      View in: PubMed
    246. Perez AL, Grodin JL, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Starling RC, O'Connor CM, Tang WH. Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy. Eur J Heart Fail. 2016 Mar; 18(3):290-7. PMID: 26663359.
      View in: PubMed
    247. Pocock SJ, McMurray JJ, Collier TJ. Making Sense of Statistics in Clinical Trial Reports: Part 1 of a 4-Part Series on Statistics for Clinical Trials. J Am Coll Cardiol. 2015 Dec 08; 66(22):2536-49. PMID: 26653629.
      View in: PubMed
    248. Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med. 2015 Dec 03; 373(23):2247-57. PMID: 26630143.
      View in: PubMed
    249. Claggett B, Packer M, McMurray JJ, Swedberg K, Rouleau J, Zile MR, Jhund P, Lefkowitz M, Shi V, Solomon SD. Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan. N Engl J Med. 2015 Dec 03; 373(23):2289-90. PMID: 26630151.
      View in: PubMed
    250. Tang WH, Wu Y, Grodin JL, Hsu AP, Hernandez AF, Butler J, Metra M, Voors AA, Felker GM, Troughton RW, Mills RM, McMurray JJ, Armstrong PW, O'Connor CM, Starling RC. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC Heart Fail. 2016 Jan; 4(1):68-77. PMID: 26656144.
      View in: PubMed
    251. Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.". Circulation. 2015 Dec 01; 132(22):e358. PMID: 26621661.
      View in: PubMed
    252. Knight JM, Mak G, Shaw J, Porter P, McDermott C, Roberts L, You R, Yuan X, Millien VO, Qian Y, Song LZ, Frazier V, Kim C, Kim JJ, Bond RA, Milner JD, Zhang Y, Mandal PK, Luong A, Kheradmand F, McMurray JS, Corry DB. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212. PMID: 26605551.
      View in: PubMed
    253. McMurray JJ. Improving outcomes in heart failure: a personal perspective. Eur Heart J. 2015 Dec 21; 36(48):3467-70. PMID: 26578200.
      View in: PubMed
    254. Simpson J, Jhund PS, Silva Cardoso J, Martinez F, Mosterd A, Ramires F, Rizkala AR, Senni M, Squire I, Gong J, Lefkowitz MP, Shi VC, Desai AS, Rouleau JL, Swedberg K, Zile MR, McMurray JJV, Packer M, Solomon SD. Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF. J Am Coll Cardiol. 2015 Nov 10; 66(19):2059-2071. PMID: 26541915.
      View in: PubMed
    255. Mandal PK, Morlacchi P, Knight JM, Link TM, Lee GR, Nurieva R, Singh D, Dhanik A, Kavraki L, Corry DB, Ladbury JE, McMurray JS. Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity. J Med Chem. 2015 Nov 25; 58(22):8970-84. PMID: 26506089.
      View in: PubMed
    256. Wang N, Hung CL, Shin SH, Claggett B, Skali H, Thune JJ, Køber L, Shah A, McMurray JJ, Pfeffer MA, Solomon SD. Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction. Eur Heart J. 2016 Feb 01; 37(5):466-72. PMID: 26530103.
      View in: PubMed
    257. McMurray J. EMPA-REG - the "diuretic hypothesis". J Diabetes Complications. 2016 Jan-Feb; 30(1):3-4. PMID: 26597600.
      View in: PubMed
    258. McMurray JJ, Cowie MR, Cohen AA, Briggs A, de Pouvourville G, Taylor M, Hancock E, Trueman D, Mumby-Croft J, Haroun R, Deschaseaux C. A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction. Value Health. 2015 Nov; 18(7):A394. PMID: 26532224.
      View in: PubMed
    259. Ambrosy AP, Hernandez AF, Armstrong PW, Butler J, Dunning A, Ezekowitz JA, Felker GM, Greene SJ, Kaul P, McMurray JJ, Metra M, O'Connor CM, Reed SD, Schulte PJ, Starling RC, Tang WH, Voors AA, Mentz RJ. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2016 Mar; 18(3):306-13. PMID: 26467269.
      View in: PubMed
    260. Krum H, McMurray JJ, Abraham WT, Dickstein K, Køber L, Desai AS, Solomon SD, Chiang Y, Gimpelewicz C, Reimund B, Ali MA, Tarnesby G, Massie BM. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics. Eur J Heart Fail. 2015 Oct; 17(10):1075-83. PMID: 26511146.
      View in: PubMed
    261. Bello NA, Lewis EF, Desai AS, Anand IS, Krum H, McMurray JJ, Olson K, Solomon SD, Swedberg K, van Veldhuisen DJ, Young JB, Pfeffer MA. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease. Eur J Heart Fail. 2015 Nov; 17(11):1201-7. PMID: 26423928.
      View in: PubMed
    262. Grodin JL, Perez AL, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Califf RM, Starling RC, O'Connor CM, Tang WH. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). JACC Heart Fail. 2015 Oct; 3(10):777-85. PMID: 26449997.
      View in: PubMed
    263. Simpson J, Castagno D, Doughty RN, Poppe KK, Earle N, Squire I, Richards M, Andersson B, Ezekowitz JA, Komajda M, Petrie MC, McAlister FA, Gamble GD, Whalley GA, McMurray JJ. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis. Eur J Heart Fail. 2015 Nov; 17(11):1182-91. PMID: 26358762.
      View in: PubMed
    264. Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O'Connor CM, Califf RM, Armstrong PW, Ezekowitz JA. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial. J Am Heart Assoc. 2015 Aug 24; 4(8):e002092. PMID: 26304935.
      View in: PubMed
    265. Askevold ET, Gullestad L, Nymo S, Kjekshus J, Yndestad A, Latini R, Cleland JG, McMurray JJ, Aukrust P, Ueland T. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). PLoS One. 2015; 10(8):e0133970. PMID: 26288364.
      View in: PubMed
    266. Sahoo A, Alekseev A, Tanaka K, Obertas L, Lerman B, Haymaker C, Clise-Dwyer K, McMurray JS, Nurieva R. Batf is important for IL-4 expression in T follicular helper cells. Nat Commun. 2015 Aug 17; 6:7997. PMID: 26278622.
      View in: PubMed
    267. Preiss D, Thomas LE, Wojdyla DM, Haffner SM, Gill JM, Yates T, Davies MJ, Holman RR, McMurray JJ, Califf RM, Kraus WE. Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study. BMJ Open. 2015 Aug 14; 5(8):e007901. PMID: 26275900.
      View in: PubMed
    268. Fisher M, Petrie MC, Ambery PD, Donaldson J, Ye J, McMurray JJ. Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis. Lancet Diabetes Endocrinol. 2015 Sep; 3(9):697-703. PMID: 26276240.
      View in: PubMed
    269. Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015 Sep; 17(9):925-35. PMID: 26250359.
      View in: PubMed
    270. Rush CJ, Campbell RT, Jhund PS, Connolly EC, Preiss D, Gardner RS, Petrie MC, McMurray JJ. Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials. JACC Heart Fail. 2015 Aug; 3(8):603-14. PMID: 26251086.
      View in: PubMed
    271. Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, McInnes IB, Sattar N, Petrie MC, Gardner RS, McMurray JJ. Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure. JACC Heart Fail. 2015 Aug; 3(8):618-25. PMID: 26251088.
      View in: PubMed
    272. Platz E, Jhund PS, Campbell RT, McMurray JJ. Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review. Eur J Heart Fail. 2015 Sep; 17(9):906-16. PMID: 26230356.
      View in: PubMed
    273. Jhund PS, Fu M, Bayram E, Chen CH, Negrusz-Kawecka M, Rosenthal A, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. Eur Heart J. 2015 Oct 07; 36(38):2576-84. PMID: 26231885.
      View in: PubMed
    274. Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J. 2015 Sep 21; 36(36):2463-9. PMID: 26188211.
      View in: PubMed
    275. Harinstein ME, Butler J, Greene SJ, Fonarow GC, Stockbridge NL, O'Connor CM, Pfeffer MA, Mehra MR, Solomon SD, Yancy CW, Fiuzat M, Mentz RJ, Collins SP, McMurray JJ, Vaduganathan M, Dunnmon PM, Rosano GM, Dinh W, Misselwitz F, Bonow RO, Gheorghiade M. Site selection for heart failure clinical trials in the USA. Heart Fail Rev. 2015 Jul; 20(4):375-83. PMID: 25649127.
      View in: PubMed
    276. Cannon JA, Collier TJ, Shen L, Swedberg K, Krum H, Van Veldhuisen DJ, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ. Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2015 Jul; 17(7):707-16. PMID: 26139584.
      View in: PubMed
    277. Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Vincent J, Pitt B, Zannad F. Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial. Eur Heart J. 2015 Sep 07; 36(34):2310-7. PMID: 26093641.
      View in: PubMed
    278. Badar AA, Perez-Moreno AC, Hawkins NM, Jhund PS, Brunton AP, Anand IS, McKelvie RS, Komajda M, Zile MR, Carson PE, Gardner RS, Petrie MC, McMurray JJ. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial. Circ Heart Fail. 2015 Jul; 8(4):717-24. PMID: 26067854.
      View in: PubMed
    279. McMurray J, Zhu L, McKillop I, Chen H. Ontological modeling of electronic health information exchange. J Biomed Inform. 2015 Aug; 56:169-78. PMID: 26065983.
      View in: PubMed
    280. Kristensen SL, Jhund PS, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Cleland JGF, Carson PE, McMurray JJV. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2015 Jun; 3(6):478-486. PMID: 26046842.
      View in: PubMed
    281. Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F, Gong J, Rizkala AR, Brahimi A, Claggett B, Finn PV, Hartley LH, Liu J, Lefkowitz M, Shi V, Zile MR, Solomon SD. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J. 2015 Aug 07; 36(30):1990-7. PMID: 26022006.
      View in: PubMed
    282. Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovich P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. Am Heart J. 2015 Aug; 170(2):322-9. PMID: 26299230.
      View in: PubMed
    283. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray JJ, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version. Eur Heart J. 2015 Aug 07; 36(30):1958-66. PMID: 25998514.
      View in: PubMed
    284. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray J, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail. 2015 Jun; 17(6):544-58. PMID: 25999021.
      View in: PubMed
    285. McMurray JJ. It is BEAUTIFUL we should be concerned about, not SIGNIFY: is ivabradine less effective in ischaemic compared with non-ischaemic LVSD? Eur Heart J. 2015 Aug 14; 36(31):2047-2049. PMID: 25994745.
      View in: PubMed
    286. Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015 Jun; 3(6):429-441. PMID: 25982110.
      View in: PubMed
    287. Jhund PS, Anand IS, Komajda M, Claggett BL, McKelvie RS, Zile MR, Carson PE, McMurray JJ. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study. Eur J Heart Fail. 2015 Aug; 17(8):809-17. PMID: 25921853.
      View in: PubMed
    288. Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2015 Sep; 66(3):429-40. PMID: 25935581.
      View in: PubMed
    289. Yates T, Davies MJ, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Preiss D, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Kraus WE. Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial. Diabet Med. 2015 Aug; 32(8):1090-6. PMID: 25818859.
      View in: PubMed
    290. Khazanie P, Heizer GM, Hasselblad V, Armstrong PW, Califf RM, Ezekowitz J, Dickstein K, Levy WC, McMurray JJ, Metra M, Tang WH, Teerlink JR, Voors AA, O'Connor CM, Hernandez AF, Starling R. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. Am Heart J. 2015 Aug; 170(2):290-7. PMID: 26299226.
      View in: PubMed
    291. Emdin CA, Callender T, Cao J, McMurray JJ, Rahimi K. Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure. Am J Cardiol. 2015 Jul 01; 116(1):155-61. PMID: 25937349.
      View in: PubMed
    292. Ezekowitz JA, Lewis BS, Lopes RD, Wojdyla DM, McMurray JJ, Hanna M, Atar D, Cecilia Bahit M, Keltai M, Lopez-Sendon JL, Pais P, Ruzyllo W, Wallentin L, Granger CB, Alexander JH. Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother. 2015 04; 1(2):86-94. PMID: 27533976.
      View in: PubMed
    293. Theilade S, Claggett B, Hansen TW, Skali H, Lewis EF, Solomon SD, Parving HH, Pfeffer M, McMurray JJ, Rossing P. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). J Hum Hypertens. 2016 Jan; 30(1):46-52. PMID: 25810068.
      View in: PubMed
    294. Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. Circulation. 2015 Apr 28; 131(17):1486-94; discussion 1494. PMID: 25810334.
      View in: PubMed
    295. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J. 2015 Jun 21; 36(24):1536-46. PMID: 25802390.
      View in: PubMed
    296. Campbell RT, Jackson CE, Wright A, Gardner RS, Ford I, Davidson PM, Denvir MA, Hogg KJ, Johnson MJ, Petrie MC, McMurray JJ. Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Fail. 2015 Mar; 2(1):25-36. PMID: 27347426.
      View in: PubMed
    297. Dalzell JR, Rocchiccioli JP, Weir RA, Jackson CE, Padmanabhan N, Gardner RS, Petrie MC, McMurray JJ. The Emerging Potential of the Apelin-APJ System in Heart Failure. J Card Fail. 2015 Jun; 21(6):489-98. PMID: 25795508.
      View in: PubMed
    298. Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015 Mar 04; 350:h910. PMID: 25740799.
      View in: PubMed
    299. McMurray JJ. Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances. Eur J Heart Fail. 2015 Mar; 17(3):242-7. PMID: 25756942.
      View in: PubMed
    300. Cannon JA, McMurray JJ, Quinn TJ. 'Hearts and minds': association, causation and implication of cognitive impairment in heart failure. Alzheimers Res Ther. 2015; 7(1):22. PMID: 25722749.
      View in: PubMed
    301. Feinstein MJ, Jhund P, Kang J, Ning H, Maggioni A, Wikstrand J, Kjekshus J, Tavazzi L, McMurray J, Lloyd-Jones DM. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF. Eur J Heart Fail. 2015 Apr; 17(4):434-41. PMID: 25684642.
      View in: PubMed
    302. McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Belohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J. 2015 Feb 14; 36(7):434-9. PMID: 25416329.
      View in: PubMed
    303. Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. Am Heart J. 2015 May; 169(5):631-638.e7. PMID: 25965710.
      View in: PubMed
    304. Lam CS, McEntegart M, Claggett B, Liu J, Skali H, Lewis E, Køber L, Rouleau J, Velazquez E, Califf R, McMurray JJ, Pfeffer M, Solomon S. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2015 Mar; 17(3):301-12. PMID: 25655011.
      View in: PubMed
    305. Voors AA, Gori M, Liu LC, Claggett B, Zile MR, Pieske B, McMurray JJ, Packer M, Shi V, Lefkowitz MP, Solomon SD. Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2015 May; 17(5):510-7. PMID: 25657064.
      View in: PubMed
    306. Haver VG, Mateo Leach I, Kjekshus J, Fox JC, Wedel H, Wikstrand J, de Boer RA, van Gilst WH, McMurray JJ, van Veldhuisen DJ, van der Harst P. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA). Eur J Heart Fail. 2015 Mar; 17(3):313-9. PMID: 25639660.
      View in: PubMed
    307. Badar AA, Perez-Moreno AC, Hawkins NM, Brunton AP, Jhund PS, Wong CM, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Gardner RS, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. Eur J Heart Fail. 2015 Feb; 17(2):196-204. PMID: 25678097.
      View in: PubMed
    308. Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis. Eur Heart J. 2015 May 07; 36(18):1106-14. PMID: 25616644.
      View in: PubMed
    309. DeVore AD, Hasselblad V, Mentz RJ, O'Connor CM, Armstrong PW, McMurray JJ, Ezekowitz JA, Tang WH, Starling RC, Voors AA, Califf RM, Hernandez AF. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2015 Mar; 17(3):340-6. PMID: 25619549.
      View in: PubMed
    310. Lewsey J, Ebueku O, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJ, MacIntyre K. Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. BMC Neurol. 2015 Jan 16; 15:3. PMID: 25591718.
      View in: PubMed
    311. Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Rainisio M, Kobrin I, McMurray JJ, Teerlink JR. Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. J Card Fail. 2015 Mar; 21(3):179-88. PMID: 25573829.
      View in: PubMed
    312. McMurray J, Zhu L, McKillop I, Chen H. Modelling system level health information exchange: an ontological approach. Stud Health Technol Inform. 2015; 208:269-74. PMID: 25676986.
      View in: PubMed
    313. Abdul-Rahim AH, Fulton RL, Frank B, McMurray JJ, Lees KR. Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA. Eur J Neurol. 2015 Jan; 22(1):163-9. PMID: 25370204.
      View in: PubMed
    314. Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie RS, Zile MR, Anand IS, Wikstrand J, Wedel H, Komajda M, Carson PE, Cleland JG, McMurray JJ. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail. 2015 Feb; 17(2):169-76. PMID: 25756844.
      View in: PubMed
    315. McMurray JJ, van Veldhuisen DJ. ß blockers, atrial fibrillation, and heart failure. Lancet. 2014 Dec 20; 384(9961):2181-3. PMID: 25625384.
      View in: PubMed
    316. Zhang H, Hu H, Greeley N, Jin J, Matthews AJ, Ohashi E, Caetano MS, Li HS, Wu X, Mandal PK, McMurray JS, Moghaddam SJ, Sun SC, Watowich SS. STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13. Nat Commun. 2014 Dec 15; 5:5798. PMID: 25503582.
      View in: PubMed
    317. McMurray JJ, Packer M, Solomon SD. Neprilysin inhibition for heart failure. N Engl J Med. 2014 12 11; 371(24):2336-7. PMID: 25494275.
      View in: PubMed
    318. Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2015 Feb; 61(2):368-78. PMID: 25451868.
      View in: PubMed
    319. Campbell RT, McKean AR, McMurray JJ. Acute heart failure: have we got it all wrong? Eur J Heart Fail. 2014 Dec; 16(12):1263-7. PMID: 25452162.
      View in: PubMed
    320. Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Wienhues-Thelen UH, Block D, Zaugg C, Gullestad L. Predictive value of endostatin in chronic heart failure patients with poor kidney function. Cardiology. 2015; 130(1):17-22. PMID: 25428583.
      View in: PubMed
    321. Katz M, Califf RM, Sun JL, McMurray JJ, Thomas L, Lopes RD. Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial. Am J Med. 2015 Mar; 128(3):297-302. PMID: 25447626.
      View in: PubMed
    322. Kristensen SL, Køber L, Jhund PS, Solomon SD, Kjekshus J, McKelvie RS, Zile MR, Granger CB, Wikstrand J, Komajda M, Carson PE, Pfeffer MA, Swedberg K, Wedel H, Yusuf S, McMurray JJ. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation. 2015 Jan 06; 131(1):43-53. PMID: 25406306.
      View in: PubMed
    323. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Belohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015 Jan 06; 131(1):54-61. PMID: 25403646.
      View in: PubMed
    324. Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie BM, Califf RM, O'Connor CM, Starling RC. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. JACC Heart Fail. 2015 Jan; 3(1):40-9. PMID: 25453534.
      View in: PubMed
    325. Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Block D, Zaugg C, Gullestad L. Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial. J Card Fail. 2015 Feb; 21(2):153-9. PMID: 25451704.
      View in: PubMed
    326. Das D, Bakal JA, Westerhout CM, Hernandez AF, O'Connor CM, Atar D, McMurray JJ, Armstrong PW, Ezekowitz JA. The association between meteorological events and acute heart failure: new insights from ASCEND-HF. Int J Cardiol. 2014 Dec 20; 177(3):819-24. PMID: 25465826.
      View in: PubMed
    327. Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail. 2014 Dec; 16(12):1362-71. PMID: 25371147.
      View in: PubMed
    328. van Diepen S, Podder M, Hernandez AF, Westerhout CM, Armstong PW, McMurray JJ, Eapen ZJ, Califf RM, Starling RC, O'Connor CM, Ezekowitz JA. Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF. Int J Cardiol. 2014 Dec 20; 177(3):840-6. PMID: 25465830.
      View in: PubMed
    329. Vazir A, Claggett B, Jhund P, Castagno D, Skali H, Yusuf S, Swedberg K, Granger CB, McMurray JJ, Pfeffer MA, Solomon SD. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. Eur Heart J. 2015 Mar 14; 36(11):669-75. PMID: 25368202.
      View in: PubMed
    330. Cannon JA, McMurray JJ. Gut feelings about heart failure. J Am Coll Cardiol. 2014 Nov 04; 64(18):1915-6. PMID: 25444146.
      View in: PubMed
    331. Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):895-902. PMID: 25326006.
      View in: PubMed
    332. Chin MP, Wrolstad D, Bakris GL, Chertow GM, de Zeeuw D, Goldsberry A, Linde PG, McCullough PA, McMurray JJ, Wittes J, Meyer CJ. Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. J Card Fail. 2014 Dec; 20(12):953-8. PMID: 25307295.
      View in: PubMed
    333. Adabag S, Rector TS, Anand IS, McMurray JJ, Zile M, Komajda M, McKelvie RS, Massie B, Carson PE. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2014 Nov; 16(11):1175-82. PMID: 25302657.
      View in: PubMed
    334. Shah AM, Kraigher-Krainer E, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD. Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF? J Am Coll Cardiol. 2014 Oct 07; 64(14):1535-6. PMID: 25277624.
      View in: PubMed
    335. Patel PA, Heizer G, O'Connor CM, Schulte PJ, Dickstein K, Ezekowitz JA, Armstrong PW, Hasselblad V, Mills RM, McMurray JJ, Starling RC, Tang WH, Califf RM, Hernandez AF. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Circ Heart Fail. 2014 Nov; 7(6):918-25. PMID: 25281655.
      View in: PubMed
    336. Jhund PS, Claggett BL, Voors AA, Zile MR, Packer M, Pieske BM, Kraigher-Krainer E, Shah AM, Prescott MF, Shi V, Lefkowitz M, McMurray JJ, Solomon SD. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail. 2014 Nov; 7(6):953-9. PMID: 25277997.
      View in: PubMed
    337. Badar AA, Perez-Moreno AC, Jhund PS, Wong CM, Hawkins NM, Cleland JG, van Veldhuisen DJ, Wikstrand J, Kjekshus J, Wedel H, Watkins S, Gardner RS, Petrie MC, McMurray JJ. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J. 2014 Dec 21; 35(48):3426-33. PMID: 25265976.
      View in: PubMed
    338. Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hansen A, Marmot MG, Krauss RM, Tsai M, Coresh J, Hoogeveen RC, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivimäki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61. PMID: 25262344.
      View in: PubMed
    339. Damman K, Perez AC, Anand IS, Komajda M, McKelvie RS, Zile MR, Massie B, Carson PE, McMurray JJ. Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment. J Am Coll Cardiol. 2014 Sep 16; 64(11):1106-13. PMID: 25212644.
      View in: PubMed
    340. Oluleye OW, Rector TS, Win S, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Massie B, Carson PE, Anand IS. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):960-6. PMID: 25225241.
      View in: PubMed
    341. Jessup M, Fox KA, Komajda M, McMurray JJ, Packer M. PARADIGM-HF--the experts' discussion. N Engl J Med. 2014 Sep 11; 371(11):e15. PMID: 25184757.
      View in: PubMed
    342. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, McMurray J, MacMahon S. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014 Oct; 2(5):440-6. PMID: 25194291.
      View in: PubMed
    343. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11; 371(11):993-1004. PMID: 25176015.
      View in: PubMed
    344. Damman K, Tang WH, Testani JM, McMurray JJ. Terminology and definition of changes renal function in heart failure. Eur Heart J. 2014 Dec 21; 35(48):3413-6. PMID: 25157110.
      View in: PubMed
    345. Mandal PK, Birtwistle JS, McMurray JS. Hydrodehalogenation of alkyl iodides with base-mediated hydrogenation and catalytic transfer hydrogenation: application to the asymmetric synthesis of N-protected a-methylamines. J Org Chem. 2014 Sep 05; 79(17):8422-7. PMID: 25116734.
      View in: PubMed
    346. Santos AB, Kraigher-Krainer E, Gupta DK, Claggett B, Zile MR, Pieske B, Voors AA, Lefkowitz M, Bransford T, Shi V, Packer M, McMurray JJ, Shah AM, Solomon SD. Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014 Oct; 16(10):1096-103. PMID: 25138249.
      View in: PubMed
    347. de Barros e Silva PG, Califf RM, Sun JL, McMurray JJ, Holman R, Haffner S, Thomas L, Lopes RD. Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial. Int J Cardiol. 2014 Oct 20; 176(3):1126-8. PMID: 25220176.
      View in: PubMed
    348. Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M, Shaikh M, Bennett D, Patel A, Lam CS, Sliwa K, Barretto A, Siswanto BB, Diaz A, Herpin D, Krum H, Eliasz T, Forbes A, Kiszely A, Khosla R, Petrinic T, Praveen D, Shrivastava R, Xin D, MacMahon S, McMurray J, Rahimi K. Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014 Aug; 11(8):e1001699. PMID: 25117081.
      View in: PubMed
    349. van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation. 2014 Sep 16; 130(12):958-65. PMID: 25074507.
      View in: PubMed
    350. MacDonald TM, Ford I, Nuki G, Mackenzie IS, De Caterina R, Findlay E, Hallas J, Hawkey CJ, Ralston S, Walters M, Webster J, McMurray J, Perez Ruiz F, Jennings CG. Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open. 2014 Jul 10; 4(7):e005354. PMID: 25011991.
      View in: PubMed
    351. Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, van Veldhuisen DJ, Vincent J, Pitt B, McMurray JJ. Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms. Heart. 2014 Nov; 100(21):1681-7. PMID: 24993605.
      View in: PubMed
    352. Campbell RT, McMurray JJ. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Fail Clin. 2014 Jul; 10(3):481-501. PMID: 24975911.
      View in: PubMed
    353. Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, Claggett B, Shah AM, Santos AB, Zile MR, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Solomon SD. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J. 2014 Dec 21; 35(48):3442-51. PMID: 24980489.
      View in: PubMed
    354. Preiss D, Haffner SM, Thomas LE, Sun JL, Sattar N, Yates T, J Davies M, McMurray JJ, Holman RR, Califf RM, Kraus WE. Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. Diabetes Obes Metab. 2014 Dec; 16(12):1265-8. PMID: 24861892.
      View in: PubMed
    355. Wong CM, Hawkins NM, Petrie MC, Jhund PS, Gardner RS, Ariti CA, Poppe KK, Earle N, Whalley GA, Squire IB, Doughty RN, McMurray JJ. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Eur Heart J. 2014 Oct 14; 35(39):2714-21. PMID: 24944329.
      View in: PubMed
    356. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz M, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Eur J Heart Fail. 2014 Jul; 16(7):817-25. PMID: 24828035.
      View in: PubMed
    357. Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014 Jul; 7(4):590-5. PMID: 24874200.
      View in: PubMed
    358. Böhm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, McKelvie RS, Anand IS, Massie BM, Carson PE, McMurray JJ. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). Eur J Heart Fail. 2014 Jul; 16(7):778-87. PMID: 24864045.
      View in: PubMed
    359. Schoberle TJ, Nguyen-Coleman CK, Herold J, Yang A, Weirauch M, Hughes TR, McMurray JS, May GS. A novel C2H2 transcription factor that regulates gliA expression interdependently with GliZ in Aspergillus fumigatus. PLoS Genet. 2014 May; 10(5):e1004336. PMID: 24784729.
      View in: PubMed
    360. Rogers JK, Jhund PS, Perez AC, Böhm M, Cleland JG, Gullestad L, Kjekshus J, van Veldhuisen DJ, Wikstrand J, Wedel H, McMurray JJ, Pocock SJ. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC Heart Fail. 2014 Jun; 2(3):289-97. PMID: 24952697.
      View in: PubMed
    361. Hood WB, Dans AL, Guyatt GH, Jaeschke R, McMurray JJ. Digitalis for treatment of heart failure in patients in sinus rhythm. Cochrane Database Syst Rev. 2014 Apr 28; (4):CD002901. PMID: 24771511.
      View in: PubMed
    362. McMurray JJ, O'Connor C. Lessons from the TOPCAT trial. N Engl J Med. 2014 Apr 10; 370(15):1453-4. PMID: 24716685.
      View in: PubMed
    363. Bello NA, Pfeffer MA, Skali H, McGill JB, Rossert J, Olson KA, Weinrauch L, Cooper ME, de Zeeuw D, Rossing P, McMurray JJ, Solomon SD. Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Res Care. 2014; 2(1):e000011. PMID: 25452859.
      View in: PubMed
    364. Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schröder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial. Am Heart J. 2014 Jul; 168(1):23-9.e2. PMID: 24952856.
      View in: PubMed
    365. Perez-Moreno AC, Jhund PS, Macdonald MR, Petrie MC, Cleland JG, Böhm M, van Veldhuisen DJ, Gullestad L, Wikstrand J, Kjekshus J, Lewsey JD, McMurray JJ. Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC Heart Fail. 2014 Apr; 2(2):187-97. PMID: 24720928.
      View in: PubMed
    366. Jhund PS, Claggett B, Packer M, Zile MR, Voors AA, Pieske B, Lefkowitz M, Shi V, Bransford T, McMurray JJ, Solomon SD. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. Eur J Heart Fail. 2014 Jun; 16(6):671-7. PMID: 24692284.
      View in: PubMed
    367. Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, Shah SJ, Ahmed A, Bonow RO, Cleland JG, Cody RJ, Chioncel O, Collins SP, Dunnmon P, Filippatos G, Lefkowitz MP, Marti CN, McMurray JJ, Misselwitz F, Nodari S, O'Connor C, Pfeffer MA, Pieske B, Pitt B, Rosano G, Sabbah HN, Senni M, Solomon SD, Stockbridge N, Teerlink JR, Georgiopoulou VV, Gheorghiade M. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014 Apr; 2(2):97-112. PMID: 24720916.
      View in: PubMed
    368. Preiss D, McMurray JJ, Sattar N. Treatment of severe hypertriglyceridaemia. Lancet Diabetes Endocrinol. 2014 Nov; 2(11):860. PMID: 25439459.
      View in: PubMed
    369. McMurray JJ, Gerstein HC, Holman RR, Pfeffer MA. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. Lancet Diabetes Endocrinol. 2014 Oct; 2(10):843-51. PMID: 24731668.
      View in: PubMed
    370. Sliwa K, Hilfiker-Kleiner D, Mebazaa A, Petrie MC, Maggioni AP, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Roos-Hesslink JW, Shah AJ, Seferovic PM, Elkayam U, van Spaendonck-Zwarts K, Bachelier-Walenta K, Mouquet F, Kraigher-Krainer E, Hall R, Ponikowski P, McMurray JJ, Pieske B. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail. 2014 May; 16(5):583-91. PMID: 24591060.
      View in: PubMed
    371. Baameur F, Hammitt RA, Friedman J, McMurray JS, Clark RB. Biochemical and Cellular Specificity of Peptide Inhibitors of G Protein-Coupled Receptor Kinases. Int J Pept Res Ther. 2014 Mar; 20(1):1-12. PMID: 25530741.
      View in: PubMed
    372. Gori M, Lam CS, Gupta DK, Santos AB, Cheng S, Shah AM, Claggett B, Zile MR, Kraigher-Krainer E, Pieske B, Voors AA, Packer M, Bransford T, Lefkowitz M, McMurray JJ, Solomon SD. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014 May; 16(5):535-42. PMID: 24574260.
      View in: PubMed
    373. Kalogeropoulos AP, Tang WH, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, McMurray JJ, Massie BM, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Butler J. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail. 2014 May; 20(5):319-26. PMID: 24530944.
      View in: PubMed
    374. Dalzell JR, Seed A, Berry C, Whelan CJ, Petrie MC, Padmanabhan N, Clarke A, Biggerstaff F, Hillier C, McMurray JJ. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat. Cardiovasc Ther. 2014 Feb; 32(1):13-8. PMID: 24138103.
      View in: PubMed
    375. Perez AC, Jhund PS, Stott DJ, Gullestad L, Cleland JG, van Veldhuisen DJ, Wikstrand J, Kjekshus J, McMurray JJ. Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure). JACC Heart Fail. 2014 Feb; 2(1):35-40. PMID: 24622117.
      View in: PubMed
    376. Huffman KM, Sun JL, Thomas L, Bales CW, Califf RM, Yates T, Davies MJ, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Haffner SM, Kraus WE. Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR. Metabolism. 2014 Apr; 63(4):554-61. PMID: 24559843.
      View in: PubMed
    377. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz J, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB. Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation. 2014 Jan 14; 129(2):e21-2. PMID: 24421367.
      View in: PubMed
    378. Calvo G, McMurray JJ, Granger CB, Alonso-García Á, Armstrong P, Flather M, Gómez-Outes A, Pocock S, Stockbridge N, Svensson A, Van de Werf F. Large streamlined trials in cardiovascular disease. Eur Heart J. 2014 Mar; 35(9):544-8. PMID: 24385376.
      View in: PubMed
    379. Morlacchi P, Robertson FM, Klostergaard J, McMurray JS. Targeting SH2 domains in breast cancer. Future Med Chem. 2014; 6(17):1909-26. PMID: 25495984.
      View in: PubMed
    380. Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Davies MJ, Kraus WE. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet. 2014 Mar 22; 383(9922):1059-66. PMID: 24361242.
      View in: PubMed
    381. Rogers JK, Pocock SJ, McMurray JJ, Granger CB, Michelson EL, Östergren J, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail. 2014 Jan; 16(1):33-40. PMID: 24453096.
      View in: PubMed
    382. Jackson CE, Myles RC, McMurray JJ. Microvolt T-wave alternans testing in patients recently hospitalized with decompensated heart failure. Eur J Heart Fail. 2014 Jan; 16(1):113. PMID: 24453101.
      View in: PubMed
    383. Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H, McMurray JJ. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol. 2014 Mar 11; 63(9):853-71. PMID: 24334210.
      View in: PubMed
    384. Shen L, Shah BR, Reyes EM, Thomas L, Wojdyla D, Diem P, Leiter LA, Charbonnel B, Mareev V, Horton ES, Haffner SM, Soska V, Holman R, Bethel MA, Schaper F, Sun JL, McMurray JJ, Califf RM, Krum H. Role of diuretics, ß blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ. 2013 Dec 09; 347:f6745. PMID: 24322398.
      View in: PubMed
    385. Moukarbel GV, Yu ZF, Dickstein K, Hou YR, Wittes JT, McMurray JJ, Pitt B, Zannad F, Pfeffer MA, Solomon SD. The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients. Eur J Heart Fail. 2014 Mar; 16(3):289-99. PMID: 24464979.
      View in: PubMed
    386. Damman K, McMurray JJ. Why and when should we worry about worsening renal function? Eur J Heart Fail. 2014 Jan; 16(1):4-5. PMID: 24453094.
      View in: PubMed
    387. Morlacchi P, Mandal PK, McMurray JS. Synthesis and in Vitro Evaluation of a Peptidomimetic Inhibitor Targeting the Src Homology 2 (SH2) Domain of STAT6. ACS Med Chem Lett. 2014 Jan 09; 5(1):69-72. PMID: 24900775.
      View in: PubMed
    388. Nymo SH, Hulthe J, Ueland T, McMurray J, Wikstrand J, Askevold ET, Yndestad A, Gullestad L, Aukrust P. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. Eur J Heart Fail. 2014 Jan; 16(1):68-75. PMID: 23918775.
      View in: PubMed
    389. Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail. 2014 Jan; 7(1):51-8. PMID: 24297687.
      View in: PubMed
    390. Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail. 2014 Jan; 7(1):96-103. PMID: 24284025.
      View in: PubMed
    391. Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Feb 11; 129(6):625-34. PMID: 24226808.
      View in: PubMed
    392. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013 Dec 26; 369(26):2492-503. PMID: 24206459.
      View in: PubMed
    393. Dhanik A, McMurray JS, Kavraki LE. DINC: a new AutoDock-based protocol for docking large ligands. BMC Struct Biol. 2013; 13 Suppl 1:S11. PMID: 24564952.
      View in: PubMed
    394. Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, Fisher M, Packard CJ, Sattar N. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014 Feb; 2(2):116-24. PMID: 24622715.
      View in: PubMed
    395. Lambers Heerspink HJ, Chertow GM, Akizawa T, Audhya P, Bakris GL, Goldsberry A, Krauth M, Linde P, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Christ-Schmidt H, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, de Zeeuw D. Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. Nephrol Dial Transplant. 2013 Nov; 28(11):2841-50. PMID: 24169612.
      View in: PubMed
    396. Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). 2014 Aug; 38(8):1110-4. PMID: 24173404.
      View in: PubMed
    397. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014 Feb 11; 63(5):447-56. PMID: 24184245.
      View in: PubMed
    398. Santos AB, Kraigher-Krainer E, Bello N, Claggett B, Zile MR, Pieske B, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Shah AM, Solomon SD. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. Eur Heart J. 2014 Jan; 35(1):42-7. PMID: 24164863.
      View in: PubMed
    399. Wikstrand J, Wedel H, Castagno D, McMurray JJ. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF. J Intern Med. 2014 Feb; 275(2):134-43. PMID: 24118421.
      View in: PubMed
    400. Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJ, Pais P, Pouleur H, Steg PG, Verheugt FW, Wojdyla DM, Granger CB, Wallentin L. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2014 Jan; 35(4):224-32. PMID: 24144788.
      View in: PubMed
    401. Latini R, Staszewsky L, Sun JL, Bethel MA, Disertori M, Haffner SM, Holman RR, Chang F, Giles TD, Maggioni AP, Rutten GE, Standl E, Thomas L, Tognoni G, Califf RM, McMurray JJ. Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Am Heart J. 2013 Nov; 166(5):935-40.e1. PMID: 24176451.
      View in: PubMed
    402. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. J Am Coll Cardiol. 2014 Jan 7-14; 63(1):52-61. PMID: 24055845.
      View in: PubMed
    403. Yancy CW, McMurray JJ. ECG--still the best for selecting patients for CRT. N Engl J Med. 2013 Oct 10; 369(15):1463-4. PMID: 23998715.
      View in: PubMed
    404. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ. Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE. Eur J Heart Fail. 2013 Nov; 15(11):1205-7. PMID: 23989432.
      View in: PubMed
    405. Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One. 2013; 8(8):e71508. PMID: 24013655.
      View in: PubMed
    406. McMurray JJ, Jhund PS. Cardiovascular risks with azithromycin. N Engl J Med. 2013 08 08; 369(6):579-80. PMID: 23924017.
      View in: PubMed
    407. Swedberg K, McMurray JJ, Young JB. Darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 08 01; 369(5):488-9. PMID: 23902504.
      View in: PubMed
    408. Preiss D, Giles TD, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Mazzone T, Rutten GE, Tognoni G, Chiang FT, McMurray JJ, Califf RM. Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Stroke. 2013 Sep; 44(9):2590-3. PMID: 23899915.
      View in: PubMed
    409. Collier TJ, Pocock SJ, McMurray JJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B. The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial. Eur Heart J. 2013 Sep; 34(36):2823-9. PMID: 23864130.
      View in: PubMed
    410. Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J Am Coll Cardiol. 2013 Nov 12; 62(20):1845-54. PMID: 23850914.
      View in: PubMed
    411. Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, McMurray JJ. Response to Letter Regarding Article, “Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction”. Circ Heart Fail. 2013 Jul; 6(4):e58. PMID: 24027781.
      View in: PubMed
    412. Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure). J Am Coll Cardiol. 2013 Oct 22; 62(17):1585-93. PMID: 23810881.
      View in: PubMed
    413. Poppe KK, Squire IB, Whalley GA, Køber L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail. 2013 Nov; 15(11):1220-7. PMID: 23803952.
      View in: PubMed
    414. Lopes RD, Dickerson S, Hafley G, Burns S, Tourt-Uhlig S, White J, Newby LK, Komajda M, McMurray J, Bigelow R, Home PD, Mahaffey KW. Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct. Am Heart J. 2013 Aug; 166(2):208-216.e28. PMID: 23895802.
      View in: PubMed
    415. Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013 Oct; 15(10):1082-94. PMID: 23787718.
      View in: PubMed
    416. Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, Ponikowski P, McMurray J, Maggioni A, Ruschitzka F, van Veldhuisen DJ, Coats A, Piepoli M, McDonagh T, Riley J, Hoes A, Pieske B, Dobric M, Papp Z, Mebazaa A, Parissis J, Ben Gal T, Vinereanu D, Brito D, Altenberger J, Gatzov P, Milinkovic I, Hradec J, Trochu JN, Amir O, Moura B, Lainscak M, Comin J, Wikström G, Anker S. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail. 2013 Sep; 15(9):947-59. PMID: 23787723.
      View in: PubMed
    417. Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail. 2013 Jul; 6(4):727-32. PMID: 23770519.
      View in: PubMed
    418. Mahaffey KW, Hafley G, Dickerson S, Burns S, Tourt-Uhlig S, White J, Newby LK, Komajda M, McMurray J, Bigelow R, Home PD, Lopes RD. Results of a reevaluation of cardiovascular outcomes in the RECORD trial. Am Heart J. 2013 Aug; 166(2):240-249.e1. PMID: 23895806.
      View in: PubMed
    419. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):e240-327. PMID: 23741058.
      View in: PubMed
    420. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15; 62(16):e147-239. PMID: 23747642.
      View in: PubMed
    421. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):1810-52. PMID: 23741057.
      View in: PubMed
    422. Dahl CP, Aukrust P, Nymo SH, Kjekshus J, Cleland JG, McMurray JJ, Wikstrand J, Gullestad L, Ueland T. Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure. Int J Cardiol. 2013 Oct 09; 168(4):4427-9. PMID: 23714594.
      View in: PubMed
    423. Jackson CE, Myles RC, Tsorlalis IK, Dalzell JR, Rocchiccioli JP, Rodgers JR, Spooner RJ, Greenlaw N, Ford I, Gardner RS, Cobbe SM, Petrie MC, McMurray JJ. Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. Eur J Heart Fail. 2013 Nov; 15(11):1253-61. PMID: 23703105.
      View in: PubMed
    424. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013 Jun 04; 127(22):2166-76. PMID: 23640971.
      View in: PubMed
    425. Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study. Circ Heart Fail. 2013 Jul; 6(4):711-8. PMID: 23625945.
      View in: PubMed
    426. Campbell RT, McMurray JJ. Reply: To PMID 23141494. J Am Coll Cardiol. 2013 Apr 23; 61(16):1749. PMID: 23500252.
      View in: PubMed
    427. Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM. A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol. 2013 Jul 15; 112(2):231-7. PMID: 23608615.
      View in: PubMed
    428. McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail. 2013 May; 6(3):451-60. PMID: 23575255.
      View in: PubMed
    429. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2013 Sep; 15(9):1062-73. PMID: 23563576.
      View in: PubMed
    430. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013 Jun 04; 61(22):2274-84. PMID: 23563134.
      View in: PubMed
    431. Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, McMurray JJ. Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ Heart Fail. 2013 May; 6(3):492-8. PMID: 23505301.
      View in: PubMed
    432. Pfeffer MA, Brenner BM, McMurray JJ. Aliskiren in type 2 diabetes and cardiorenal end points. N Engl J Med. 2013 03 14; 368(11):1065-6. PMID: 23484839.
      View in: PubMed
    433. Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials. Eur J Heart Fail. 2013 Jul; 15(7):747-55. PMID: 23487539.
      View in: PubMed
    434. Perez AC, Jhund P, Preiss D, Kjekshus J, McMurray JJ. Effect of rosuvastatin on fatigue in patients with heart failure. J Am Coll Cardiol. 2013 Mar 12; 61(10):1121-2. PMID: 23473415.
      View in: PubMed
    435. Bourge RC, Fleg JL, Fonarow GC, Cleland JG, McMurray JJ, van Veldhuisen DJ, Gheorghiade M, Patel K, Aban IB, Allman RM, White-Williams C, White M, Filippatos GS, Anker SD, Ahmed A. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med. 2013 Aug; 126(8):701-8. PMID: 23490060.
      View in: PubMed
    436. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 Mar 28; 368(13):1210-9. PMID: 23473338.
      View in: PubMed
    437. Mandal PK, Ren Z, Chen X, Kaluarachchi K, Liao WS, McMurray JS. Structure-Activity Studies of Phosphopeptidomimetic Prodrugs Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3 (Stat3). Int J Pept Res Ther. 2013 Mar; 19(1):3-12. PMID: 24707243.
      View in: PubMed
    438. de Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris GL, Chin M, Krauth M, Lambers Heerspink HJ, Meyer CJ, McMurray JJ, Parving HH, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM. Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). Am J Nephrol. 2013; 37(3):212-22. PMID: 23467003.
      View in: PubMed
    439. Wong YW, Thomas L, Sun JL, McMurray JJ, Krum H, Hernandez AF, Rutten GE, Leiter LA, Standl E, Haffner SM, Mazzone T, Martinez FA, Tognoni G, Giles T, Califf RM. Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study. Circ Heart Fail. 2013 Mar; 6(2):203-10. PMID: 23388113.
      View in: PubMed
    440. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013 Sep 01; 167(5):1807-24. PMID: 23380698.
      View in: PubMed
    441. Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F. Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. Eur Heart J. 2013 Jun; 34(22):1621-9. PMID: 23382466.
      View in: PubMed
    442. Rienstra M, Damman K, Mulder BA, Van Gelder IC, McMurray JJ, Van Veldhuisen DJ. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis. JACC Heart Fail. 2013 Feb; 1(1):21-8. PMID: 24621795.
      View in: PubMed
    443. MacDonald MR, McMurray JJ, Petrie MC. Letter by MacDonald et al regarding article, "Catheter ablation of atrial fibrillation". Circulation. 2013 Jan 29; 127(4):e433. PMID: 23357669.
      View in: PubMed
    444. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-McKay PA. Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med. 2013 Feb 11; 210(2):321-37. PMID: 23359069.
      View in: PubMed
    445. Gheorghiade M, Patel K, Filippatos G, Anker SD, van Veldhuisen DJ, Cleland JG, Metra M, Aban IB, Greene SJ, Adams KF, McMurray JJ, Ahmed A. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail. 2013 May; 15(5):551-9. PMID: 23355060.
      View in: PubMed
    446. McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail. 2013 Mar; 15(3):334-41. PMID: 23329651.
      View in: PubMed
    447. Dhanik A, McMurray JS, Kavraki LE. Binding modes of peptidomimetics designed to inhibit STAT3. PLoS One. 2012; 7(12):e51603. PMID: 23251591.
      View in: PubMed
    448. Askevold ET, Nymo S, Ueland T, Gravning J, Wergeland R, Kjekshus J, Yndestad A, Cleland JG, McMurray JJ, Aukrust P, Gullestad L. Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Circ Heart Fail. 2013 Jan; 6(1):91-8. PMID: 23230311.
      View in: PubMed
    449. Preiss D, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Leiter LA, Mazzone T, Rutten GE, Tognoni G, Martinez FA, Chiang FT, Califf RM, McMurray JJ. Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open. 2012; 2(6). PMID: 23204139.
      View in: PubMed
    450. van Veldhuisen DJ, McMurray JJ. Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel? Eur J Heart Fail. 2013 Jan; 15(1):5-8. PMID: 23193144.
      View in: PubMed
    451. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, Hou YR, Pitt B, Dargie HJ, Ford I, Kjekshus J, Zannad F, Dickstein K, McMurray JJ. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol. 2013 Sep 30; 168(2):1094-101. PMID: 23194780.
      View in: PubMed
    452. Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P. Iron status in patients with chronic heart failure. Eur Heart J. 2013 Mar; 34(11):827-34. PMID: 23178646.
      View in: PubMed
    453. Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis. 2013 Feb; 61(2):238-46. PMID: 23159232.
      View in: PubMed
    454. Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol. 2012 Dec 11; 60(23):2349-56. PMID: 23141494.
      View in: PubMed
    455. Pettit SJ, Jhund PS, Hawkins NM, Gardner RS, Haj-Yahia S, McMurray JJ, Petrie MC. How small is too small? A systematic review of center volume and outcome after cardiac transplantation. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):783-90. PMID: 23132331.
      View in: PubMed
    456. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29; 367(22):2089-99. PMID: 23126252.
      View in: PubMed
    457. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012 Dec 06; 367(23):2204-13. PMID: 23121378.
      View in: PubMed
    458. Mentz RJ, Bakris GL, Waeber B, McMurray JJ, Gheorghiade M, Ruilope LM, Maggioni AP, Swedberg K, Piña IL, Fiuzat M, O'Connor CM, Zannad F, Pitt B. The past, present and future of renin-angiotensin aldosterone system inhibition. Int J Cardiol. 2013 Sep 01; 167(5):1677-87. PMID: 23121914.
      View in: PubMed
    459. Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Aukrust P. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Am Heart J. 2012 Dec; 164(6):878-83. PMID: 23194488.
      View in: PubMed
    460. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013 May; 34(19):1404-13. PMID: 23095984.
      View in: PubMed
    461. McMurray JJ, Haffner SM, Califf RM, Holman RR. Prediabetes and the risk of diabetes. Lancet. 2012 Oct 06; 380(9849):1225-6; author reply 1226. PMID: 23040850.
      View in: PubMed
    462. Rogers JK, McMurray JJ, Pocock SJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation. 2012 Nov 06; 126(19):2317-23. PMID: 23042980.
      View in: PubMed
    463. Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet. 2012 Nov 17; 380(9855):1749-58. PMID: 23036896.
      View in: PubMed
    464. McMurray JS, Mandal PK, Liao WS, Klostergaard J, Robertson FM. The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain. JAKSTAT. 2012 Oct 01; 1(4):263-347. PMID: 24058783.
      View in: PubMed
    465. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik K, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zeiher A. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012]. Turk Kardiyol Dern Ars. 2012 Oct; 40 Suppl 3:77-137. PMID: 27305718.
      View in: PubMed
    466. Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, Robertson M, Wikstrand J, McMurray J. Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med. 2012; 9(9):e1001310. PMID: 23028261.
      View in: PubMed
    467. Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, Struthers AD, Voors AA, Ruilope LM, Bakris GL, O'Connor CM, Gheorghiade M, Mentz RJ, Cohen-Solal A, Maggioni AP, Beygui F, Filippatos GS, Massy ZA, Pathak A, Piña IL, Sabbah HN, Sica DA, Tavazzi L, Pitt B. Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J. 2012 Nov; 33(22):2782-95. PMID: 22942339.
      View in: PubMed
    468. Anker SD, McMurray JJ. Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials? Eur Heart J. 2012 Nov; 33(22):2764-5. PMID: 22927554.
      View in: PubMed
    469. Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012 Oct 20; 380(9851):1387-95. PMID: 22932717.
      View in: PubMed
    470. Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012 Aug 22; 308(8):804-11. PMID: 22910758.
      View in: PubMed
    471. Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie BM, Kitzman DW. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2012 Sep 01; 5(5):571-8. PMID: 22887722.
      View in: PubMed
    472. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012 Aug; 14(8):803-69. PMID: 22828712.
      View in: PubMed
    473. McMurray JJ, Califf RM, Bethel AM, Haffner SM, Holman RR. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study. J Clin Hypertens (Greenwich). 2012 Oct; 14(10):731. PMID: 23031154.
      View in: PubMed
    474. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail. 2012 Nov; 14(11):1257-64. PMID: 22764184.
      View in: PubMed
    475. Weir RA, Miller AM, Petrie CJ, Clements S, Steedman T, Dargie HJ, Squire IB, Ng LL, McInnes IB, McMurray JJ. Interleukin-21--a biomarker of importance in predicting myocardial function following acute infarction? Cytokine. 2012 Oct; 60(1):220-5. PMID: 22748465.
      View in: PubMed
    476. Inglis SC, Lewsey JD, Lowe GD, Jhund P, Gillies M, Stewart S, Capewell S, Macintyre K, McMurray JJ. Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: impact on general and mental health, quality of life and five-year mortality. Int J Cardiol. 2013 Sep 01; 167(5):2149-55. PMID: 22704868.
      View in: PubMed
    477. Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2012 Aug; 14(8):909-15. PMID: 22611047.
      View in: PubMed
    478. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul; 33(14):1787-847. PMID: 22611136.
      View in: PubMed
    479. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012 May 15; 59(20):1785-95. PMID: 22575317.
      View in: PubMed
    480. Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H, Vincent J, Pitt B. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol. 2012 May 01; 59(18):1598-603. PMID: 22538330.
      View in: PubMed
    481. Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J. 2012 Sep; 33(18):2290-6. PMID: 22513778.
      View in: PubMed
    482. Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, Bakal JA, Califf RM, McMurray JJ, Armstrong PW. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol. 2012 Apr 17; 59(16):1441-8. PMID: 22497823.
      View in: PubMed
    483. McMurray JJ, Abraham WT, Dickstein K, Køber L, Massie BM, Krum H. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail. 2012 Apr; 14(4):341-3. PMID: 22431404.
      View in: PubMed
    484. Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, de Voogd HJ, McMurray J, Davenport AP. The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci. 2012 Oct 15; 91(13-14):743-8. PMID: 22480515.
      View in: PubMed
    485. MacDonald MR, McMurray JJ, Petrie MC. Catheter ablation for atrial fibrillation. N Engl J Med. 2012 03 15; 366(11):1060; author reply 1060-1. PMID: 22417267.
      View in: PubMed
    486. Zannad F, Stough WG, Pocock SJ, Sleight P, Cushman WC, Cleland JG, McMurray JJ, Lonn E, Geller NL, Wedel H, Abadie E, Alonso-Garcia A, Pitt B. Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? Eur Heart J. 2012 May; 33(9):1049-57. PMID: 22422830.
      View in: PubMed
    487. Welsh P, McMurray JJ. B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway? Diabetologia. 2012 May; 55(5):1240-3. PMID: 22398647.
      View in: PubMed
    488. Martínez-Sellés M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Køber L, Berry C, Squire I. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012 May; 14(5):473-9. PMID: 22402958.
      View in: PubMed
    489. Castagno D, Petrie MC, Claggett B, McMurray J. Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. Eur Heart J. 2012 May; 33(9):1137-41. PMID: 22408030.
      View in: PubMed
    490. Zannad F, Gattis Stough W, McMurray JJ, Remme WJ, Pitt B, Borer JS, Geller NL, Pocock SJ. When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail. 2012 Mar 01; 5(2):294-302. PMID: 22438522.
      View in: PubMed
    491. Jackson CE, Myles RC, Cobbe SM, Petrie MC, McMurray JJ. Microvolt T-wave alternans testing has no role at present in guiding therapy for patients at high risk of ventricular arrhythmias. J Am Coll Cardiol. 2012 Feb 28; 59(9):856. PMID: 22361408.
      View in: PubMed
    492. Jackson CE, Myles RC, Tsorlalis IK, Dalzell JR, Spooner RJ, Rodgers JR, Bezlyak V, Greenlaw N, Ford I, Cobbe SM, Petrie MC, McMurray JJ. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. Eur J Heart Fail. 2012 Apr; 14(4):377-86. PMID: 22334727.
      View in: PubMed
    493. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Nicolaides M, Richard A, Xiang Z, Armbrecht J, Pfeffer MA. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). J Renin Angiotensin Aldosterone Syst. 2012 Sep; 13(3):387-93. PMID: 22333485.
      View in: PubMed
    494. Meris A, Amigoni M, Verma A, Thune JJ, Køber L, Velazquez E, McMurray JJ, Pfeffer MA, Califf R, Levine RA, Solomon SD. Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction. J Am Soc Echocardiogr. 2012 May; 25(5):535-42. PMID: 22305962.
      View in: PubMed
    495. Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. Eur J Heart Fail. 2012 Mar; 14(3):268-77. PMID: 22302661.
      View in: PubMed
    496. Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012 Feb; 14(2):138-46. PMID: 22253454.
      View in: PubMed
    497. McMurray JJ. Heart failure in 2011: Heart failure therapy--technology to the fore. Nat Rev Cardiol. 2012 Jan 25; 9(2):73-4. PMID: 22273714.
      View in: PubMed
    498. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, Komajda M, Kuskowski M, Massie BM. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial. Circ Heart Fail. 2012 Mar 01; 5(2):217-25. PMID: 22267751.
      View in: PubMed
    499. Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*. J Intern Med. 2012 May; 271(5):436-43. PMID: 22211640.
      View in: PubMed
    500. Auzenne EJ, Klostergaard J, Mandal PK, Liao WS, Lu Z, Gao F, Bast RC, Robertson FM, McMurray JS. A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis. J Exp Ther Oncol. 2012; 10(2):155-62. PMID: 23350355.
      View in: PubMed
    501. Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJ, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 2011 Dec 20; 124(25):2903-8. PMID: 22104547.
      View in: PubMed
    502. Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012 Feb; 33(3):314-24. PMID: 22083873.
      View in: PubMed
    503. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011 Dec 06; 124(23):2491-501. PMID: 22064591.
      View in: PubMed
    504. McMurray JJ, Smith GL. Calcium handling in the failing heart and SUMO--weighing the evidence. N Engl J Med. 2011 Nov 03; 365(18):1738-9. PMID: 22047567.
      View in: PubMed
    505. Ariti CA, Cleland JG, Pocock SJ, Pfeffer MA, Swedberg K, Granger CB, McMurray JJ, Michelson EL, Ostergren J, Yusuf S. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J. 2011 Nov; 162(5):900-6. PMID: 22093207.
      View in: PubMed
    506. Castagno D, Baird-Gunning J, Jhund PS, Biondi-Zoccai G, MacDonald MR, Petrie MC, Gaita F, McMurray JJ. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J. 2011 Nov; 162(5):938-948.e2. PMID: 22093212.
      View in: PubMed
    507. McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, Parfrey P, Parving HH, Toto RM, Solomon SD, Pfeffer MA. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). Am Heart J. 2011 Oct; 162(4):748-755.e3. PMID: 21982669.
      View in: PubMed
    508. Shah AM, Shin SH, Takeuchi M, Skali H, Desai AS, Køber L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, Keefe D, McMurray JJ, Pfeffer MA, Solomon SD. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur J Heart Fail. 2012 Feb; 14(2):185-92. PMID: 21965526.
      View in: PubMed
    509. Weir RA, Tsorlalis IK, Steedman T, Dargie HJ, Fraser R, McMurray JJ, Connell JM. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. Eur J Heart Fail. 2011 Dec; 13(12):1305-13. PMID: 21940729.
      View in: PubMed
    510. Shah AM, Hung CL, Shin SH, Skali H, Verma A, Ghali JK, Køber L, Velazquez EJ, Rouleau JL, McMurray JJ, Pfeffer MA, Solomon SD. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. Am Heart J. 2011 Oct; 162(4):685-91. PMID: 21982661.
      View in: PubMed
    511. Milo-Cotter O, Cotter-Davison B, Lombardi C, Sun H, Bettari L, Bugatti S, Rund M, Metra M, Kaluski E, Kobrin I, Frey A, Rainisio M, McMurray JJ, Teerlink JR, Cotter-Davison G. Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology. 2011; 119(2):96-105. PMID: 21912122.
      View in: PubMed
    512. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15; 365(11):981-92. PMID: 21870978.
      View in: PubMed
    513. Mandal PK, Freiter EM, Bagsby AL, Robertson FM, McMurray JS. Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. Bioorg Med Chem Lett. 2011 Oct 15; 21(20):6071-3. PMID: 21903394.
      View in: PubMed
    514. Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011 Nov; 58(5):717-28. PMID: 21820220.
      View in: PubMed
    515. McMurray JJ. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. Eur J Heart Fail. 2011 Sep; 13(9):929-36. PMID: 21816763.
      View in: PubMed
    516. Sidik NP, Solomon SD, Latini R, Maggioni AP, Wright M, Gimpelewicz CR, Pitt B, McMurray JJ. Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trial. Cardiovasc Drugs Ther. 2011 Aug; 25(4):315-21. PMID: 21779784.
      View in: PubMed
    517. Lowrie R, Mair FS, Greenlaw N, Forsyth P, McConnachie A, Richardson J, Khan N, Morrison D, Messow CM, Rae B, McMurray JJ. The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. Eur J Heart Fail. 2011 Aug; 13(8):917-24. PMID: 21791543.
      View in: PubMed
    518. McMurray J, Ponikowski P. Heart failure not enough pump iron? J Am Coll Cardiol. 2011 Jul 26; 58(5):481-2. PMID: 21777744.
      View in: PubMed
    519. Krum H, Elsik M, Schneider HG, Ptaszynska A, Black M, Carson PE, Komajda M, Massie BM, McKelvie RS, McMurray JJ, Zile MR, Anand IS. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail. 2011 Sep; 4(5):561-8. PMID: 21750125.
      View in: PubMed
    520. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 07; 365(1):32-43. PMID: 21732835.
      View in: PubMed
    521. Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie BM, Carson PE. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail. 2011 Sep; 4(5):569-77. PMID: 21715583.
      View in: PubMed
    522. Hawkins NM, Petrie MC, Macdonald MR, Jhund PS, Fabbri LM, Wikstrand J, McMurray JJ. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists. J Am Coll Cardiol. 2011 May 24; 57(21):2127-38. PMID: 21596228.
      View in: PubMed
    523. Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention. Circulation. 2011 Jun 14; 123(23):2674-80. PMID: 21606398.
      View in: PubMed
    524. MacDonald MR, Petrie MC, Home PD, Komajda M, Jones NP, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, Curtis PS, McMurray JJ. Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care. 2011 Jun; 34(6):1394-6. PMID: 21562320.
      View in: PubMed
    525. Verma A, Pfeffer MA, Skali H, Rouleau J, Maggioni A, McMurray JJ, Califf RM, Velazquez EJ, Solomon SD. Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction. Am Heart J. 2011 Jun; 161(6):1156-62. PMID: 21641363.
      View in: PubMed
    526. Mandal PK, Gao F, Lu Z, Ren Z, Ramesh R, Birtwistle JS, Kaluarachchi KK, Chen X, Bast RC, Liao WS, McMurray JS. Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3. J Med Chem. 2011 May 26; 54(10):3549-63. PMID: 21486047.
      View in: PubMed
    527. Pitt B, Latini R, Maggioni AP, Solomon SD, Smith BA, Wright M, Prescott MF, McMurray JJ. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study. Eur J Heart Fail. 2011 Jul; 13(7):755-64. PMID: 21467028.
      View in: PubMed
    528. Piepoli MF, Conraads V, Corrà U, Dickstein K, Francis DP, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid JP, Anker SD, Solal AC, Filippatos GS, Hoes AW, Gielen S, Giannuzzi P, Ponikowski PP. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011 Apr; 13(4):347-57. PMID: 21436360.
      View in: PubMed
    529. Jackson CE, MacDonald MR, Petrie MC, Solomon SD, Pitt B, Latini R, Maggioni AP, Smith BA, Prescott MF, Lewsey J, McMurray JJ. Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. Eur J Heart Fail. 2011 Jul; 13(7):746-54. PMID: 21459891.
      View in: PubMed
    530. Macpherson KJ, Lewsey JD, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJ, MacIntyre K. Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986-2005: a retrospective cohort study. BMC Neurol. 2011 Mar 29; 11:38. PMID: 21447158.
      View in: PubMed
    531. Weir RA, Clements S, Steedman T, Dargie HJ, McMurray JJ, Squire IB, Ng LL. Plasma TIMP-4 predicts left ventricular remodeling after acute myocardial infarction. J Card Fail. 2011 Jun; 17(6):465-71. PMID: 21624734.
      View in: PubMed
    532. McMurray JJ. Heart failure: acute ischemic events in HF--should we include sudden death? Nat Rev Cardiol. 2011 Apr; 8(4):192-3. PMID: 21343900.
      View in: PubMed
    533. Solomon SD, Shin SH, Shah A, Skali H, Desai A, Kober L, Maggioni AP, Rouleau JL, Kelly RY, Hester A, McMurray JJ, Pfeffer MA. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Eur Heart J. 2011 May; 32(10):1227-34. PMID: 21317148.
      View in: PubMed
    534. Horowitz JD, Rosenson RS, McMurray JJ, Marx N, Remme WJ. Clinical Trials Update AHA Congress 2010. Cardiovasc Drugs Ther. 2011 Feb; 25(1):69-76. PMID: 21340529.
      View in: PubMed
    535. Gallanagh S, Castagno D, Wilson B, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ, McMurray JJ. Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II). Cardiovasc Drugs Ther. 2011 Feb; 25(1):77-85. PMID: 21287410.
      View in: PubMed
    536. Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J, Zweidler-McKay PA. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Blood. 2011 Mar 10; 117(10):2891-900. PMID: 21224467.
      View in: PubMed
    537. Lewis EF, Pfeffer MA, Feng A, Uno H, McMurray JJ, Toto R, Gandra SR, Solomon SD, Moustafa M, Macdougall IC, Locatelli F, Parfrey PS. Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol. 2011 Apr; 6(4):845-55. PMID: 21212421.
      View in: PubMed
    538. Preiss D, Sattar N, McMurray JJ. A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. Am Heart J. 2011 Jan; 161(1):210-219.e1. PMID: 21167356.
      View in: PubMed
    539. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011 Jan; 13(1):107-14. PMID: 21169387.
      View in: PubMed
    540. Dhanik A, McMurray JS, Kavraki L. On modeling peptidomimetics in complex with the SH2 domain of Stat3. Conf Proc IEEE Eng Med Biol Soc. 2011; 2011:3229-32. PMID: 22255027.
      View in: PubMed
    541. Gheorghiade M, Pang PS, O'Connor CM, Prasad K, McMurray J, Teerlink JR, Fiuzat M, Sabbah H, Komajda M. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase. Am Heart J. 2011 Feb; 161(2):224-32. PMID: 21315202.
      View in: PubMed
    542. Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, McDonagh T, McMurray JJ, Ryder M, Stewart S, Strömberg A, Jaarsma T. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2011 Feb; 13(2):115-26. PMID: 21148593.
      View in: PubMed
    543. Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA, Solomon SD. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol. 2010 Nov 23; 56(22):1812-22. PMID: 21087709.
      View in: PubMed
    544. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011 Jan 06; 364(1):11-21. PMID: 21073363.
      View in: PubMed
    545. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail. 2011 Jan; 4(1):27-35. PMID: 21068341.
      View in: PubMed
    546. MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, Denvir M, Bhagra S, Small S, Martin W, McMurray JJ, Petrie MC. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011 May; 97(9):740-7. PMID: 21051458.
      View in: PubMed
    547. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail. 2010 Nov; 12(11):1143-53. PMID: 20965877.
      View in: PubMed
    548. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace. 2010 Nov; 12(11):1526-36. PMID: 20974767.
      View in: PubMed
    549. Shah AM, Uno H, Køber L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail. 2010 Nov; 12(11):1229-37. PMID: 20965879.
      View in: PubMed
    550. Thune JJ, Signorovitch JE, Kober L, McMurray JJ, Swedberg K, Rouleau J, Maggioni A, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. Eur J Heart Fail. 2011 Feb; 13(2):148-53. PMID: 21037250.
      View in: PubMed
    551. McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Böhm M, Kamenský G, Komajda M, Mareev V, Wikstrand J. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010 Oct 05; 56(15):1196-204. PMID: 20883926.
      View in: PubMed
    552. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med. 2010 Sep 16; 363(12):1146-55. PMID: 20843249.
      View in: PubMed
    553. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J. 2010 Nov; 31(21):2677-87. PMID: 20801924.
      View in: PubMed
    554. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010 Aug; 12(8):767-78. PMID: 20675664.
      View in: PubMed
    555. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010 Aug 10; 122(6):597-602. PMID: 20660803.
      View in: PubMed
    556. Langhorne P, Lewsey JD, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, Walters M, Capewell S, McMurray JJ, MacIntyre K. Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. J Neurol Neurosurg Psychiatry. 2010 Dec; 81(12):1301-5. PMID: 20601665.
      View in: PubMed
    557. Shamshad F, Kenchaiah S, Finn PV, Soler-Soler J, McMurray JJ, Velazquez EJ, Maggioni AP, Califf RM, Swedberg K, Kober L, Belenkov Y, Varshavsky S, Pfeffer MA, Solomon SD. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010 Jul; 160(1):145-51. PMID: 20598985.
      View in: PubMed
    558. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010 Aug; 31(15):1872-80. PMID: 20570952.
      View in: PubMed
    559. Desai A, Lewis E, Solomon S, McMurray JJ, Pfeffer M. Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. Eur J Heart Fail. 2010 Sep; 12(9):936-42. PMID: 20525985.
      View in: PubMed
    560. Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S, Cristofanilli M. Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 2010 Jun 01; 116(11 Suppl):2806-14. PMID: 20503412.
      View in: PubMed
    561. Inglis SC, McMurray JJ, Böhm M, Schaufelberger M, van Veldhuisen DJ, Lindberg M, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Eur J Heart Fail. 2010 Jul; 12(7):698-705. PMID: 20501489.
      View in: PubMed
    562. Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2010 Jul; 12(7):738-45. PMID: 20418272.
      View in: PubMed
    563. Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart. 2010 Jun; 96(11):838-42. PMID: 20406769.
      View in: PubMed
    564. Zannad F, McMurray JJ, Drexler H, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2010 Jun; 12(6):617-22. PMID: 20388647.
      View in: PubMed
    565. Lewsey J, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJ, MacIntyre K. Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Med. 2010 Apr 09; 8:23. PMID: 20380701.
      View in: PubMed
    566. Park JH, Balmain S, Berry C, Morton JJ, McMurray JJ. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart. 2010 Apr; 96(7):533-8. PMID: 20350990.
      View in: PubMed
    567. Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggioni AP, McMurray JJ. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. Eur J Heart Fail. 2010 Jun; 12(6):557-65. PMID: 20356870.
      View in: PubMed
    568. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May; 12(5):423-33. PMID: 20354029.
      View in: PubMed
    569. Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. Eur J Heart Fail. 2010 Jun; 12(6):607-16. PMID: 20354032.
      View in: PubMed
    570. Weir RA, Murphy CA, Petrie CJ, Martin TN, Balmain S, Clements S, Steedman T, Wagner GS, Dargie HJ, McMurray JJ. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging. 2010 Jul; 3(4):360-7. PMID: 20348438.
      View in: PubMed
    571. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Struhman I, Hilfiker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010 Apr 06; 121(13):1465-73. PMID: 20308616.
      View in: PubMed
    572. MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS, Petrie MC, McMurray JJ, Petrie JR, McAlister FA. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care. 2010 Jun; 33(6):1213-8. PMID: 20299488.
      View in: PubMed
    573. Weir RA, Murphy CA, Petrie CJ, Martin TN, Clements S, Steedman T, Wagner GS, McMurray JJ, Dargie HJ. Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man? Cytokine. 2010 May; 50(2):158-62. PMID: 20299238.
      View in: PubMed
    574. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010 Mar 30; 121(12):1393-405. PMID: 20231531.
      View in: PubMed
    575. McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1477-90. PMID: 20228403.
      View in: PubMed
    576. Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1463-76. PMID: 20228402.
      View in: PubMed
    577. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25. PMID: 20233993.
      View in: PubMed
    578. Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J. 2010 Mar; 159(3):331-9. PMID: 20211292.
      View in: PubMed
    579. Preiss D, Sattar N, McMurray JJ. Event rates in trials of patients with type 2 diabetes. JAMA. 2010 Feb 24; 303(8):732-3; author reply 733. PMID: 20179281.
      View in: PubMed
    580. Krum H, McMurray JJ, Horton E, Gerlock T, Holzhauer B, Zuurman L, Haffner SM, Bethel MA, Holman RR, Califf RM. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials. Cardiovasc Ther. 2010 Apr; 28(2):124-32. PMID: 20184589.
      View in: PubMed
    581. Hogg KJ, McMurray JJ. Evaluating dyspnoea in acute heart failure: progress at last! Eur Heart J. 2010 Apr; 31(7):771-2. PMID: 20167742.
      View in: PubMed
    582. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010 Feb 27; 375(9716):735-42. PMID: 20167359.
      View in: PubMed
    583. McMurray JJ, Swedberg K. HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials. Eur J Heart Fail. 2010 Feb; 12(2):99-103. PMID: 20083618.
      View in: PubMed
    584. Hogg KJ, McMurray JJ. Heart Failure: Hospital-at-home care for CHF-verdict, 'not proven'. Nat Rev Cardiol. 2010 Feb; 7(2):63-4. PMID: 20104238.
      View in: PubMed
    585. Komajda M, McMurray JJ, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, Curtis PS, Jones NP, Home PD. Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J. 2010 Apr; 31(7):824-31. PMID: 20118174.
      View in: PubMed
    586. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010 Jan 21; 362(3):228-38. PMID: 20089973.
      View in: PubMed
    587. Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, McInnes IB, Dargie HJ, McMurray JJ. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol. 2010 Jan 19; 55(3):243-50. PMID: 20117403.
      View in: PubMed
    588. McMurray J, Zerah S, Hallworth M, Koeller U, Blaton V, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O'Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Huisman W, Solnica B, Reguengo H, Grigore C, Spanár J, Strakl G, Queralto J, Wallinder H, Schuff-Werner P. [The European Register of specialists in clinical chemistry and laboratory medicine: code of conduct Version 2-2008]. Ann Biol Clin (Paris). 2010 Jan-Feb; 68(1):121-5. PMID: 20146983.
      View in: PubMed
    589. Lorgelly PK, Briggs AH, Wedel H, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, Jánosi A, van Veldhuisen DJ, Barrios V, Fonseca C, McMurray JJ. An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. Eur J Heart Fail. 2010 Jan; 12(1):66-74. PMID: 20023047.
      View in: PubMed
    590. Baameur F, Morgan DH, Yao H, Tran TM, Hammitt RA, Sabui S, McMurray JS, Lichtarge O, Clark RB. Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation. Mol Pharmacol. 2010 Mar; 77(3):405-15. PMID: 20038610.
      View in: PubMed
    591. Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J. 2009 Dec; 158(6):896-901.e3. PMID: 19958854.
      View in: PubMed
    592. Jackson CE, Dalzell JR, Bezlyak V, Tsorlalis IK, Myles RC, Spooner R, Ford I, Petrie MC, Cobbe SM, McMurray JJ. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail. 2009 Dec; 11(12):1152-4. PMID: 19926598.
      View in: PubMed
    593. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail. 2010 Jan; 12(1):17-24. PMID: 19951962.
      View in: PubMed
    594. McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamenský G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis. Circulation. 2009 Dec 01; 120(22):2188-96. PMID: 19917888.
      View in: PubMed
    595. Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol. 2009 Nov 10; 54(20):1850-9. PMID: 19892235.
      View in: PubMed
    596. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie BM. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail. 2010 Feb; 16(2):128-34. PMID: 20142024.
      View in: PubMed
    597. Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJ, Yusuf S, Pfeffer MA, Swedberg K. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009 Nov; 11(11):1092-8. PMID: 19875409.
      View in: PubMed
    598. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19; 361(21):2019-32. PMID: 19880844.
      View in: PubMed
    599. Piccini JP, Zhang M, Pieper K, Solomon SD, Al-Khatib SM, Van de Werf F, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. Eur Heart J. 2010 Jan; 31(2):211-21. PMID: 19854729.
      View in: PubMed
    600. Mandal PK, Ren Z, Chen X, Xiong C, McMurray JS. Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3. J Med Chem. 2009 Oct 08; 52(19):6126-41. PMID: 19728728.
      View in: PubMed
    601. Freel EM, Tsorlalis IK, Lewsey JD, Latini R, Maggioni AP, Solomon S, Pitt B, Connell JM, McMurray JJ. Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study. Heart. 2009 Dec; 95(23):1920-4. PMID: 19713201.
      View in: PubMed
    602. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009 Aug 15; 374(9689):543-50. PMID: 19683640.
      View in: PubMed
    603. Mandal PK, Liao WS, McMurray JS. Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3. Org Lett. 2009 Aug 06; 11(15):3394-7. PMID: 19594124.
      View in: PubMed
    604. Lu M, Yang J, Ren Z, Sabui S, Espejo A, Bedford MT, Jacobson RH, Jeruzalmi D, McMurray JS, Chen X. Crystal structure of the three tandem FF domains of the transcription elongation regulator CA150. J Mol Biol. 2009 Oct 23; 393(2):397-408. PMID: 19660470.
      View in: PubMed
    605. Somaratne JB, Berry C, McMurray JJ, Poppe KK, Doughty RN, Whalley GA. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail. 2009 Sep; 11(9):855-62. PMID: 19654140.
      View in: PubMed
    606. McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, van Veldhuisen DJ, Wasserman SM, Young JB. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail. 2009 Aug; 11(8):795-801. PMID: 19633103.
      View in: PubMed
    607. Lewsey JD, Jhund PS, Gillies M, Chalmers JW, Redpath A, Kelso L, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJ, MacIntyre K. Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):475-83. PMID: 20031880.
      View in: PubMed
    608. McMurray JJ, Granger CB, Ostergren J, Yusuf S, Pfeffer MA, Swedberg K. Dual renin-angiotensin system blockade in heart failure. J Am Coll Cardiol. 2009 Jul 14; 54(3):278; author reply 279-80. PMID: 19589444.
      View in: PubMed
    609. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA. Dual renin-angiotensin system blockade and kidney disease. J Am Coll Cardiol. 2009 Jul 14; 54(3):278-9; author reply 279-80. PMID: 19589445.
      View in: PubMed
    610. Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur Heart J. 2009 Sep; 30(18):2226-32. PMID: 19556260.
      View in: PubMed
    611. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009 Jun 20; 373(9681):2125-35. PMID: 19501900.
      View in: PubMed
    612. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2009 Jul; 54(1):59-69. PMID: 19501439.
      View in: PubMed
    613. Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial). Am J Cardiol. 2009 Jul 15; 104(2):151-7. PMID: 19576338.
      View in: PubMed
    614. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70. PMID: 19464405.
      View in: PubMed
    615. MacDonald MR, Petrie MC, Fisher M, McMurray JJ. Pharmacologic management of patients with both heart failure and diabetes. Curr Heart Fail Rep. 2009 Jun; 6(2):126-32. PMID: 19486597.
      View in: PubMed
    616. Weir RA, Mark PB, Petrie CJ, Clements S, Steedman T, Ford I, Ng LL, Squire IB, Wagner GS, McMurray JJ, Dargie HJ. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? Am Heart J. 2009 Jun; 157(6):1088-96. PMID: 19464421.
      View in: PubMed
    617. Hawkins NM, Petrie MC, Burgess MI, McMurray JJ. Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol. 2009 May 26; 53(21):1944-59. PMID: 19460607.
      View in: PubMed
    618. Hawkins NM, MacDonald MR, Petrie MC, Chalmers GW, Carter R, Dunn FG, McMurray JJ. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial. Eur J Heart Fail. 2009 Jul; 11(7):684-90. PMID: 19460848.
      View in: PubMed
    619. Wang W, Shao R, Wu Q, Ke S, McMurray J, Lang FF, Charnsangavej C, Gelovani JG, Li C. Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide. Mol Imaging Biol. 2009 Nov-Dec; 11(6):424-33. PMID: 19424760.
      View in: PubMed
    620. Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 May; 11(5):433-43. PMID: 19386813.
      View in: PubMed
    621. Mandal PK, Limbrick D, Coleman DR, Dyer GA, Ren Z, Birtwistle JS, Xiong C, Chen X, Briggs JM, McMurray JS. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling. J Med Chem. 2009 Apr 23; 52(8):2429-42. PMID: 19334714.
      View in: PubMed
    622. Weir RA, Chong KS, Dalzell JR, Petrie CJ, Murphy CA, Steedman T, Mark PB, McDonagh TA, Dargie HJ, McMurray JJ. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail. 2009 Jun; 11(6):551-8. PMID: 19351633.
      View in: PubMed
    623. Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Eur Heart J. 2009 Jun; 30(12):1450-6. PMID: 19346225.
      View in: PubMed
    624. Lewsey JD, Gillies M, Jhund PS, Chalmers JW, Redpath A, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJ, Macintyre K. Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke. 2009 Apr; 40(4):1038-43. PMID: 19211485.
      View in: PubMed
    625. Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009 May; 32(5):915-20. PMID: 19196892.
      View in: PubMed
    626. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschöpe C, Van Bilsen M, Zannad F, McMurray J, Shah AM. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 Feb; 11(2):119-29. PMID: 19168509.
      View in: PubMed
    627. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009 Feb; 11(2):130-9. PMID: 19168510.
      View in: PubMed
    628. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009 Feb; 11(2):170-7. PMID: 19168515.
      View in: PubMed
    629. McMurray JJ, Jhund P, MacIntyre K, Stewart S. Heart failure in the UK. Heart. 2009 Feb; 95(2):156; author reply 156-7. PMID: 19109518.
      View in: PubMed
    630. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009 Mar; 11(3):292-8. PMID: 19176539.
      View in: PubMed
    631. Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, Dunselman P, Hjalmarson A, Kjekshus J, Komajda M, Kuusi T, Vanhaecke J, Waagstein F. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail. 2009 Mar; 11(3):281-91. PMID: 19168876.
      View in: PubMed
    632. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009 Feb 03; 119(4):515-23. PMID: 19153268.
      View in: PubMed
    633. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant. 2009 May; 24(5):1663-71. PMID: 19145003.
      View in: PubMed
    634. Mandal PK, McMurray JS. Application of triethylsilane and palladium-charcoal-induced reductions in the synthesis of Fmoc-glutamic acid analogues. Adv Exp Med Biol. 2009; 611:181-2. PMID: 19400150.
      View in: PubMed
    635. McMurray JS, Ren Z, Mandal PK, Chen X. Model of intermolecular interactions between high affinity phosphopeptides and Stat3. Adv Exp Med Biol. 2009; 611:543-4. PMID: 19400305.
      View in: PubMed
    636. McMurray JS, Mandal PK, Liao WS, Ren Z, Chen X. Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain. Adv Exp Med Biol. 2009; 611:545-6. PMID: 19400306.
      View in: PubMed
    637. Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJ, Naylor MD, Rich MW, Riegel B, Stewart S. What works in chronic care management: the case of heart failure. Health Aff (Millwood). 2009 Jan-Feb; 28(1):179-89. PMID: 19124869.
      View in: PubMed
    638. Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):271-7. PMID: 19185633.
      View in: PubMed
    639. Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol. 2008 Dec 09; 52(24):2000-7. PMID: 19055992.
      View in: PubMed
    640. Rocchiccioli JP, McMurray JJ, Dominiczak AF. Biomarkers in heart failure: a clinical review. Heart Fail Rev. 2010 Jul; 15(4):251-73. PMID: 19051010.
      View in: PubMed
    641. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation. 2008 Dec 02; 118(23):2360-7. PMID: 19029467.
      View in: PubMed
    642. Jhund PS, McMurray JJ. Heart failure after acute myocardial infarction: a lost battle in the war on heart failure? Circulation. 2008 Nov 11; 118(20):2019-21. PMID: 19001032.
      View in: PubMed
    643. Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, Bourgoun M, McMurray JJ, Velazquez EJ, Maggioni AP, Ghali J, Arnold JM, Zelenkofske S, Pfeffer MA, Solomon SD. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. Eur Heart J. 2009 Jan; 30(1):56-65. PMID: 19001474.
      View in: PubMed
    644. Abrahamsson P, Dobson J, Granger CB, McMurray JJ, Michelson EL, Pfeffer M, Pocock S, Solomon SD, Yusuf S, Swedberg K. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. Eur Heart J. 2009 Feb; 30(3):338-45. PMID: 19001475.
      View in: PubMed
    645. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008 Dec 04; 359(23):2456-67. PMID: 19001508.
      View in: PubMed
    646. Cohen-Solal A, McMurray JJ, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme. Eur Heart J. 2008 Dec; 29(24):3022-8. PMID: 18987098.
      View in: PubMed
    647. MacDonald MR, Jhund PS, Petrie MC, Lewsey JD, Hawkins NM, Bhagra S, Munoz N, Varyani F, Redpath A, Chalmers J, MacIntyre K, McMurray JJ. Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circ Heart Fail. 2008 Nov; 1(4):234-41. PMID: 19808297.
      View in: PubMed
    648. Weir RA, Martin TN, Petrie CJ, Murphy A, Clements S, Steedman T, Wagner GS, McMurray JJ, Dargie HJ. Cardiac and extracardiac abnormalities detected by cardiac magnetic resonance in a post-myocardial infarction cohort. Cardiology. 2009; 113(1):1-8. PMID: 18849604.
      View in: PubMed
    649. Califf RM, Boolell M, Haffner SM, Bethel M, McMurray J, Duggal A, Holman RR. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. Am Heart J. 2008 Oct; 156(4):623-32. PMID: 18946890.
      View in: PubMed
    650. Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008 Nov; 29(21):2641-50. PMID: 18819960.
      View in: PubMed
    651. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008 Oct; 29(19):2388-442. PMID: 18799522.
      View in: PubMed
    652. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008 Oct; 10(10):933-89. PMID: 18826876.
      View in: PubMed
    653. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008 Sep; 1(5):582-91. PMID: 19356485.
      View in: PubMed
    654. Stanton T, Hawkins NM, Hogg KJ, Goodfield NE, Petrie MC, McMurray JJ. How should we optimize cardiac resynchronization therapy? Eur Heart J. 2008 Oct; 29(20):2458-72. PMID: 18755703.
      View in: PubMed
    655. Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med. 2008 Aug 11; 168(15):1699-704. PMID: 18695086.
      View in: PubMed
    656. Bethel MA, Holman R, Haffner SM, Califf RM, Huntsman-Labed A, Hua TA, McMurray J. Determining the most appropriate components for a composite clinical trial outcome. Am Heart J. 2008 Oct; 156(4):633-40. PMID: 18926145.
      View in: PubMed
    657. Køber L, Torp-Pedersen C, McMurray JJ, Gøtzsche O, Lévy S, Crijns H, Amlie J, Carlsen J. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008 Jun 19; 358(25):2678-87. PMID: 18565860.
      View in: PubMed
    658. Remme WJ, McMurray JJ, Hobbs FD, Cohen-Solal A, Lopez-Sendon J, Boccanelli A, Zannad F, Rauch B, Keukelaar K, Macarie C, Ruzyllo W, Cline C. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J. 2008 Jul; 29(14):1739-52. PMID: 18506054.
      View in: PubMed
    659. Radauceanu A, Ducki C, Virion JM, Rossignol P, Mallat Z, McMurray J, Van Veldhuisen DJ, Tavazzi L, Mann DL, Capiaumont-Vin J, Li M, Hanriot D, Zannad F. Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J Card Fail. 2008 Aug; 14(6):467-74. PMID: 18672194.
      View in: PubMed
    660. Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 May 24; 371(9626):1761-8. PMID: 18502300.
      View in: PubMed
    661. Prisant LM, Thomas KL, Lewis EF, Huang Z, Francis GS, Weaver WD, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol. 2008 May 13; 51(19):1865-71. PMID: 18466801.
      View in: PubMed
    662. McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail. 2008 May; 1(1):17-24. PMID: 19808266.
      View in: PubMed
    663. Ren Z, Mao X, Mertens C, Krishnaraj R, Qin J, Mandal PK, Romanowski MJ, McMurray JS, Chen X. Crystal structure of unphosphorylated STAT3 core fragment. Biochem Biophys Res Commun. 2008 Sep 12; 374(1):1-5. PMID: 18433722.
      View in: PubMed
    664. MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJ. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008 May; 29(10):1224-40. PMID: 18424786.
      View in: PubMed
    665. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008 Jun; 29(11):1377-85. PMID: 18413309.
      View in: PubMed
    666. Murphy CL, McMurray JJ. Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Fail Rev. 2008 Dec; 13(4):431-8. PMID: 18392791.
      View in: PubMed
    667. Anavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA. Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. Am J Cardiol. 2008 Apr 01; 101(7):925-9. PMID: 18359309.
      View in: PubMed
    668. McMurray JJ. ACE inhibitors in cardiovascular disease--unbeatable? N Engl J Med. 2008 Apr 10; 358(15):1615-6. PMID: 18378521.
      View in: PubMed
    669. Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol. 2008 Mar 01; 101(5):607-12. PMID: 18308007.
      View in: PubMed
    670. Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J. 2008 Mar; 29(6):748-56. PMID: 18308687.
      View in: PubMed
    671. Macdonald MR, Hawkins NM, Balmain S, Dalzell J, McMurray JJ, Petrie MC. Transthoracic echocardiography: a survey of current practice in the UK. QJM. 2008 May; 101(5):345-9. PMID: 18281365.
      View in: PubMed
    672. Clark AM, Reid ME, Morrison CE, Capewell S, Murdoch DL, McMurray JJ. The complex nature of informal care in home-based heart failure management. J Adv Nurs. 2008 Feb; 61(4):373-83. PMID: 18234035.
      View in: PubMed
    673. McMurray JJ, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie BM. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008 Feb; 10(2):149-56. PMID: 18279770.
      View in: PubMed
    674. Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Eur J Heart Fail. 2008 Feb; 10(2):157-63. PMID: 18242128.
      View in: PubMed
    675. Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Am Heart J. 2008 Apr; 155(4):706-11. PMID: 18371480.
      View in: PubMed
    676. McMurray JS. Structural basis for the binding of high affinity phosphopeptides to Stat3. Biopolymers. 2008; 90(1):69-79. PMID: 18058821.
      View in: PubMed
    677. Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. J Exp Ther Oncol. 2008; 7(4):299-312. PMID: 19227010.
      View in: PubMed
    678. Torp-Pedersen C, Køber L, Carlsen JE, Akkan D, Bruun NE, Dacoronias D, Dickstein K, Haghfelt T, Ohlin H, McMurray JJ. A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. Eur J Heart Fail. 2008 Jan; 10(1):89-95. PMID: 18164245.
      View in: PubMed
    679. Myles RC, Jackson CE, Tsorlalis I, Petrie MC, McMurray JJ, Cobbe SM. Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation. 2007 Dec 18; 116(25):2984-91. PMID: 18086940.
      View in: PubMed
    680. Recio-Mayoral A, Kaski JC, McMurray JJ, Horowitz J, van Veldhuisen DJ, Remme WJ. Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovasc Drugs Ther. 2007 Dec; 21(6):459-65. PMID: 17992567.
      View in: PubMed
    681. Thune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension. 2008 Jan; 51(1):48-54. PMID: 18025296.
      View in: PubMed
    682. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA. 2007 Nov 07; 298(17):2009-19. PMID: 17986694.
      View in: PubMed
    683. Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007 Nov 29; 357(22):2248-61. PMID: 17984166.
      View in: PubMed
    684. Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol. 2007 Nov 13; 50(20):1959-66. PMID: 17996561.
      View in: PubMed
    685. Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. Am Heart J. 2008 Jan; 155(1):87-93. PMID: 18082495.
      View in: PubMed
    686. Seed A, Gardner R, McMurray J, Hillier C, Murdoch D, MacFadyen R, Bobillier A, Mann J, McDonagh T. Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. Eur J Heart Fail. 2007 Nov; 9(11):1120-7. PMID: 17945530.
      View in: PubMed
    687. Taylor GL, Murphy NF, Berry C, Christie J, Finlayson A, MacIntyre K, Morrison C, McMurray J. Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic. Heart. 2008 May; 94(5):628-32. PMID: 17916663.
      View in: PubMed
    688. Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD. The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol. 2007 Sep 25; 50(13):1238-45. PMID: 17888840.
      View in: PubMed
    689. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007 Sep 25; 116(13):1482-7. PMID: 17724259.
      View in: PubMed
    690. Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart. 2008 Mar; 94(3):296-304. PMID: 17664189.
      View in: PubMed
    691. Balmain S, Padmanabhan N, Ferrell WR, Morton JJ, McMurray JJ. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail. 2007 Sep; 9(9):865-71. PMID: 17644472.
      View in: PubMed
    692. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Aug 07; 116(6):627-36. PMID: 17638930.
      View in: PubMed
    693. Mandal PK, McMurray JS. Pd-C-induced catalytic transfer hydrogenation with triethylsilane. J Org Chem. 2007 Aug 17; 72(17):6599-601. PMID: 17630799.
      View in: PubMed
    694. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 03; 50(1):40-7. PMID: 17601544.
      View in: PubMed
    695. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Piña IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Jun 19; 115(24):3111-20. PMID: 17562950.
      View in: PubMed
    696. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med. 2007 Jul 05; 357(1):28-38. PMID: 17551159.
      View in: PubMed
    697. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, Fraser AG, Jaarsma T, Pitsis A, Mohacsi P, Böhm M, Anker S, Dargie H, Brutsaert D, Komajda M. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007 Jun-Jul; 9(6-7):684-94. PMID: 17481947.
      View in: PubMed
    698. Murphy A, McMurray JJ. Heart failure: are we neglecting the silent majority? Eur Heart J. 2007 May; 28(9):1047-8. PMID: 17463009.
      View in: PubMed
    699. Carrington M, Murphy NF, Strange G, Peacock A, McMurray JJ, Stewart S. Prognostic impact of pulmonary arterial hypertension: a population-based analysis. Int J Cardiol. 2008 Feb 29; 124(2):183-7. PMID: 17433474.
      View in: PubMed
    700. Dargie HJ, Hildebrandt PR, Riegger GA, McMurray JJ, McMorn SO, Roberts JN, Zambanini A, Wilding JP. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. J Am Coll Cardiol. 2007 Apr 24; 49(16):1696-704. PMID: 17448371.
      View in: PubMed
    701. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, McMurray JJ. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J. 2007 Apr; 28(7):829-35. PMID: 17403719.
      View in: PubMed
    702. Petrie MC, McMurray JJ. Dysglycemia and heart failure hospitalization: what is the link? Circulation. 2007 Mar 20; 115(11):1334-5. PMID: 17372185.
      View in: PubMed
    703. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007 Jul; 30(1):104-9. PMID: 17360728.
      View in: PubMed
    704. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. Eur J Heart Fail. 2007 May; 9(5):510-7. PMID: 17317308.
      View in: PubMed
    705. Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJ. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007 May; 93(5):606-12. PMID: 17277353.
      View in: PubMed
    706. van Veldhuisen DJ, McMurray JJ. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail. 2007 Feb; 9(2):110-2. PMID: 17270493.
      View in: PubMed
    707. Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Eur Heart J. 2007 Feb; 28(3):326-33. PMID: 17251259.
      View in: PubMed
    708. Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, Pfeffer MA. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007 Jan; 9(1):83-91. PMID: 17188020.
      View in: PubMed
    709. Weir RA, McMurray JJ. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep. 2006 Dec; 3(4):175-80. PMID: 17129511.
      View in: PubMed
    710. Stephenson K, Skali H, McMurray JJ, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience. Heart Rhythm. 2007 Mar; 4(3):308-13. PMID: 17341394.
      View in: PubMed
    711. Berry C, Murphy NF, Murphy N, De Vito G, Galloway S, Seed A, Fisher C, Sattar N, Vallance P, Hillis WS, McMurray J. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. Eur J Heart Fail. 2007 Apr; 9(4):429-34. PMID: 17126073.
      View in: PubMed
    712. Hawkins NM, Petrie MC, Macdonald MR, Hogg KJ, McMurray JJ. QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence? Eur Heart J. 2006 Dec; 27(24):3074-5; author reply 3075. PMID: 17121753.
      View in: PubMed
    713. Mandal PK, Heard PA, Ren Z, Chen X, McMurray JS. Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics. Bioorg Med Chem Lett. 2007 Feb 01; 17(3):654-6. PMID: 17113289.
      View in: PubMed
    714. McMurray JS. A new small-molecule Stat3 inhibitor. Chem Biol. 2006 Nov; 13(11):1123-4. PMID: 17113993.
      View in: PubMed
    715. Pitt B, Ferrari R, Gheorghiade M, van Veldhuisen DJ, Krum H, McMurray J, Lopez-Sendon J. Aldosterone blockade in post-acute myocardial infarction heart failure. Clin Cardiol. 2006 Oct; 29(10):434-8. PMID: 17063946.
      View in: PubMed
    716. Sampson UK, Pfeffer MA, McMurray JJ, Lokhnygina Y, White HD, Solomon SD. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. Eur Heart J. 2007 Mar; 28(6):685-91. PMID: 16984929.
      View in: PubMed
    717. McMurray J. Renin angiotensin blockade in heart failure with preserved ejection fraction: The signal gets stronger. Eur Heart J. 2006 Oct; 27(19):2257-9. PMID: 16963471.
      View in: PubMed
    718. Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation. 2006 Sep 05; 114(10):1028-35. PMID: 16943394.
      View in: PubMed
    719. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart. 2007 Jan; 93(1):59-64. PMID: 16952975.
      View in: PubMed
    720. Reed SD, McMurray JJ, Velazquez EJ, Schulman KA, Califf RM, Kober L, Maggioni AP, Van de Werf F, White HD, Diaz R, Mareev V, Murin J. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Am Heart J. 2006 Sep; 152(3):500-8. PMID: 16923421.
      View in: PubMed
    721. Granger CB, McMurray JJ. Using measures of disease progression to determine therapeutic effect: a sirens' song. J Am Coll Cardiol. 2006 Aug 01; 48(3):434-7. PMID: 16875965.
      View in: PubMed
    722. McMurray J, Swedberg K. Treatment of chronic heart failure: a comparison between the major guidelines. Eur Heart J. 2006 Aug; 27(15):1773-7. PMID: 16820365.
      View in: PubMed
    723. Janardhanan R, Kenchaiah S, Velazquez EJ, Park Y, McMurray JJ, Weaver WD, Finn PV, White HD, Marin-Neto JA, O'Connor C, Pfeffer MA, Califf RM, Solomon SD. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. Am Heart J. 2006 Jul; 152(1):183-9. PMID: 16824854.
      View in: PubMed
    724. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2006 Jul; 152(1):86-92. PMID: 16838426.
      View in: PubMed
    725. Murphy NF, Stewart S, Hart CL, MacIntyre K, Hole D, McMurray JJ. A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study. Heart. 2006 Dec; 92(12):1739-46. PMID: 16807274.
      View in: PubMed
    726. Capewell S, Murphy NF, MacIntyre K, Frame S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, McMurray JJ. Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study. Heart. 2006 Nov; 92(11):1563-70. PMID: 16775090.
      View in: PubMed
    727. Jhund P, McMurray JJ. Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis. Circulation. 2006 Jun 06; 113(22):2566-8. PMID: 16754810.
      View in: PubMed
    728. Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Fail Rev. 2006 Jun; 11(2):141-6. PMID: 16937033.
      View in: PubMed
    729. Berry C, Norrie J, Hogg K, Brett M, Stevenson K, McMurray JJ. The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J. 2006 Jun; 151(6):1313-21. PMID: 16781243.
      View in: PubMed
    730. McMurray JJ, Andersson FL, Stewart S, Svensson K, Solal AC, Dietz R, Vanhaecke J, van Veldhuisen DJ, Ostergren J, Granger CB, Yusuf S, Pfeffer MA, Swedberg K. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2006 Jun; 27(12):1447-58. PMID: 16754631.
      View in: PubMed
    731. Valeur N, Nielsen OW, McMurray JJ, Torp-Pedersen C, Køber L. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail. 2006 Oct; 8(6):577-84. PMID: 16678485.
      View in: PubMed
    732. Walker A, McMurray J, Stewart S, Berger W, McMahon AD, Dargie H, Fox K, Hillis S, Henderson NJ, Ford I. Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart. 2006 May; 92(5):619-24. PMID: 16614274.
      View in: PubMed
    733. MacIntyre K, Murphy NF, Chalmers J, Capewell S, Frame S, Finlayson A, Pell J, Redpath A, McMurray JJ. Hospital burden of suspected acute coronary syndromes: recent trends. Heart. 2006 May; 92(5):691-2. PMID: 16614290.
      View in: PubMed
    734. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2006 May; 151(5):985-91. PMID: 16644318.
      View in: PubMed
    735. McMurray JJ, Young JB, Dunlap ME, Granger CB, Hainer J, Michelson EL, Earle S, Olofsson B, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Am Heart J. 2006 May; 151(5):985-91. PMID: 16644319.
      View in: PubMed
    736. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006 May 16; 47(10):1997-2004. PMID: 16697316.
      View in: PubMed
    737. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol. 2006 May 22; 97(10A):13F-25F. PMID: 16698331.
      View in: PubMed
    738. Capewell S, Unal B, Critchley JA, McMurray JJ. Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Heart. 2006 Apr; 92(4):521-3. PMID: 16537767.
      View in: PubMed
    739. Hawkins NM, Petrie MC, MacDonald MR, Hogg KJ, McMurray JJ. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J. 2006 Jun; 27(11):1270-81. PMID: 16527827.
      View in: PubMed
    740. Stewart S, Murphy NF, McMurray JJ, Jhund P, Hart CL, Hole D. Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: an analysis of the Renfrew/Paisley Study. Eur J Heart Fail. 2006 Dec; 8(8):856-63. PMID: 16713336.
      View in: PubMed
    741. Yerra L, Anavekar N, Skali H, Zelenkofske S, Velazquez E, McMurray J, Pfeffer M, Solomon SD. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm. 2006 Mar; 3(3):313-6. PMID: 16500304.
      View in: PubMed
    742. Stewart S, McMurray JJ. Chilling findings: the need for winter vigilance in heart failure. J Card Fail. 2006 Mar; 12(2):120-1. PMID: 16520259.
      View in: PubMed
    743. Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail. 2006 Oct; 8(6):591-8. PMID: 16507350.
      View in: PubMed
    744. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006 Feb 21; 113(7):986-94. PMID: 16476847.
      View in: PubMed
    745. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006 Feb 07; 113(5):671-8. PMID: 16461840.
      View in: PubMed
    746. Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane L, McMurray JJ, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol. 2006 Mar 22; 108(1):101-8. PMID: 16466665.
      View in: PubMed
    747. McMurray JJ. Drug safety in cardiovascular disease: a call to ACTION. Cardiovasc Drugs Ther. 2006 Feb; 20(1):9-10. PMID: 16552471.
      View in: PubMed
    748. McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol. 2006 Feb 21; 47(4):726-33. PMID: 16487836.
      View in: PubMed
    749. Murphy NF, Simpson CR, MacIntyre K, McAlister FA, Chalmers J, McMurray JJ. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart. 2006 Aug; 92(8):1047-54. PMID: 16399851.
      View in: PubMed
    750. Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JJ, Rouleau JL, Aylward PE, White HD, Califf RM, Schulman KA. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J. 2006 Jan; 151(1):206-12. PMID: 16368320.
      View in: PubMed
    751. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005 Dec 10; 366(9502):2005-11. PMID: 16338449.
      View in: PubMed
    752. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005 Dec 13; 112(24):3738-44. PMID: 16330684.
      View in: PubMed
    753. Clark AM, McMurray JJ, Morrison CE, Murdoch DL, Capewell S, Reid ME. A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharm World Sci. 2005 Dec; 27(6):453-8. PMID: 16341953.
      View in: PubMed
    754. Mandal PK, Kaluarachchi KK, Ogrin D, Bott SG, McMurray JS. An efficient synthesis of the constrained peptidomimetic 2-oxo-3-(N-9-fluorenyloxycarbonylamino)-1-azabicyclo[4.3.0]nonane-9-carboxylic acid from pyroglutamic acid. J Org Chem. 2005 Nov 25; 70(24):10128-31. PMID: 16292854.
      View in: PubMed
    755. White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation. 2005 Nov 29; 112(22):3391-9. PMID: 16301343.
      View in: PubMed
    756. Coleman DR, Ren Z, Mandal PK, Cameron AG, Dyer GA, Muranjan S, Campbell M, Chen X, McMurray JS. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. J Med Chem. 2005 Oct 20; 48(21):6661-70. PMID: 16220982.
      View in: PubMed
    757. Demers C, McMurray JJ, Swedberg K, Pfeffer MA, Granger CB, Olofsson B, McKelvie RS, Ostergren J, Michelson EL, Johansson PA, Wang D, Yusuf S. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA. 2005 Oct 12; 294(14):1794-8. PMID: 16219883.
      View in: PubMed
    758. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006 Jan; 27(1):65-75. PMID: 16219658.
      View in: PubMed
    759. Wang W, McMurray JS, Wu Q, Campbell ML, Li C. Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues. Cancer Biother Radiopharm. 2005 Oct; 20(5):547-56. PMID: 16248770.
      View in: PubMed
    760. Carson P, Massie BM, McKelvie R, McMurray J, Komajda M, Zile M, Ptaszynska A, Frangin G. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005 Oct; 11(8):576-85. PMID: 16230259.
      View in: PubMed
    761. McMurray JJ. Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment. Kidney Int. 2005 Oct; 68(4):1419-26. PMID: 16164616.
      View in: PubMed
    762. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J. 2006 Jan; 27(1):96-106. PMID: 16183687.
      View in: PubMed
    763. Remme WJ, McMurray JJ, Rauch B, Zannad F, Keukelaar K, Cohen-Solal A, Lopez-Sendon J, Hobbs FD, Grobbee DE, Boccanelli A, Cline C, Macarie C, Dietz R, Ruzyllo W. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J. 2005 Nov; 26(22):2413-21. PMID: 16135524.
      View in: PubMed
    764. MacIntrye IM, Jhund PS, McMurray JJ. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure. Cardiovasc Drugs Ther. 2005 Aug; 19(4):261-5. PMID: 16187007.
      View in: PubMed
    765. Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). Am Heart J. 2005 Aug; 150(2):323-9. PMID: 16086938.
      View in: PubMed
    766. McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, Krum H, Maggioni A, McKelvie RS, Piña IL, Soler-Soler J, Swedberg K. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail. 2005 Aug; 7(5):710-21. PMID: 16087129.
      View in: PubMed
    767. Reid M, Clark A, Murdoch DL, Morrison C, Capewell S, McMurray J. Patients strategies for managing medication for chronic heart failure. Int J Cardiol. 2006 Apr 28; 109(1):66-73. PMID: 15993960.
      View in: PubMed
    768. Berry C, Hogg K, Norrie J, Stevenson K, Brett M, McMurray J. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart. 2005 Jul; 91(7):907-13. PMID: 15958359.
      View in: PubMed
    769. Teerlink JR, McMurray JJ, Bourge RC, Cleland JG, Cotter G, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, Van Veldhuisen DJ, Frey A, Rainisio M, Kobrin I. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J. 2005 Jul; 150(1):46-53. PMID: 16084150.
      View in: PubMed
    770. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005 Jun 23; 352(25):2581-8. PMID: 15972864.
      View in: PubMed
    771. Szummer KE, Solomon SD, Velazquez EJ, Kilaru R, McMurray J, Rouleau JL, Mahaffey KW, Maggioni AP, Califf RM, Pfeffer MA, White HD. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. Eur Heart J. 2005 Oct; 26(20):2114-9. PMID: 15972293.
      View in: PubMed
    772. Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med. 2005 Jun 13; 165(11):1311; author reply 1311-2. PMID: 15956014.
      View in: PubMed
    773. O'Meara E, Lewis E, Granger C, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Ostergren J, Carlsson J, Olofsson B, McMurray J, Yusuf S, Swedberg K, Pfeffer MA. Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2005 Jun; 7(4):650-6. PMID: 15921807.
      View in: PubMed
    774. Murphy NF, MacIntyre K, Stewart S, Capewell S, McMurray JJ. Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care? Heart. 2005 Jun; 91(6):726-30. PMID: 15894761.
      View in: PubMed
    775. McMurray J. Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate. BMJ. 2005 May 28; 330(7502):1269; author reply 1270-1. PMID: 15920134.
      View in: PubMed
    776. Wang W, Wu Q, Pasuelo M, McMurray JS, Li C. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. Bioconjug Chem. 2005 May-Jun; 16(3):729-34. PMID: 15898744.
      View in: PubMed
    777. Weir R, McMurray JJ. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction. Heart. 2005 May; 91 Suppl 2:ii17-20; discussion ii31, ii43-8. PMID: 15831602.
      View in: PubMed
    778. Hogg K, McMurray J. Neurohumoral pathways in heart failure with preserved systolic function. Prog Cardiovasc Dis. 2005 May-Jun; 47(6):357-66. PMID: 16115515.
      View in: PubMed
    779. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005 May 28-Jun 3; 365(9474):1877-89. PMID: 15924986.
      View in: PubMed
    780. Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, McMurray JJ, van Veldhuisen DJ. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J. 2005 Sep; 26(17):1759-64. PMID: 15833758.
      View in: PubMed
    781. Stewart S, McMurray JJ, Hebborn A, Coats AJ, Packer M. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom. Int J Cardiol. 2005 Apr 08; 100(1):143-9. PMID: 15820297.
      View in: PubMed
    782. Böhm M, Hjalmarson A, Kjekshus J, Laufs U, McMurray J, van Veldhuisen DJ. Heart failure and statins--why do we need a clinical trial? Z Kardiol. 2005 Apr; 94(4):223-30. PMID: 15803258.
      View in: PubMed
    783. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE, Chen X. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell. 2005 Mar 18; 17(6):761-71. PMID: 15780933.
      View in: PubMed
    784. Blue L, McMurray J. How much responsibility should heart failure nurses take? Eur J Heart Fail. 2005 Mar 16; 7(3):351-61. PMID: 15718175.
      View in: PubMed
    785. Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94. PMID: 15650766.
      View in: PubMed
    786. Mix TC, Brenner RM, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, McGill JB, McMurray JJ, Parfrey PS, Parving HH, Pereira BJ, Remuzzi G, Singh AK, Solomon SD, Stehman-Breen C, Toto RD, Pfeffer MA. Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J. 2005 Mar; 149(3):408-13. PMID: 15864229.
      View in: PubMed
    787. Berry C, Norrie J, McMurray JJ. Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovasc Drugs Ther. 2005 Mar; 19(2):149-51. PMID: 16025234.
      View in: PubMed
    788. McMurray JJ. Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy? Nat Clin Pract Cardiovasc Med. 2005 Mar; 2(3):128-9. PMID: 16265452.
      View in: PubMed
    789. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005 Mar 17; 352(11):1071-80. PMID: 15713944.
      View in: PubMed
    790. McMurray J, Køber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, Remme W, Sharpe DN, Ford I. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005 Feb 15; 45(4):525-30. PMID: 15708698.
      View in: PubMed
    791. Packer M, McMurray J, Massie BM, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005 Feb; 11(1):12-20. PMID: 15704058.
      View in: PubMed
    792. O'Meara E, McMurray JJ. Myocardial metabolic manipulation: a new therapeutic approach in heart failure? Heart. 2005 Feb; 91(2):131-2. PMID: 15657211.
      View in: PubMed
    793. McMurray J. Making sense of SENIORS. Eur Heart J. 2005 Feb; 26(3):203-6. PMID: 15647290.
      View in: PubMed
    794. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. [Expert Consensus document on beta-adrenergic receptor blockers]. Rev Esp Cardiol. 2005 Jan; 58(1):65-90. PMID: 15680133.
      View in: PubMed
    795. Pfeffer MA, Solomon SD, Singh AK, Ivanovich P, McMurray JJ. Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med. 2005; 6 Suppl 3:S35-41. PMID: 16340937.
      View in: PubMed
    796. McMurray JJ, Pfeffer MA. The year in heart failure. J Am Coll Cardiol. 2004 Dec 21; 44(12):2398-405. PMID: 15607404.
      View in: PubMed
    797. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C, Priori SG, Alonso García MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernández Burgos E, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Ardissino D, Avendano C, Blomström-Lundqvist C, Clément D, Drexler H, Ferrari R, Fox KA, Julian D, Kearney P, Klein W, Köber L, Mancia G, Nieminen M, Ruzillo W, Simoons M, Thygesen K, Tognoni G, Tritto I, Wallentin L. [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. Rev Esp Cardiol. 2004 Dec; 57(12):1213-32. PMID: 15617645.
      View in: PubMed
    798. O'Meara E, Murphy C, McMurray JJ. Anemia and heart failure. Curr Heart Fail Rep. 2004 Dec; 1(4):176-82. PMID: 16036042.
      View in: PubMed
    799. McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation. 2004 Nov 16; 110(20):3281-8. PMID: 15545527.
      View in: PubMed
    800. Velazquez EJ, Francis GS, Armstrong PW, Aylward PE, Diaz R, O'Connor CM, White HD, Henis M, Rittenhouse LM, Kilaru R, van Gilst W, Ertl G, Maggioni AP, Spac J, Weaver WD, Rouleau JL, McMurray JJ, Pfeffer MA, Califf RM. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. Eur Heart J. 2004 Nov; 25(21):1911-9. PMID: 15522470.
      View in: PubMed
    801. O'Meara E, Solomon S, McMurray J, Pfeffer M, Yusuf S, Michelson E, Granger C, Olofsson B, Young JB, Swedberg K. Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2004 Nov; 25(21):1920-6. PMID: 15522471.
      View in: PubMed
    802. Murphy NF, Stewart S, MacIntyre K, Capewell S, McMurray JJ. Seasonal variation in morbidity and mortality related to atrial fibrillation. Int J Cardiol. 2004 Nov; 97(2):283-8. PMID: 15458696.
      View in: PubMed
    803. Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation. 2004 Oct 26; 110(17):2618-26. PMID: 15492298.
      View in: PubMed
    804. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004 Oct 12; 110(15):2180-3. PMID: 15466644.
      View in: PubMed
    805. Murphy NF, Simpson CR, McAlister FA, Stewart S, MacIntyre K, Kirkpatrick M, Chalmers J, Redpath A, Capewell S, McMurray JJ. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart. 2004 Oct; 90(10):1129-36. PMID: 15367505.
      View in: PubMed
    806. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004 Sep 23; 351(13):1285-95. PMID: 15385655.
      View in: PubMed
    807. Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004 Sep 21; 110(12):1572-8. PMID: 15364810.
      View in: PubMed
    808. Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJ. The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther. 2004 Sep; 103(3):179-201. PMID: 15464589.
      View in: PubMed
    809. McMurray JJ. Angiotensin inhibition in heart failure. J Renin Angiotensin Aldosterone Syst. 2004 Sep; 5 Suppl 1:S17-22. PMID: 15526237.
      View in: PubMed
    810. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004 Aug 18; 44(4):810-9. PMID: 15312864.
      View in: PubMed
    811. McMurray JJ, O'Meara E. Treatment of heart failure with spironolactone--trial and tribulations. N Engl J Med. 2004 Aug 05; 351(6):526-8. PMID: 15295043.
      View in: PubMed
    812. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J. 2004 Aug; 25(16):1454-70. PMID: 15302105.
      View in: PubMed
    813. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004 Aug; 25(15):1341-62. PMID: 15288162.
      View in: PubMed
    814. Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, Ruschitzka F, Lüscher TF. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet. 2004 Jul 24-30; 364(9431):347-54. PMID: 15276394.
      View in: PubMed
    815. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004 Jul 13; 110(2):149-54. PMID: 15210591.
      View in: PubMed
    816. Riegel B, Naylor M, Stewart S, McMurray JJ, Rich MW. Interventions to prevent readmission for congestive heart failure. JAMA. 2004 Jun 16; 291(23):2816; author reply 2816-7. PMID: 15199026.
      View in: PubMed
    817. Meredith PA, Murray LS, McMurray JJ. A putative placebo comparison of the SCOPE and LIFE trials. J Renin Angiotensin Aldosterone Syst. 2004 Jun; 5(2):59-63. PMID: 15295716.
      View in: PubMed
    818. Murphy NF, MacIntyre K, Capewell S, Stewart S, Pell J, Chalmers J, Redpath A, Frame S, Boyd J, McMurray JJ. Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis. BMJ. 2004 Jun 12; 328(7453):1413-4. PMID: 15155470.
      View in: PubMed
    819. Petrie MC, Hogg K, Caruana L, McMurray JJ. Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? Heart. 2004 May; 90(5):511-7. PMID: 15084546.
      View in: PubMed
    820. McAlister FA, Murphy NF, Simpson CR, Stewart S, MacIntyre K, Kirkpatrick M, Chalmers J, Redpath A, Capewell S, McMurray JJ. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. BMJ. 2004 May 08; 328(7448):1110. PMID: 15107312.
      View in: PubMed
    821. Hood WB, Dans AL, Guyatt GH, Jaeschke R, McMurray JJ. Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. J Card Fail. 2004 Apr; 10(2):155-64. PMID: 15101028.
      View in: PubMed
    822. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004 Apr 06; 109(13):1594-602. PMID: 15023878.
      View in: PubMed
    823. Stewart S, Murphy NF, Murphy N, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004 Mar; 90(3):286-92. PMID: 14966048.
      View in: PubMed
    824. Swedberg K, McMurray JJ. Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT? Eur Heart J. 2004 Mar; 25(5):357-8. PMID: 15033244.
      View in: PubMed
    825. Remme W, Boccanelli A, Cline C, Cohen-Solal A, Dietz R, Hobbs R, Keukelaar K, Sendon JL, Macarie C, McMurray J, Rauch B, Ruzyllo W, Zannad F. Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study. Cardiovasc Drugs Ther. 2004 Mar; 18(2):153-9. PMID: 15162077.
      View in: PubMed
    826. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004 Feb 04; 43(3):317-27. PMID: 15013109.
      View in: PubMed
    827. McMurray JJ. What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail. 2004 Feb; 10(1 Suppl):S10-2. PMID: 15007794.
      View in: PubMed
    828. Hood WB, Dans AL, Guyatt GH, Jaeschke R, McMurray JJ. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database Syst Rev. 2004; (2):CD002901. PMID: 15106182.
      View in: PubMed
    829. Jhund PS, Dawson N, Davie AP, Norrie J, O'Kane KP, McMurray JJ. 17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women. Cardiovasc Drugs Ther. 2004 Jan; 18(1):31-6. PMID: 15115901.
      View in: PubMed
    830. Dunselman P, Hjalmarson A, Kjekshus J, McMurray J, Waagstein F. The statin wars. Lancet. 2003 Nov 29; 362(9398):1854; discussion 1856. PMID: 14654327.
      View in: PubMed
    831. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003 Nov 13; 349(20):1893-906. PMID: 14610160.
      View in: PubMed
    832. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003 Sep 06; 362(9386):777-81. PMID: 13678871.
      View in: PubMed
    833. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003 Sep 06; 362(9386):759-66. PMID: 13678868.
      View in: PubMed
    834. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003 Sep 06; 362(9386):767-71. PMID: 13678869.
      View in: PubMed
    835. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003 Sep 06; 362(9386):772-6. PMID: 13678870.
      View in: PubMed
    836. Stergren J, McMurray JJ. Angiotensin receptor blockers in heart failure. J Renin Angiotensin Aldosterone Syst. 2003 Sep; 4(3):171-5. PMID: 14608522.
      View in: PubMed
    837. McMurray JJ, Hillier C. The rise and fall of myotrophin in heart failure. J Am Coll Cardiol. 2003 Aug 20; 42(4):726-7. PMID: 12932610.
      View in: PubMed
    838. Stewart S, Murphy NF, Murphy N, Walker A, McGuire A, McMurray JJ. The current cost of angina pectoris to the National Health Service in the UK. Heart. 2003 Aug; 89(8):848-53. PMID: 12860855.
      View in: PubMed
    839. Fisher C, Berry C, Blue L, Morton JJ, McMurray J. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart. 2003 Aug; 89(8):879-81. PMID: 12860863.
      View in: PubMed
    840. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem. 2003 Oct 10; 278(41):40057-66. PMID: 12869565.
      View in: PubMed
    841. Fisher C, Al-Benna S, Kirk A, Morton JJ, McMurray JJ. Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin. Heart. 2003 Jul; 89(7):789-90. PMID: 12807861.
      View in: PubMed
    842. McMurray J, Ostergren J, Pfeffer M, Swedberg K, Granger C, Yusuf S, Held P, Michelson E, Olofsson B. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2003 Jun; 5(3):261-70. PMID: 12798823.
      View in: PubMed
    843. Ren Z, Cabell LA, Schaefer TS, McMurray JS. Identification of a high-affinity phosphopeptide inhibitor of Stat3. Bioorg Med Chem Lett. 2003 Feb 24; 13(4):633-6. PMID: 12639546.
      View in: PubMed
    844. Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the aging population: an increasing burden in the 21st century? Heart. 2003 Jan; 89(1):49-53. PMID: 12482791.
      View in: PubMed
    845. McMurray J, Davie AP. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation. 2002 Nov 12; 106(20):e147; author reply e147. PMID: 12427668.
      View in: PubMed
    846. Stewart S, McMurray JJ. Palliative care for heart failure. BMJ. 2002 Oct 26; 325(7370):915-6. PMID: 12399323.
      View in: PubMed
    847. Lee S, Lin X, McMurray J, Sun G. Contribution of an active site cation-pi interaction to the spectroscopic properties and catalytic function of protein tyrosine kinase Csk. Biochemistry. 2002 Oct 08; 41(40):12107-14. PMID: 12356311.
      View in: PubMed
    848. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002 Oct 01; 113(5):359-64. PMID: 12401529.
      View in: PubMed
    849. McMurray JJ. Heart failure in 10 years time: focus on pharmacological treatment. Heart. 2002 Oct; 88 Suppl 2:ii40-6. PMID: 12213800.
      View in: PubMed
    850. Berry C, McMurray J. CHF: a GP guide to management. Practitioner. 2002 Oct; 246(1639):669-72, 675-81. PMID: 12407951.
      View in: PubMed
    851. Stewart S, Blue L, Walker A, Morrison C, McMurray JJ. An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it? Eur Heart J. 2002 Sep; 23(17):1369-78. PMID: 12191748.
      View in: PubMed
    852. Packer M, Califf RM, Konstam MA, Krum H, McMurray JJ, Rouleau JL, Swedberg K. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation. 2002 Aug 20; 106(8):920-6. PMID: 12186794.
      View in: PubMed
    853. Fisher C, MacLean M, Morecroft I, Seed A, Johnston F, Hillier C, McMurray J. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation. 2002 Jul 16; 106(3):292-5. PMID: 12119241.
      View in: PubMed
    854. Pfeffer MA, McMurray JJ. Myocardial infarct: no one size fits all. Circulation. 2002 Jun 04; 105(22):2577-9. PMID: 12045157.
      View in: PubMed
    855. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002 Jun; 4(3):361-71. PMID: 12034163.
      View in: PubMed
    856. Fisher C, McMurray JJ. Current management of heart failure. Practitioner. 2002 Jun; 246(1635):438-43. PMID: 12073702.
      View in: PubMed
    857. Krum H, McMurray JJ. Statins and chronic heart failure: do we need a large-scale outcome trial? J Am Coll Cardiol. 2002 May 15; 39(10):1567-73. PMID: 12020481.
      View in: PubMed
    858. McMurray J, Pfeffer MA. New therapeutic options in congestive heart failure: Part II. Circulation. 2002 May 07; 105(18):2223-8. PMID: 11994259.
      View in: PubMed
    859. McMurray J, Pfeffer MA. New therapeutic options in congestive heart failure: Part I. Circulation. 2002 Apr 30; 105(17):2099-106. PMID: 11980691.
      View in: PubMed
    860. Stewart S, Demers C, Murdoch DR, McIntyre K, MacLeod ME, Kendrick S, Capewell S, McMurray JJ. Substantial between-hospital variation in outcome following first emergency admission for heart failure. Eur Heart J. 2002 Apr; 23(8):650-7. PMID: 11969280.
      View in: PubMed
    861. Stewart S, McIntyre K, Capewell S, McMurray JJ. Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol. 2002 Mar 06; 39(5):760-6. PMID: 11869838.
      View in: PubMed
    862. Stewart S, MacIntyre K, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, Capewell S, McMurray JJ. Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995. Int J Cardiol. 2002 Mar; 82(3):229-36. PMID: 11911910.
      View in: PubMed
    863. Pell JP, MacIntyre K, Walsh D, Capewell S, McMurray JJ, Chalmers JW, Boyd JH, Finlayson AR, Stewart S, Redpath AD. Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study. BMJ. 2002 Jan 26; 324(7331):201-2. PMID: 11809641.
      View in: PubMed
    864. Davie AP, McMurray JJ. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. Br J Clin Pharmacol. 2002 Jan; 53(1):37-42. PMID: 11849193.
      View in: PubMed
    865. Byrne J, Murdoch D, Morrison C, McMurray J. An audit of activity and outcome from a daily and a weekly "one stop" rapid assessment chest pain clinic. Postgrad Med J. 2002 Jan; 78(915):43-6. PMID: 11796873.
      View in: PubMed
    866. Davie AP, McMurray JJ. Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for? Eur Heart J. 2002 Jan; 23(1):1-3. PMID: 11741352.
      View in: PubMed
    867. De Vito G, Galloway SD, Nimmo MA, Maas P, McMurray JJ. Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans. Clin Physiol Funct Imaging. 2002 Jan; 22(1):32-8. PMID: 12003097.
      View in: PubMed
    868. Sun G, Ramdas L, Wang W, Vinci J, McMurray J, Budde RJ. Effect of autophosphorylation on the catalytic and regulatory properties of protein tyrosine kinase Src. Arch Biochem Biophys. 2002 Jan 01; 397(1):11-7. PMID: 11747305.
      View in: PubMed
    869. Petrie MC, Caruana L, Berry C, McMurray JJ. "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart. 2002 Jan; 87(1):29-31. PMID: 11751660.
      View in: PubMed
    870. Davie AP, Rumley A, Lowe GD, McMurray JJ. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure. Thromb Haemost. 2001 Dec; 86(6):1585-6. PMID: 11776334.
      View in: PubMed
    871. Seed A, Love MP, McMurray JJ. Clinical experience with endothelin receptor antagonists in chronic heart failure. Heart Fail Rev. 2001 Dec; 6(4):317-23. PMID: 11447306.
      View in: PubMed
    872. Berry C, McMurray J. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone. Am J Med. 2001 Nov; 111(7):587. PMID: 11705445.
      View in: PubMed
    873. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001 Nov; 86(5):516-21. PMID: 11602543.
      View in: PubMed
    874. Petrie MC, Berry C, Stewart S, McMurray JJ. Failing ageing hearts. Eur Heart J. 2001 Nov; 22(21):1978-90. PMID: 11603905.
      View in: PubMed
    875. Berry C, Stewart S, Payne EM, McArthur JD, McMurray JJ. Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice. Int J Cardiol. 2001 Nov; 81(1):29-35. PMID: 11690662.
      View in: PubMed
    876. Capewell S, MacIntyre K, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet. 2001 Oct 13; 358(9289):1213-7. PMID: 11675057.
      View in: PubMed
    877. McDonald JE, Padmanabhan N, Petrie MC, Hillier C, Connell JM, McMurray JJ. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. Circulation. 2001 Oct 09; 104(15):1805-8. PMID: 11591618.
      View in: PubMed
    878. Blue L, Lang E, McMurray JJ, Davie AP, McDonagh TA, Murdoch DR, Petrie MC, Connolly E, Norrie J, Round CE, Ford I, Morrison CE. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ. 2001 Sep 29; 323(7315):715-8. PMID: 11576977.
      View in: PubMed
    879. Prabhu NV, Siddiqui SA, McMurray JS, Pettitt BM. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors. Biopolymers. 2001 Sep; 59(3):167-79. PMID: 11391566.
      View in: PubMed
    880. Morris ST, McMurray JJ, Spiers A, Jardine AG. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int. 2001 Sep; 60(3):1077-82. PMID: 11532102.
      View in: PubMed
    881. Petrie MC, Hillier C, Johnston F, McMurray JJ. Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure. Hypertension. 2001 Sep; 38(3):412-6. PMID: 11566914.
      View in: PubMed
    882. MacIntyre K, Stewart S, Capewell S, Chalmers JW, Pell JP, Boyd J, Finlayson A, Redpath A, Gilmour H, McMurray JJ. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol. 2001 Sep; 38(3):729-35. PMID: 11527625.
      View in: PubMed
    883. Petrie M, McMurray J. Changes in notions about heart failure. Lancet. 2001 Aug 11; 358(9280):432-4. PMID: 11513900.
      View in: PubMed
    884. Hood WB, Dans A, Guyatt GH, Jaeschke R, McMurray J. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Nurs Times. 2001 Aug 23-29; 97(34):40. PMID: 11957658.
      View in: PubMed
    885. Berry C, Anderson N, Kirk AJ, Dominiczak AF, McMurray JJ. Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart. 2001 Aug; 86(2):217-20. PMID: 11454847.
      View in: PubMed
    886. Petrie MC, McDonald JE, Hillier C, Morton JJ, McMurray JJ. Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. Br J Clin Pharmacol. 2001 Aug; 52(2):165-8. PMID: 11488773.
      View in: PubMed
    887. McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs R, Maggioni A, Pina I, Soler-Soler J, Swedberg K. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail. 2001 Aug; 3(4):495-502. PMID: 11511437.
      View in: PubMed
    888. McMurray JJ. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction. Heart. 2001 Jul; 86(1):97-103. PMID: 11410575.
      View in: PubMed
    889. Hillier C, Petrie MC, Love MP, Johnston F, MacLean MR, McMurray JJ. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure. Clin Sci (Lond). 2001 Jul; 101(1):45-51. PMID: 11410113.
      View in: PubMed
    890. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 2001 Jul; 86(1):21-6. PMID: 11410555.
      View in: PubMed
    891. McMurray JJ. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? J Renin Angiotensin Aldosterone Syst. 2001 Jun; 2(2):89-92. PMID: 11881104.
      View in: PubMed
    892. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail. 2001 Jun; 3(3):283-91. PMID: 11377998.
      View in: PubMed
    893. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001 Jun; 3(3):315-22. PMID: 11378002.
      View in: PubMed
    894. Macintyre K, Stewart S, Chalmers J, Pell J, Finlayson A, Boyd J, Redpath A, McMurray J, Capewell S. Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ. 2001 May 12; 322(7295):1152-3. PMID: 11348909.
      View in: PubMed
    895. Seed A, McMurray J. Acute endothelin a receptor blockade in heart failure. Circulation. 2001 May 08; 103(18):E94-4. PMID: 11342484.
      View in: PubMed
    896. Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. Am Heart J. 2001 May; 141(5):800-7. PMID: 11320369.
      View in: PubMed
    897. Jhund PS, Davie AP, McMurray JJ. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol. 2001 Apr; 37(5):1234-8. PMID: 11300428.
      View in: PubMed
    898. Berry C, McMurray JJ. Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart. 2001 Apr; 85(4):E8. PMID: 11250985.
      View in: PubMed
    899. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. Eur Heart J. 2001 Apr; 22(8):693-701. PMID: 11286527.
      View in: PubMed
    900. Jhund PS, Dawson N, Davie AP, Sattar N, Norrie J, O'Kane KP, McMurray JJ. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. J Am Coll Cardiol. 2001 Apr; 37(5):1367-73. PMID: 11300448.
      View in: PubMed
    901. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Endothelium-derived hyperpolarizing factor : identification and mechanisms of action in human subcutaneous resistance arteries. Circulation. 2001 Mar 27; 103(12):1702-8. PMID: 11274000.
      View in: PubMed
    902. Berry C, McMurray J. Undertreatment of heart failure has high cost to patients. BMJ. 2001 Mar 24; 322(7288):731-2. PMID: 11264218.
      View in: PubMed
    903. Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol. 2001 Mar 15; 37(4):1056-61. PMID: 11263608.
      View in: PubMed
    904. Hillier C, Berry C, Petrie MC, O'Dwyer PJ, Hamilton C, Brown A, McMurray J. Effects of urotensin II in human arteries and veins of varying caliber. Circulation. 2001 Mar 13; 103(10):1378-81. PMID: 11245639.
      View in: PubMed
    905. Caruana L, Petrie MC, McMurray JJ, MacFarlane NG. Altered diaphragm position and function in patients with chronic heart failure. Eur J Heart Fail. 2001 Mar; 3(2):183-7. PMID: 11246055.
      View in: PubMed
    906. Stewart S, Blue L, Capewell S, Horowitz JD, McMurray JJ. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. Eur J Heart Fail. 2001 Mar; 3(2):249-55. PMID: 11246064.
      View in: PubMed
    907. Berry C, Norrie J, McMurray JJ. Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly. Am J Cardiol. 2001 Mar 01; 87(5):606-7, A9. PMID: 11230847.
      View in: PubMed
    908. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries. Cardiovasc Res. 2001 Mar; 49(4):828-37. PMID: 11230983.
      View in: PubMed
    909. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J. 2001 Feb; 22(3):209-17. PMID: 11161932.
      View in: PubMed
    910. Burke TR, Yao ZJ, Liu DG, Voigt J, Gao Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers. 2001; 60(1):32-44. PMID: 11376431.
      View in: PubMed
    911. Love MP, McMurray JJ. Endothelin receptor antagonists and cardiovascular diseases of aging. Drugs Aging. 2001; 18(6):425-40. PMID: 11419917.
      View in: PubMed
    912. McMurray JS, Coleman DR, Wang W, Campbell ML. The synthesis of phosphopeptides. Biopolymers. 2001; 60(1):3-31. PMID: 11376430.
      View in: PubMed
    913. Hood WB, Dans A, Guyatt GH, Jaeschke R, McMurray J. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database Syst Rev. 2001; (1):CD002901. PMID: 11279775.
      View in: PubMed
    914. Capewell S, Livingston BM, MacIntyre K, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, Evans CJ, McMurray JJ. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000 Nov; 21(22):1833-40. PMID: 11052855.
      View in: PubMed
    915. Pfeffer MA, McMurray J, Leizorovicz A, Maggioni AP, Rouleau JL, Van De Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers MA, Velazquez E, Califf R. Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J. 2000 Nov; 140(5):727-50. PMID: 11054617.
      View in: PubMed
    916. Shah MR, Granger CB, Bart BA, McMurray JJ, Petrie MC, Michelson EL, Tudor GE, Swedberg K, Stevenson LW, Califf RM, Pfeffer MA. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med. 2000 Oct 15; 109(6):489-92. PMID: 11042239.
      View in: PubMed
    917. Murdoch DR, McMurray JJ. Acute heart failure: a practical guide to management. Hosp Med. 2000 Oct; 61(10):725-9. PMID: 11103286.
      View in: PubMed
    918. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000 Sep 26; 102(13):1511-6. PMID: 11004141.
      View in: PubMed
    919. Berry C, McMurray J. Anticoagulation for patients with atrial fibrillation. Warfarin should be given for up to one year after successful cardioversion. BMJ. 2000 Sep 09; 321(7261):639. PMID: 11023332.
      View in: PubMed
    920. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 Sep 05; 102(10):1126-31. PMID: 10973841.
      View in: PubMed
    921. Galloway SD, De Vito G, McClure S, Nimmo MA, McMurray JJ. Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans. Clin Sci (Lond). 2000 Sep; 99(3):223-30. PMID: 11787475.
      View in: PubMed
    922. McMurray J. Why we need new strategies in CHF management. J Renin Angiotensin Aldosterone Syst. 2000 Sep; 1 Suppl 1:12-6. PMID: 11967787.
      View in: PubMed
    923. McMurray J. AT(1) receptor antagonists-beyond blood pressure control: possible place in heart failure treatment. Heart. 2000 Sep; 84 Suppl 1:i42-5: discussion i50. PMID: 10956322.
      View in: PubMed
    924. Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol. 2000 Sep; 183(3):759-69. PMID: 10992206.
      View in: PubMed
    925. Capewell S, McMurray J. Coronary heart disease trends in France and elsewhere. Heart. 2000 Aug; 84(2):121-2. PMID: 10908236.
      View in: PubMed
    926. Morris ST, McMurray JJ, Rodger RS, Jardine AG. Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant. 2000 Aug; 15(8):1194-200. PMID: 10910444.
      View in: PubMed
    927. Mcmurray J. Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems. Eur Heart J. 2000 Aug; 21(15):1214-5. PMID: 10924310.
      View in: PubMed
    928. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ. 2000 Jul 22; 321(7255):215-8. PMID: 10903655.
      View in: PubMed
    929. Love MP, Ferro CJ, Haynes WG, Plumpton C, Davenport AP, Webb DJ, McMurray JJ. Endothelin receptor antagonism in patients with chronic heart failure. Cardiovasc Res. 2000 Jul; 47(1):166-72. PMID: 10869543.
      View in: PubMed
    930. Jhund PS, McMurray JJ, Davie AP. The acute vascular effects of frusemide in heart failure. Br J Clin Pharmacol. 2000 Jul; 50(1):9-13. PMID: 10886111.
      View in: PubMed
    931. McMurray J, Berry C. Ongoing Clinical trials with angiotensin II receptor antagonists in chronic heart failure and myocardial infarction. J Renin Angiotensin Aldosterone Syst. 2000 Jun; 1(2):131-6. PMID: 11967803.
      View in: PubMed
    932. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation. 2000 May 09; 101(18):2206-12. PMID: 10801763.
      View in: PubMed
    933. Wang W, Ramdas L, Sun G, Ke S, Obeyesekere NU, Budde RJ, McMurray JS. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src). Biochemistry. 2000 May 02; 39(17):5221-8. PMID: 10819990.
      View in: PubMed
    934. Davie AP, Love MP, McMurray JJ. Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure. Clin Pharmacol Ther. 2000 May; 67(5):530-7. PMID: 10824632.
      View in: PubMed
    935. McMurray J. Heart failure: we need more trials in typical patients. Eur Heart J. 2000 May; 21(9):699-700. PMID: 10739720.
      View in: PubMed
    936. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000 May; 83(5):596-602. PMID: 10768918.
      View in: PubMed
    937. Capewell S, McMurray J. "Chest pain-please admit": is there an alternative?. A rapid cardiological assessment service may prevent unnecessary admissions. BMJ. 2000 Apr 08; 320(7240):951-2. PMID: 10753127.
      View in: PubMed
    938. Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J. 2000 Apr; 139(4):609-17. PMID: 10740141.
      View in: PubMed
    939. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology. 2000 Apr; 55(4):477-80. PMID: 10736486.
      View in: PubMed
    940. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int. 2000 Mar; 57(3):1100-6. PMID: 10720962.
      View in: PubMed
    941. Evans C, Chalmers J, Capewell S, Redpath A, Finlayson A, Boyd J, Pell J, McMurray J, Macintyre K, Graham L. "I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ. 2000 Jan 22; 320(7229):218-9. PMID: 10642230.
      View in: PubMed
    942. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. Urology. 2000 Jan; 55(1):109-13. PMID: 10654905.
      View in: PubMed
    943. Petrie MC, Hillier C, Morton JJ, McMurray JJ. Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens. 2000 Jan; 18(1):61-4. PMID: 10678544.
      View in: PubMed
    944. McMurray J. Digoxin and heart failure. Lancet. 2000 Jan 01; 355(9197):69-70. PMID: 10615915.
      View in: PubMed
    945. Love MP, Haynes WG, Webb DJ, McMurray JJ. Venous endothelin receptor function in patients with chronic heart failure. Clin Sci (Lond). 2000 Jan; 98(1):65-70. PMID: 10600660.
      View in: PubMed
    946. Berry C, McMurray JJ. Elevated serum and monocyte tumour necrosis factor alpha in patients with congestive heart failure. Int J Cardiol. 1999 Dec 01; 71(3):263-4. PMID: 10636533.
      View in: PubMed
    947. McMurray JJ. Future management of heart failure. Heart. 1999 Dec; 82 Suppl 4:IV1. PMID: 10574901.
      View in: PubMed
    948. McMurray JJ. Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999 Dec; 82 Suppl 4:IV14-22. PMID: 10574906.
      View in: PubMed
    949. Hillier C, Cowburn PJ, Morton JJ, Dargie HJ, Cleland JG, McMurray JJ, McGrath JC. Structural and functional assessment of small arteries in patients with chronic heart failure. Clin Sci (Lond). 1999 Dec; 97(6):671-9. PMID: 10585894.
      View in: PubMed
    950. Konrad TR, Williams ES, Linzer M, McMurray J, Pathman DE, Gerrity M, Schwartz MD, Scheckler WE, Van Kirk J, Rhodes E, Douglas J. Measuring physician job satisfaction in a changing workplace and a challenging environment. SGIM Career Satisfaction Study Group. Society of General Internal Medicine. Med Care. 1999 Nov; 37(11):1174-82. PMID: 10549620.
      View in: PubMed
    951. Murdoch DR, McMurray JJ. Cardiac cachexia--lean and mean. Eur Heart J. 1999 Nov; 20(22):1609-11. PMID: 10543919.
      View in: PubMed
    952. Williams ES, Konrad TR, Linzer M, McMurray J, Pathman DE, Gerrity M, Schwartz MD, Scheckler WE, Van Kirk J, Rhodes E, Douglas J. Refining the measurement of physician job satisfaction: results from the Physician Worklife Survey. SGIM Career Satisfaction Study Group. Society of General Internal Medicine. Med Care. 1999 Nov; 37(11):1140-54. PMID: 10549616.
      View in: PubMed
    953. Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, Dargie H. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999 Nov; 116(5):1208-17. PMID: 10559077.
      View in: PubMed
    954. Bousquet B, Brombacher PJ, Zérah S, Beastall GH, Blaton V, Charret J, Gurr E, Halpern M, Jansen RT, Kenny D, Kohse KP, Köller U, Lund E, McMurray J, Opp M, Parviainen M, Pazzagli M, Queraltó JM, Sotiropoulou G, Sanders GT. EC4 European syllabus for post-graduate training in clinical chemistry. Version 2--1999. European Communities Confederation of Clinical Chemistry, EC4 Register Commission. Clin Chem Lab Med. 1999 Nov-Dec; 37(11-12):1119-27. PMID: 10726821.
      View in: PubMed
    955. McMurray J. The health economics of the treatment of hyperlipidemia and hypertension. Am J Hypertens. 1999 Oct; 12(10 Pt 2):99S-104S. PMID: 10555609.
      View in: PubMed
    956. Capewell S, Pell JP, Morrison C, McMurray J. Increasing the impact of cardiological treatments. How best to reduce deaths. Eur Heart J. 1999 Oct; 20(19):1386-92. PMID: 10487799.
      View in: PubMed
    957. Davie AP, McMurray JJ. Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor. Hypertension. 1999 Sep; 34(3):457-60. PMID: 10489393.
      View in: PubMed
    958. Berry C, McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics. 1999 Sep; 16(3):247-71. PMID: 10558038.
      View in: PubMed
    959. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart. 1999 Sep; 82(3):352-6. PMID: 10455089.
      View in: PubMed
    960. Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, Olofsson B, Ostergren J, Yusuf S. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. J Card Fail. 1999 Sep; 5(3):276-82. PMID: 10496201.
      View in: PubMed
    961. Bart BA, Ertl G, Held P, Kuch J, Maggioni AP, McMurray J, Michelson EL, Rouleau JL, Warner Stevenson L, Swedberg K, Young JB, Yusuf S, Sellers MA, Granger CB, Califf RM, Pfeffer MA. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J. 1999 Aug; 20(16):1182-90. PMID: 10448027.
      View in: PubMed
    962. Darnley GM, Gray AC, McClure SJ, Neary P, Petrie M, McMurray JJ, MacFarlane NG. Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease. Eur J Heart Fail. 1999 Aug; 1(3):297-300. PMID: 10935679.
      View in: PubMed
    963. Davie AP, Dargie HJ, McMurray JJ. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure. Circulation. 1999 Jul 20; 100(3):268-73. PMID: 10411851.
      View in: PubMed
    964. Davie A, McMurray J. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. Circulation. 1999 Jun 08; 99(22):2966; author reply 2966-7. PMID: 10359745.
      View in: PubMed
    965. McMurray J. Transmyocardial laser revascularisation. Lancet. 1999 May 15; 353(9165):1704; author reply 1706-7. PMID: 10335808.
      View in: PubMed
    966. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJ. Failure of women's hearts. Circulation. 1999 May 04; 99(17):2334-41. PMID: 10226101.
      View in: PubMed
    967. Ramdas L, Obeyesekere NU, Sun G, McMurray JS, Budde RJ. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor. J Pept Res. 1999 May; 53(5):569-77. PMID: 10424353.
      View in: PubMed
    968. Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, Dargie HJ, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension. 1999 May; 33(5):1169-74. PMID: 10334806.
      View in: PubMed
    969. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999 Apr; 81(4):380-6. PMID: 10092564.
      View in: PubMed
    970. Davie AP, McMurray JJ. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad Med J. 1999 Apr; 75(882):219-2. PMID: 10715761.
      View in: PubMed
    971. Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, McMurray JJ, Dargie HJ, Morton JJ. Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 1999 Mar 15; 33(4):932-8. PMID: 10091818.
      View in: PubMed
    972. Davie AP, Morrison CE, Forrester JE, Mcmurray JJ. Prescribing and emergency admissions for heart failure in greater Glasgow. J Card Fail. 1999 Mar; 5(1):3-7. PMID: 10194654.
      View in: PubMed
    973. Caruana L, Davie AP, Petrie M, McMurray J. Diagnosing heart failure. Eur Heart J. 1999 Mar; 20(5):393. PMID: 10206386.
      View in: PubMed
    974. Bonnar CE, Davie AP, Caruana L, Fenn L, Ogston SA, McMurray JJ, Struthers AD. QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. Heart. 1999 Mar; 81(3):297-302. PMID: 10026356.
      View in: PubMed
    975. Petrie MC, McClure SJ, Love MP, McMurray JJ. Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1. Eur J Heart Fail. 1999 Mar; 1(1):25-9. PMID: 10937975.
      View in: PubMed
    976. Northridge DB, Currie PF, Newby DE, McMurray JJ, Ford M, Boon NA, Dargie HJ. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure. Eur J Heart Fail. 1999 Mar; 1(1):67-72. PMID: 10937982.
      View in: PubMed
    977. McMurray J. Communicating risk reductions. Data were selectively used. BMJ. 1999 Feb 27; 318(7183):602; author reply 603-4. PMID: 10037654.
      View in: PubMed
    978. Bonewald LF, Bibbs L, Kates SA, Khatri A, McMurray JS, Medzihradszky KF, Weintraub ST. Study on the synthesis and characterization of peptides containing phosphorylated tyrosine. J Pept Res. 1999 Feb; 53(2):161-9. PMID: 10195453.
      View in: PubMed
    979. Morris ST, McMurray JJ, Rodger RS, Briggs JD, Jardine AG. Impaired vascular responsiveness to nitric oxide in renal transplant recipients. Transplant Proc. 1999 Feb-Mar; 31(1-2):304-5. PMID: 10083118.
      View in: PubMed
    980. Schilling B, Wang W, McMurray JS, Medzihradszky KF. Fragmentation and sequencing of cyclic peptides by matrix-assisted laser desorption/ionization post-source decay mass spectrometry. Rapid Commun Mass Spectrom. 1999; 13(21):2174-9. PMID: 10523777.
      View in: PubMed
    981. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J. 1998 Dec; 19 Suppl P:P9-16. PMID: 9886707.
      View in: PubMed
    982. Murdoch DR, Love MP, Robb SD, McDonagh TA, Davie AP, Ford I, Capewell S, Morrison CE, McMurray JJ. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart J. 1998 Dec; 19(12):1829-35. PMID: 9886726.
      View in: PubMed
    983. McMurray JJ, Stewart S. Nurse led, multidisciplinary intervention in chronic heart failure. Heart. 1998 Nov; 80(5):430-1. PMID: 9930038.
      View in: PubMed
    984. McMurray JJ. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J. 1998 Oct; 19 Suppl L:L15-21. PMID: 9821004.
      View in: PubMed
    985. Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, Dargie HJ, McMurray JJ, Morton JJ. Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction. Cardiovasc Res. 1998 Sep; 39(3):563-70. PMID: 9861298.
      View in: PubMed
    986. McClure SJ, Caruana L, Davie AP, Goldthorp S, McMurray JJ. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ. 1998 Aug 22; 317(7157):516-9. PMID: 9712601.
      View in: PubMed
    987. Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, McMurray JJ, Dargie HJ. Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure. Lancet. 1998 Jul 18; 352(9123):201-2. PMID: 9683214.
      View in: PubMed
    988. McMurray JS, Budde RJ, Ke S, Obeyesekere NU, Wang W, Ramdas L, Lewis CA. Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src. Arch Biochem Biophys. 1998 Jul 01; 355(1):124-30. PMID: 9647675.
      View in: PubMed
    989. Davie AP, Caesar D, Caruana L, Clegg G, Spiller J, Capewell S, Starkey IR, Shaw TR, McMurray JJ. Outcome from a rapid-assessment chest pain clinic. QJM. 1998 May; 91(5):339-43. PMID: 9709467.
      View in: PubMed
    990. Grant S, McMurray J, Aitchison T, McDonagh T, Christie J, Davie A, Dargie HJ. The reproducibility of symptoms during a submaximal exercise test in chronic heart failure. Br J Clin Pharmacol. 1998 Mar; 45(3):287-90. PMID: 9517373.
      View in: PubMed
    991. McMurray J, Davie AP, McClure SJ. Assessment of heart failure with plasma natriuretic peptides. Lancet. 1998 Feb 07; 351(9100):444; author reply 445. PMID: 9482327.
      View in: PubMed
    992. Murdoch DR, McMurray JJ. ACE inhibitors in acute myocardial infarction. Hosp Med. 1998 Feb; 59(2):111-5. PMID: 9797884.
      View in: PubMed
    993. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998 Jan 03; 351(9095):9-13. PMID: 9433422.
      View in: PubMed
    994. Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, McMurray JJ, Dargie HJ. Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction. J Cardiovasc Pharmacol. 1998; 31 Suppl 1:S290-3. PMID: 9595462.
      View in: PubMed
    995. McMurray JS. The use of polyacrylamide-based peptide synthesis resins for the generation of antipeptide antibodies. Biopolymers. 1998; 47(5):405-11. PMID: 9973868.
      View in: PubMed
    996. Caro J, Klittich W, McGuire A, Ford I, Norrie J, Pettitt D, McMurray J, Shepherd J. The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ. 1997 Dec 13; 315(7122):1577-82. PMID: 9437275.
      View in: PubMed
    997. McMurray J, McGuire A, Raikou M, Morrison C. Use of statins. Glasgow has already produced strategy for treatment. BMJ. 1997 Dec 13; 315(7122):1617-8. PMID: 9437292.
      View in: PubMed
    998. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, Ford I, McMurray JJ, Dargie HJ. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart. 1997 Dec; 78(6):594-7. PMID: 9470878.
      View in: PubMed
    999. Clark AL, Galloway S, MacFarlane N, Henderson E, Aitchison T, McMurray JJ. Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans. Eur Heart J. 1997 Nov; 18(11):1829-33. PMID: 9402459.
      View in: PubMed
    1000. McMurray J, Morrison C. Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. Heart. 1997 Oct; 78(4):421-2. PMID: 9404265.
      View in: PubMed
    1001. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997 Sep 20; 350(9081):829-33. PMID: 9310600.
      View in: PubMed
    1002. Davie A, McMurray J. Investigation of left ventricular dysfunction in acute dyspnoea. A 100% sensitivity would be difficult to achieve. BMJ. 1997 Sep 06; 315(7108):604. PMID: 9302973.
      View in: PubMed
    1003. Morrison C, McMurray JJ. Heart failure: the Cinderella of cardiology? Public Health. 1997 Sep; 111(5):351-4. PMID: 9308386.
      View in: PubMed
    1004. McMurray JJ, McGuire A, Davie AP, Hughes D. Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction. Eur Heart J. 1997 Sep; 18(9):1411-5. PMID: 9458446.
      View in: PubMed
    1005. McMurray J, Davie AP. Digoxin for patients with heart failure in sinus rhythm. Lancet. 1997 Aug 16; 350(9076):519. PMID: 9274604.
      View in: PubMed
    1006. McDonagh TA, Woodward M, Morrison CE, McMurray JJ, Tunstall-Pedoe H, Lowe GD, McColl KE, Dargie HJ. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J. 1997 Aug; 18(8):1257-60. PMID: 9458417.
      View in: PubMed
    1007. Hummel S, Piercy J, Wright R, Davie A, Bagust A, McMurray J. An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom. Pharmacoeconomics. 1997 Aug; 12(2 Pt 1):182-92. PMID: 10169670.
      View in: PubMed
    1008. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. Eur Heart J. 1997 Jun; 18(6):981-4. PMID: 9183590.
      View in: PubMed
    1009. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. Assessing diagnosis in heart failure: which features are any use? QJM. 1997 May; 90(5):335-9. PMID: 9205668.
      View in: PubMed
    1010. Morrison C, McMurray J. Lipid-lowering strategies for the prevention of coronary heart disease. Clin Sci (Lond). 1997 Apr; 92(4):431-2. PMID: 9176044.
      View in: PubMed
    1011. McMurray J, Murdoch D. Calcium-antagonist controversy: the long and short of it? Lancet. 1997 Mar 01; 349(9052):585-6. PMID: 9057725.
      View in: PubMed
    1012. Love MP, McMurray JJ. Endothelin in heart failure: a promising therapeutic target? Heart. 1997 Feb; 77(2):93-4. PMID: 9068384.
      View in: PubMed
    1013. Nishi T, Budde RJ, McMurray JS, Obeyesekere NU, Safdar N, Levin VA, Saya H. Tight-binding inhibitory sequences against pp60(c-src) identified using a random 15-amino-acid peptide library. FEBS Lett. 1996 Dec 16; 399(3):237-40. PMID: 8985153.
      View in: PubMed
    1014. Murdoch DR, Byrne J, McDonagh T, Morton JJ, McMurray JJ. Measurement of brain natriuretic peptide. Lancet. 1996 Dec 07; 348(9041):1589. PMID: 8950904.
      View in: PubMed
    1015. Davie A, McMurray J. Open-access echocardiography. Lancet. 1996 Nov 16; 348(9038):1387-8. PMID: 8918303.
      View in: PubMed
    1016. McMurray JJ, Morrison CE. Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment. BMJ. 1996 Nov 02; 313(7065):1142; author reply 1144. PMID: 8916707.
      View in: PubMed
    1017. Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996 Nov 01; 94(9):2131-7. PMID: 8901663.
      View in: PubMed
    1018. Sparrow JT, Knieb-Cordonier NG, Obeyseskere NU, McMurray JS. Large-pore polydimethylacrylamide resin for solid-phase peptide synthesis: applications in Fmoc chemistry. Pept Res. 1996 Nov-Dec; 9(6):297-304. PMID: 9048423.
      View in: PubMed
    1019. Davie AP, Love MP, McMurray JJ. Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. BMJ. 1996 Aug 03; 313(7052):300-1. PMID: 8704562.
      View in: PubMed
    1020. Davie AP, McMurray JJ. Cost-benefit analysis of lipid lowering therapy. Eur Heart J. 1996 Jul; 17(7):974-5. PMID: 8809507.
      View in: PubMed
    1021. Laycock SK, Kane KA, McMurray J, Parratt JR. Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats. J Cardiovasc Pharmacol. 1996 May; 27(5):667-72. PMID: 8859936.
      View in: PubMed
    1022. Davie AP, McMurray JJ. Economic aspects of treatment with captopril after MI. Eur Heart J. 1996 May; 17(5):648-50. PMID: 8737090.
      View in: PubMed
    1023. Love MP, McMurray JJ. Endothelin in chronic heart failure: current position and future prospects. Cardiovasc Res. 1996 May; 31(5):665-74. PMID: 8763394.
      View in: PubMed
    1024. Dargie HJ, McMurray JJ, McDonagh TA. Heart failure--implications of the true size of the problem. J Intern Med. 1996 Apr; 239(4):309-15. PMID: 8774385.
      View in: PubMed
    1025. McMurray J, Davie A. The pharmacoeconomics of ACE inhibitors in chronic heart failure. Pharmacoeconomics. 1996 Mar; 9(3):188-97. PMID: 10160096.
      View in: PubMed
    1026. Ramdas L, Obeyesekere NU, McMurray JS, Budde RJ. A synthetic peptidic substrate of minimal size and semioptimal sequence for the protein tyrosine kinase pp60c-src. Arch Biochem Biophys. 1996 Feb 01; 326(1):73-8. PMID: 8579374.
      View in: PubMed
    1027. Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, Sutherland GR, McMurray JJ. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ. 1996 Jan 27; 312(7025):222. PMID: 8563589.
      View in: PubMed
    1028. Love MP, McMurray JJ. Endothelin in congestive heart failure. Basic Res Cardiol. 1996; 91 Suppl 1:21-9. PMID: 8896740.
      View in: PubMed
    1029. Ramdas L, Obeyesekere NU, McMurray JS, Gallick GE, Seifert WE, Budde RJ. A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization. Arch Biochem Biophys. 1995 Nov 10; 323(2):237-42. PMID: 7487083.
      View in: PubMed
    1030. Laycock SK, McMurray J, Kane KA, Parratt JR. Effects of chronic norepinephrine administration on cardiac function in rats. J Cardiovasc Pharmacol. 1995 Oct; 26(4):584-9. PMID: 8569219.
      View in: PubMed
    1031. McMurray J. Stents versus angioplasty. Lancet. 1995 Aug 05; 346(8971):383. PMID: 7662023.
      View in: PubMed
    1032. McMurray J. Dosage of angiotensin converting enzyme inhibitors. BMJ. 1995 Jul 01; 311(6996):59. PMID: 7613346.
      View in: PubMed
    1033. Clapperton M, Beswick PH, Abdullah I, Dargie HJ, Fisher AC, McMurray J. Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils. Br J Clin Pharmacol. 1995 Jul; 40(1):31-5. PMID: 8527265.
      View in: PubMed
    1034. Clapperton M, McMurray J, Fisher AC, Dargie HJ. Does luminol chemiluminescence detect free radical scavengers? Br J Clin Pharmacol. 1995 Jun; 39(6):688-91. PMID: 7654490.
      View in: PubMed
    1035. Budde RJ, Obeyesekere NU, Ke S, McMurray JS. Use of synthetic peptides and copolymers to study the substrate specificity and inhibition of the protein tyrosine kinase pp60c-src. Biochim Biophys Acta. 1995 Apr 05; 1248(1):50-6. PMID: 7536039.
      View in: PubMed
    1036. Davie AP, McMurray JJ. ACE inhibitors and health-care economics. Coron Artery Dis. 1995 Apr; 6(4):315-9. PMID: 7655715.
      View in: PubMed
    1037. Francis CM, Caruana L, Kearney P, Love M, Sutherland GR, Starkey IR, Shaw TR, McMurray JJ. Open access echocardiography in management of heart failure in the community. BMJ. 1995 Mar 11; 310(6980):634-6. PMID: 7503841.
      View in: PubMed
    1038. Nishioka K, Obeyesekere NU, McMurray JS. Enhanced phagocytosis activity of cyclic analogs of tuftsin. Biochem Pharmacol. 1995 Mar 01; 49(5):735-8. PMID: 7887989.
      View in: PubMed
    1039. Jackson DC, Fitzmaurice C, Sheppard RC, McMurray J, Brown LE. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers. Biomed Pept Proteins Nucleic Acids. 1995; 1(3):171-6. PMID: 9346849.
      View in: PubMed
    1040. McMurray J, Rankin A. Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias. BMJ. 1994 Dec 17; 309(6969):1631-5. PMID: 7819948.
      View in: PubMed
    1041. McMurray J, Slattery J. Scandinavian simvastatin study (4S) Lancet. 1994 Dec 24-31; 344(8939-8940):1765-6; author reply 1767-8. PMID: 7997012.
      View in: PubMed
    1042. McMurray J, Rankin A. Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ. 1994 Nov 19; 309(6965):1343-50. PMID: 7866084.
      View in: PubMed
    1043. Webb DJ, McMurray JJ. Enhanced basal nitric oxide production in heart failure. Lancet. 1994 Sep 24; 344(8926):887; author reply 888. PMID: 7993474.
      View in: PubMed
    1044. McMurray J. ACE inhibitors after myocardial infarction. Lancet. 1994 Aug 13; 344(8920):475-6. PMID: 7914584.
      View in: PubMed
    1045. Clapperton M, McMurray J, Fisher AC, Dargie HJ. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro. Br J Clin Pharmacol. 1994 Jul; 38(1):53-6. PMID: 7946937.
      View in: PubMed
    1046. Russell J, Ness J, Chopra M, McMurray J, Smith WE. The assessment of the HO. scavenging action of therapeutic agents. J Pharm Biomed Anal. 1994 Jul; 12(7):863-6. PMID: 7981313.
      View in: PubMed
    1047. McMurray JS, Lewis CA, Obeyesekere NU. Influence of solid support, solvent and coupling reagent on the head-to-tail cyclization of resin-bound peptides. Pept Res. 1994 Jul-Aug; 7(4):195-206. PMID: 7696839.
      View in: PubMed
    1048. Russell J, Spickett CM, Reglinski J, Smith WE, McMurray J, Abdullah IB. Alteration of the erythrocyte glutathione redox balance by N-acetylcysteine, captopril and exogenous glutathione. FEBS Lett. 1994 Jun 27; 347(2-3):215-20. PMID: 8034006.
      View in: PubMed
    1049. Ramdas L, McMurray JS, Budde RJ. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability. Cancer Res. 1994 Feb 15; 54(4):867-9. PMID: 7508821.
      View in: PubMed
    1050. Obeyesekere NU, La Croix JN, Budde RJ, Dyckes DF, McMurray JS. Solid-phase synthesis of (tyrosyl-alanyl-glutamyl)n by segment condensation. Int J Pept Protein Res. 1994 Feb; 43(2):118-26. PMID: 8200729.
      View in: PubMed
    1051. Dargie HJ, McMurray JJ. Diagnosis and management of heart failure. BMJ. 1994 Jan 29; 308(6924):321-8. PMID: 7907244.
      View in: PubMed
    1052. McMurray J, Francis M. Problems solved and lives saved? Chronic heart failure. Br J Clin Pract. 1994 Jan-Feb; 48(1):29-36. PMID: 8179979.
      View in: PubMed
    1053. Godfrey EG, Stewart J, Dargie HJ, Reid JL, Dominiczak M, Hamilton CA, McMurray J. Effects of ACE inhibitors on oxidation of human low density lipoprotein. Br J Clin Pharmacol. 1994 Jan; 37(1):63-6. PMID: 8148219.
      View in: PubMed
    1054. McMurray J. ACE inhibitors after myocardial infarction. Lancet. 1993 Dec 04; 342(8884):1418. PMID: 7901693.
      View in: PubMed
    1055. Dowell FJ, Hamilton CA, McMurray J, Reid JL. Effects of a xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit aortic rings. J Cardiovasc Pharmacol. 1993 Dec; 22(6):792-7. PMID: 7509895.
      View in: PubMed
    1056. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J. 1993 Nov; 14(11):1493-8. PMID: 8299631.
      View in: PubMed
    1057. McLay JS, McMurray JJ, Bridges AB, Fraser CG, Struthers AD. Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. Am Heart J. 1993 Oct; 126(4):879-86. PMID: 8213445.
      View in: PubMed
    1058. Laycock SK, McMurray J, Kane KA, Parratt JR. Effects of the xanthine oxidase system on cardiac function in anaesthetised rats. Free Radic Biol Med. 1993 Sep; 15(3):249-55. PMID: 8406124.
      View in: PubMed
    1059. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993 Sep; 14(9):1158-62. PMID: 8223728.
      View in: PubMed
    1060. McMurray JS, Budde RJ, Dyckes DF. Cyclic peptide substrates of pp60c-src. Synthesis and evaluation. Int J Pept Protein Res. 1993 Sep; 42(3):209-15. PMID: 7693604.
      View in: PubMed
    1061. McMurray J, Dargie HJ. ACE inhibitors for myocardial infarction and unstable angina. Lancet. 1992 Dec 19-26; 340(8834-8835):1547-8. PMID: 1361633.
      View in: PubMed
    1062. McLay JS, McMurray J, Bridges A, Struthers AD. Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed? Eur Heart J. 1992 Nov; 13(11):1521-7. PMID: 1464341.
      View in: PubMed
    1063. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence for oxidative stress in unstable angina. Br Heart J. 1992 Nov; 68(5):454-7. PMID: 1467028.
      View in: PubMed
    1064. Garner M, Reglinski J, Smith WE, McMurray J. Oxidation state of glutathione in the erythrocyte. Clin Sci (Lond). 1992 Nov; 83(5):637. PMID: 1335404.
      View in: PubMed
    1065. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin is not extracted by the pulmonary circulation in man. Chest. 1992 Oct; 102(4):1143-4. PMID: 1395757.
      View in: PubMed
    1066. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischaemic syndromes. Br Heart J. 1992 May; 67(5):383-6. PMID: 1389718.
      View in: PubMed
    1067. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992 Apr; 85(4):1374-9. PMID: 1532540.
      View in: PubMed
    1068. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol. 1992 Mar; 19(3):330-40. PMID: 1378110.
      View in: PubMed
    1069. McMurray J, McInnes GT. The J-curve hypothesis. Lancet. 1992 Feb 29; 339(8792):561-2. PMID: 1346917.
      View in: PubMed
    1070. Budde RJ, McMurray JS, Tinker DA. An assay for acidic peptide substrates of protein kinases. Anal Biochem. 1992 Feb 01; 200(2):347-51. PMID: 1378706.
      View in: PubMed
    1071. Tinker DA, Cartron JL, McMurray JS, Levin VA. Influence of acidic residues on substrate specificity of oncogene products pp60v-src and p56lck in vitro. Anticancer Res. 1992 Jan-Feb; 12(1):123-7. PMID: 1567157.
      View in: PubMed
    1072. McMurray J, Chopra M. Response to editorial on antioxidant therapy for chronic heart failure. J Intern Med. 1992 Jan; 231(1):91; author reply 91-2. PMID: 1732407.
      View in: PubMed
    1073. McMurray J, Dargie HJ. Coronary heart disease. BMJ. 1991 Dec 14; 303(6816):1546-7. PMID: 1843459.
      View in: PubMed
    1074. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J. 1991 Nov; 66(5):356-8. PMID: 1747295.
      View in: PubMed
    1075. MacFarlane N, McMurray J, O'Dowd JJ, Dargie HJ, Miller DJ. Synergism of histidyl dipeptides as antioxidants. J Mol Cell Cardiol. 1991 Nov; 23(11):1205-7. PMID: 1803015.
      View in: PubMed
    1076. Lang CC, McMurray JJ, Moyses C, Struthers AD. Comparison of the effects of ANF 99-126 and ANF 103-126 on captopril-induced renin release in man. Clin Endocrinol (Oxf). 1991 Jun; 34(6):493-9. PMID: 1832344.
      View in: PubMed
    1077. McMurray J, Lang CC, MacLean D, Struthers AD, McDevitt DG. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course. Int J Cardiol. 1991 Jun; 31(3):295-303. PMID: 1679047.
      View in: PubMed
    1078. McMurray J, MacLenachan J, Dargie HJ. Unique cardioprotective potential of angiotensin converting enzyme inhibitors: a hypothesis still to be tested on humans. J Hypertens. 1991 May; 9(5):393-7. PMID: 1677371.
      View in: PubMed
    1079. Northridge DB, McMurray J, Dargie HJ. Atrial natriuretic factor in chronic heart failure. Herz. 1991 Apr; 16(2):92-101. PMID: 1829707.
      View in: PubMed
    1080. McMurray J, Chopra M. Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope? Br J Clin Pharmacol. 1991 Apr; 31(4):373-9. PMID: 2049244.
      View in: PubMed
    1081. Chopra M, McMurray J, Stewart J, Dargie HJ, Smith WE. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors. Biochem Soc Trans. 1990 Dec; 18(6):1184-5. PMID: 2088853.
      View in: PubMed
    1082. Northridge DB, Grant S, Ford I, Christie J, McLenachan J, Connelly D, McMurray J, Ray S, Henderson E, Dargie HJ. Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. Br Heart J. 1990 Nov; 64(5):313-6. PMID: 2245110.
      View in: PubMed
    1083. McMurray JJ, Lang CC, MacLean D, McDevitt DG, Struthers AD. Neuroendocrine changes post myocardial infarction: effects of xamoterol. Am Heart J. 1990 Jul; 120(1):56-62. PMID: 1972861.
      View in: PubMed
    1084. McMurray J, McLay J, Chopra M, Bridges A, Belch JJ. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1990 May 15; 65(18):1261-2. PMID: 2337039.
      View in: PubMed
    1085. Chopra M, McMurray J, McLay J, Bridges A, Scott N, Smith WE, Belch JJ. Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging? Adv Exp Med Biol. 1990; 264:251-5. PMID: 2244503.
      View in: PubMed
    1086. Northridge DB, McMurray J, Ray S, Jardine A, Dargie HJ. Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion. BMJ. 1989 Sep 02; 299(6699):603-4. PMID: 2529936.
      View in: PubMed
    1087. McMurray J. ABC of child abuse. Case conferences. BMJ. 1989 Aug 19; 299(6697):500-2. PMID: 2507037.
      View in: PubMed
    1088. McMurray J, McFarlane L, Coutie W, Balfour D, Struthers A. Atrial natriuretic factor attenuates prostaglandin E2-stimulated plasma renin activity in humans. J Cardiovasc Pharmacol. 1989 Aug; 14(2):326-30. PMID: 2476609.
      View in: PubMed
    1089. Seidelin PH, McMurray JJ, Struthers AD. Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man. Clin Sci (Lond). 1989 Jun; 76(6):653-8. PMID: 2736884.
      View in: PubMed
    1090. Lipworth BJ, McMurray JJ, Clark RA, Struthers AD. Development of persistent late onset asthma following treatment with captopril. Eur Respir J. 1989 Jun; 2(6):586-8. PMID: 2663536.
      View in: PubMed
    1091. Seidelin PH, McMurray JJ, Brown RA, Struthers AD. The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man. Br J Clin Pharmacol. 1989 Jun; 27(6):803-9. PMID: 2757896.
      View in: PubMed
    1092. McMurray J, Lang CC, Maclean DD, McDevitt DG, Struthers AD. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure. Scott Med J. 1989 Apr; 34(2):425-7. PMID: 2740888.
      View in: PubMed
    1093. Chopra M, Scott N, McMurray J, McLay J, Bridges A, Smith WE, Belch JJ. Captopril: a free radical scavenger. Br J Clin Pharmacol. 1989 Mar; 27(3):396-9. PMID: 2655686.
      View in: PubMed
    1094. McMurray J, Struthers AD. Sympathoadrenal responses during bradycardia-hypotension associated with combined infusion of atrial natriuretic factor and prostaglandin E2. J Hum Hypertens. 1989 Feb; 3(1):61-3. PMID: 2524591.
      View in: PubMed
    1095. Seidelin PH, McMurray JJ, Stolarek IH, Robertson CE. The basic and advanced cardiopulmonary resuscitation skills of trained hospital nursing staff. Scott Med J. 1989 Feb; 34(1):393-4. PMID: 2711170.
      View in: PubMed
    1096. McMurray JJ, Struthers AD. Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humans. Hypertension. 1989 Jan; 13(1):9-14. PMID: 2521333.
      View in: PubMed
    1097. McMurray JJ, Seidelin PH, Brown RA, Struthers AD. Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man. Br J Clin Pharmacol. 1989 Jan; 27(1):7-12. PMID: 2523228.
      View in: PubMed
    1098. Lewis RV, McMurray J, McDevitt DG. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol. 1989 Jan; 13(1):1-6. PMID: 2468920.
      View in: PubMed
    1099. McMurray J, Seidelin PH, Struthers AD. Evidence for a proximal and distal nephron action of atrial natriuretic factor in man. Nephron. 1989; 51(1):39-43. PMID: 2521696.
      View in: PubMed
    1100. McMurray J, Forsling ML, Struthers AD. Arginine vasopressin dissociates the diuresis and natriuresis due to atrial natriuretic factor in man. Eur J Clin Invest. 1988 Dec; 18(6):627-32. PMID: 2975995.
      View in: PubMed
    1101. McMurray J, Seidelin PH, Howey JE, Balfour DJ, Struthers AD. The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man. J Hypertens. 1988 Oct; 6(10):783-6. PMID: 2974052.
      View in: PubMed
    1102. McMurray JJ, Seidelin PH, Balfour DJ, Struthers AD. Physiological increases in circulating noradrenaline are antinatriuretic in man. J Hypertens. 1988 Sep; 6(9):757-61. PMID: 3183378.
      View in: PubMed
    1103. McMurray J, Struthers AD. The place of ACE inhibitors in the current treatment of chronic heart failure. Postgrad Med J. 1988 Sep; 64(755):653-5. PMID: 3075041.
      View in: PubMed
    1104. McMurray J, Struthers AD. Significance of atrial natriuretic factor in chronic heart failure. Br J Hosp Med. 1988 Jul; 40(1):55-7. PMID: 2971411.
      View in: PubMed
    1105. McMurray J, Struthers AD. Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in man. Clin Sci (Lond). 1988 Apr; 74(4):419-25. PMID: 2965633.
      View in: PubMed
    1106. McMurray JJ, Struthers AD. Captopril in patients with ileus. Lancet. 1988 Feb 27; 1(8583):471. PMID: 2893888.
      View in: PubMed
    1107. McMurray J, Struthers AD. Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man. Eur J Clin Pharmacol. 1988; 35(4):333-8. PMID: 2973989.
      View in: PubMed
    1108. McMurray J, Coutie WJ, McFarlane L, Struthers AD. Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man. Eur J Clin Pharmacol. 1988; 35(4):409-12. PMID: 2848707.
      View in: PubMed
    1109. McMurray JJ, Struthers AD. Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man. J Hypertens Suppl. 1987 Dec; 5(5):S59-62. PMID: 2965232.
      View in: PubMed
    1110. McMurray JJ, Northridge DB, Abernethy VA, Lawson AA. Trends in analgesic self-poisoning in West-Fife, 1971-1985. Q J Med. 1987 Oct; 65(246):835-43. PMID: 3449888.
      View in: PubMed
    1111. McMurray J, Struthers AD. The role of neuroendocrine abnormalities in the enhanced sodium and water retention of chronic heart failure. Pharmacol Toxicol. 1987 Oct; 61(4):209-14. PMID: 3324091.
      View in: PubMed
    1112. McMurray JJ, Fraser DM, Brogan O. Fatal Streptococcus pyogenes pneumonia. J R Soc Med. 1987 Aug; 80(8):525-6. PMID: 3309306.
      View in: PubMed
    1113. McMurray J, Matthews DM. Consequences of fluid loss in patients treated with ACE inhibitors. Postgrad Med J. 1987 May; 63(739):385-7. PMID: 2823245.
      View in: PubMed
    1114. Lawson A, McMurray J, Northridge DB. Association between liberalization of Scotland's liquor licensing laws and admissions for self poisoning. Br Med J (Clin Res Ed). 1987 Feb 07; 294(6568):371-2. PMID: 3101883.
      View in: PubMed
    1115. Northridge DB, McMurray J, Lawson AA. Association between liberalization of Scotland's liquor licensing laws and admissions for self poisoning in West Fife. Br Med J (Clin Res Ed). 1986 Dec 06; 293(6560):1466-8. PMID: 3099914.
      View in: PubMed
    1116. McMurray J, Matthews DM. Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure. Br Heart J. 1986 Nov; 56(5):490. PMID: 18610332.
      View in: PubMed
    1117. McMurray J, Fraser DM. Pneumonia. Postgrad Med J. 1986 Sep; 62(731):895. PMID: 3543914.
      View in: PubMed
    1118. McMurray J, Bloomfield P, Miller HC. Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J (Clin Res Ed). 1986 Jul 05; 293(6538):51-2. PMID: 3089403.
      View in: PubMed
    1119. McMurray J, Fraser DM. Captopril, enalapril, and blood glucose. Lancet. 1986 May 03; 1(8488):1035. PMID: 2871313.
      View in: PubMed
    1120. McMurray JS, Dyckes DF. Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones. Biochemistry. 1986 Apr 22; 25(8):2298-301. PMID: 3518799.
      View in: PubMed
    1121. McMurray J, Bloomfield P, Miller HC. Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J (Clin Res Ed). 1986 Jan 25; 292(6515):239-40. PMID: 3081088.
      View in: PubMed
    1122. Puxty JA, Haskew AE, Ratcliffe JG, McMurray J. Changes in erythrocyte transketolase activity and the thiamine pyrophosphate effect during storage of blood. Ann Clin Biochem. 1985 Jul; 22 ( Pt 4):423-7. PMID: 4037670.
      View in: PubMed
    1123. McMurray J, Matthews DM. Effect of diarrhoea on a patient taking captopril. Lancet. 1985 Mar 09; 1(8428):581. PMID: 2857931.
      View in: PubMed
    1124. Heckmatt JZ, Peacock M, Davies AE, McMurray J, Isherwood DM. Plasma 25-hydroxyvitamin D in pregnant Asian women and their babies. Lancet. 1979 Sep 15; 2(8142):546-8. PMID: 89556.
      View in: PubMed
    1125. BRODRIBB HS, McMURRAY J, SCOTT LG. Two cases of diabetes mellitus in infants under 1 year. Br Med J. 1952 May 17; 1(4767):1060-1. PMID: 14925364.
      View in: PubMed
    1126. Auto dock-based incremental docking protocol to improve docking of large ligands. 48-55.
    1127. Tetrahedron Letters. 42:8409-8413.
    1128. Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.
    1129. A solubilisable polymer support suitable for solid phase peptide synthesis and for injection into experimental animals. Journal of the Chemical Society, Chemical Communications. 1025-1027.
    1130. Batf is important for IL-4 expression in T follicular helper cells. Nature Communications. 6.
    1131. On modeling peptidomimetics in complex with the SH2 domain of Stat3. 3229-3232.
    1132. STAT3 signaling in cancer. 216-267.
    1133. The synthesis of cyclic peptides using fmoc solid-phase chemistry and the linkage agent 4-(4-Hydroxymethyl-3-methoxyphenoxy)-butyric acid. Tetrahedron Letters. 34:8059-8062.
    1134. A simple and convenient method for the preparation of ketomethylene peptide analogues. Journal of Organic Chemistry. 50:1112-1115.
    1135. Discovery, development, and testing of substrates and inhibitors of pp60(c-src). International Journal of Pharmacognosy. 33:27-34.
    1136. A selective method for the preparation of primary amides. Tetrahedron Letters. 40:2501-2504.
    1137. Discovery, development, and testing of substrates and inhibitors of pp60c-SRC . Pharmaceutical Biology. 33:27-34.
    1138. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma. Oncotarget. 7:3461-3476.
    1139. Analysis of racemization during "Standard" solid phase peptide synthesis. Techniques in Protein Chemistry. 8:875-890.
    1140. Tuftsin and tuftsin analogs. Current Medicinal Chemistry. 3:153-166.
    1141. Formation of a disulfide bond in an octreotide-like peptide. Techniques in Protein Chemistry. 7:261-274.
    1142. Solid phase synthesis of a cyclic peptide using fmoc chemistry. Tetrahedron Letters. 32:7679-7682.
    1143. Convenient preparation of 4-(tetrazol-5-yl)-phenylalanine for use in Fmoc-based solid-phase peptide synthesis. Tetrahedron Letters. 41:6555-6558.
    1144. Structure-activity studies of phosphopeptidomimetic prodrugs targeting the src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3). International Journal of Peptide Research and Therapeutics. 19:3-12.
    1145. Tetrahedron Letters. 46:3715-3718.
    1146. Biochemical and cellular specificity of peptide inhibitors of g protein-coupled receptor kinases. International Journal of Peptide Research and Therapeutics. 20:1-12.
    1147. Solid phase synthesis of phosphopeptides incorporating 2,2- dimethyloxazolidine pseudoproline analogs. International Journal of Peptide Research and Therapeutics. 14:1-9.
    1148. Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones. Biochemistry. 25:2293-2298.
    1149. Long-acting beta agonists enhance allergic airway disease. PLoS One. 10.
    1150. Two-carbon ring expansion of β-lactams via N(1)-C(4) cleavage reactions. Tetrahedron Letters. 43:2491-2493.
    1151. Editorial. Biopolymers - Peptide Science Section. 60:1-2.
    1152. Stereospecific synthesis of 4-carboxyphenylalanine and derivatives for use in Fmoc-based solid-phase peptide synthesis. Tetrahedron Letters. 37:6661-6664.
    1153. Synthesis and in vitro evaluation of a peptidomimetic inhibitor targeting the Src Homology 2 (SH2) domain of STAT6. ACS Medicinal Chemistry Letters. 5:69-72.
    MCMURRAY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description